Archer-Daniels-Midland (ADM) 10-K 12 Mar 24 2023 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2023	Mar. 08, 2024	Jun. 30, 2023
Class of Stock [Line Items]
Document Period End Date	Dec. 31, 2023
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Entity File Number	1-44
Entity Registrant Name	ARCHER-DANIELS-MIDLAND CO
City Area Code	312
Local Phone Number	634-8100
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	41-0129150
Entity Address, Address Line One	77 West Wacker Drive, Suite 4600
Entity Address, City or Town	Chicago,
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60601
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 40.3
Entity Common Stock, Shares Outstanding		509,849,153
Documents Incorporated by Reference	Portions of the Registrant’s definitive proxy statement relating to its 2024 annual meeting of stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.
Entity Central Index Key	0000007084
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Amendment Flag	false
Auditor Name	Ernst & Young LLP
Auditor Location	Saint Louis, Missouri
Auditor Firm ID	42
Document Financial Statement Error Correction [Flag]	true
Document Financial Statement Restatement Recovery Analysis [Flag]	false
Common Stock [Member]
Class of Stock [Line Items]
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	ADM
Security Exchange Name	NYSE
Debt Securities [Member]
Class of Stock [Line Items]
Title of 12(b) Security	1.000% Notes due 2025
No Trading Symbol Flag	true
Security Exchange Name	NYSE

Consolidated Statements Of Earn

Consolidated Statements Of Earnings - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenues	$ 93,935	$ 101,556	$ 85,249
Cost of products sold	86,422	93,986	79,262
Gross Profit	7,513	7,570	5,987
Selling, general and administrative expenses	3,456	3,358	2,994
Asset impairment, exit, and restructuring costs	342	66	164
Equity in earnings of unconsolidated affiliates	(551)	(832)	(595)
(Gain) Loss on Extinguishment of Debt	0	0	36
Interest and investment income	(499)	(293)	(96)
Interest Expense	647	396	265
Other Nonoperating Income (Expense)	(176)	(358)	(94)
Earnings Before Income Taxes	4,294	5,233	3,313
Income tax expense	828	868	578
Net Earnings Including Noncontrolling Interests	3,466	4,365	2,735
Less:  Net earnings (losses) attributable to noncontrolling interests	(17)	25	26
Net Earnings Attributable to Controlling Interests	$ 3,483	$ 4,340	$ 2,709
Average number of shares outstanding - basic	541	562	564
Average number of shares outstanding - diluted	542	563	566
Basic earnings per common share (dollars per share)	$ 6.44	$ 7.72	$ 4.80
Diluted earnings per common share (dollars per share)	$ 6.43	$ 7.71	$ 4.79

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net earnings including noncontrolling interests	$ 3,466	$ 4,365	$ 2,735
Other Comprehensive Income (Loss), Before tax
Foreign currency translation adjustment, before tax	48	(301)	279
Pension and other postretirement benefit liabilities adjustment, before tax	(88)	140	289
Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), Before Reclassification, Before Tax	15	(84)	33
Unrealized gain (loss) on investments, before tax	16	(12)	(2)
Other Comprehensive Income (Loss), Tax
Foreign currency translation adjustment, tax effect	32	(93)	(103)
Pension and other postretirement benefit liabilities adjustment, tax effect	2	(15)	(71)
Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), After Reclassification Adjustment, Tax	(5)	7	7
Unrealized gain (loss) on investments, tax effect	(1)	1	0
Other Comprehensive Income (Loss), Net of Tax
Foreign currency translation adjustment, net of tax	80	(394)	176
Pension and other postretirement benefit liabilities adjustment, net of tax	(86)	125	218
Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), After Reclassification Adjustment, After Tax	10	(77)	40
Unrealized gain (loss) on investments, net of tax	15	(11)	(2)
Other comprehensive income (loss)	19	(357)	432
Comprehensive income (loss)	3,485	4,008	3,167
Less:  Comprehensive income (loss) attributable to noncontrolling interests	(20)	5	26
Comprehensive income (loss) attributable to controlling interests	$ 3,505	$ 4,003	$ 3,141

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 1,368	$ 1,037
Segregated cash and investments	7,228	9,010
Trade receivables - net	4,232	4,926
Inventories	11,957	14,771
Other current assets	4,982	5,666
Total Current Assets	29,767	35,410
Investments and Other Assets
Investments in and advances to affiliates	5,500	5,467
Goodwill and other intangible assets	6,341	6,544
Operating Lease, Right-of-Use Asset	1,211	1,088
Other assets	1,304	1,332
Total Investments and Other Assets	14,356	14,431
Property, Plant, and Equipment
Land and Land Improvements	573	502
Buildings	5,876	5,639
Machinery and equipment	20,223	19,194
Construction in progress	1,360	1,440
Gross Property, Plant, and Equipment	28,032	26,775
Accumulated depreciation	(17,524)	(16,842)
Net Property, Plant, and Equipment	10,508	9,933
Total Assets	54,631	59,774
Current Liabilities
Short-term debt	105	503
Trade payables	6,313	7,803
Payables to brokerage customers	7,867	9,856
Operating Lease, Liability, Current	300	292
Accrued expenses and other payables	4,076	4,795
Current maturities of long-term debt	1	942
Total Current Liabilities	18,662	24,191
Long-Term Liabilities
Long-term debt	8,259	7,735
Deferred income taxes	1,309	1,402
Operating Lease, Liability, Noncurrent	931	816
Other	1,005	1,014
Total Long-Term Liabilities	11,504	10,967
Redeemable Noncontrolling Interest, Equity, Carrying Amount	320	299
Shareholders’ Equity
Common stock	3,154	3,147
Reinvested earnings	23,465	23,646
Accumulated other comprehensive income (loss)	(2,487)	(2,509)
Noncontrolling interests	13	33
Total Shareholders’ Equity	24,145	24,317
Total Liabilities, Temporary Equity, and Shareholders’ Equity	$ 54,631	$ 59,774

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating Activities
Net earnings including noncontrolling interests	$ 3,466	$ 4,365	$ 2,735
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization	1,059	1,028	996
Asset impairment charges	309	37	125
Deferred income taxes	(23)	(89)	(129)
Equity in earnings of affiliates, net of dividends	(143)	(457)	(177)
Stock compensation expense	112	147	161
Deferred Cash Flow Hedges	15	(84)	34
(Gain) Loss on Extinguishment of Debt	0	0	36
(Gain) loss on sale and revaluation of assets	38	(115)	(149)
Other Noncash Income (Expense)	(106)	178	309
Changes in operating assets and liabilities, net of acquisitions and dispositions
Segregated investments	(194)	(1,512)	400
Trade receivables	737	(1,682)	(578)
Inventories	2,889	(295)	(2,839)
Other current assets	694	(279)	1,298
Trade payables	(1,544)	1,389	1,919
Payables to brokerage customers	(2,059)	891	2,527
Accrued expenses and other payables	(790)	(44)	(73)
Total Operating Activities	4,460	3,478	6,595
Investing Activities
Capital expenditures	(1,494)	(1,319)	(1,169)
Net assets of businesses acquired	(23)	(22)	(1,564)
Proceeds from sales of assets and businesses	60	131	245
Payments to Acquire Equity Method Investments	(18)	(77)	(34)
Payments to Acquire Other Investments	0	(155)	(69)
Other – net	(21)	42	(78)
Total Investing Activities	(1,496)	(1,400)	(2,669)
Financing Activities
Proceeds from notes recorded as long-term debt	501	752	1,329
Long-term debt payments	(963)	(482)	(534)
Net borrowings (payments) under lines of credit agreements	(390)	(428)	(1,085)
Share repurchases	(2,673)	(1,450)	0
Cash dividends	(977)	(899)	(834)
Other – net	(102)	8	6
Total Financing Activities	(4,604)	(2,499)	(1,118)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(3)	0	0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(1,643)	(421)	2,808
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Start	7,033	7,454	4,646
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period End	5,390	7,033	7,454
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents to consolidated balance sheets [Abstract]
Cash and cash equivalents	1,368	1,037	943
Restricted cash and cash equivalents included in segregated cash and investments	4,022	5,996	6,511
Cash paid for interest and income taxes were as follows:
Interest Paid, Excluding Capitalized Interest, Operating Activities	711	409	276
Income taxes	$ 742	$ 708	$ 553

Consolidated Statements Of Shar

Consolidated Statements Of Shareholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Previously Reported	Common Stock [Member]	Reinvested Earnings [Member]	Reinvested Earnings [Member] Previously Reported	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interest [Member]
Balance, shares at Dec. 31, 2020			556
Balance at Dec. 31, 2020	$ 20,022		$ 2,824	$ 19,780		$ (2,604)	$ 22
Comprehensive income
Net earnings	2,735			2,709			26
Other comprehensive income (loss)	432					432	0
Total comprehensive income	$ 3,167
Common Stock, Dividends, Per Share, Cash Paid	$ 1.48
Cash dividends paid	$ (834)			(834)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture			3
Stock compensation expense	161		$ 161
Stock option exercises net of taxes, shares			1
Stock option exercises net of taxes, value	4		$ 4
Other, shares			0
Other	(12)		$ 5	0			(17)
Balance, shares at Dec. 31, 2021			560
Balance at Dec. 31, 2021	22,508		$ 2,994	21,655		(2,172)	31
Comprehensive income
Net earnings	4,365			4,340			25
Other comprehensive income (loss)	(357)					(337)	(20)
Total comprehensive income	$ 4,008
Common Stock, Dividends, Per Share, Cash Paid	$ 1.60
Cash dividends paid	$ (899)			(899)
Stock Repurchased During Period, Shares			(17)
Stock Repurchased During Period, Value	(1,450)			(1,450)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture			3
Stock compensation expense	147		$ 147
Stock option exercises net of taxes, shares			1
Stock option exercises net of taxes, value	4		$ 4
Other, shares			0
Other	(1)		$ 2	0			(3)
Balance, shares at Dec. 31, 2022			547
Balance at Dec. 31, 2022	24,317	$ 24,317	$ 3,147		$ 23,646	(2,509)	33
Comprehensive income
Net earnings	3,466			3,483			(17)
Other comprehensive income (loss)	19					22	(3)
Total comprehensive income	$ 3,485
Common Stock, Dividends, Per Share, Cash Paid	$ 1.80
Cash dividends paid	$ (977)			(977)
Stock Repurchased During Period, Shares			(36)
Stock Repurchased During Period, Value	(2,697)			(2,697)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture			3
Stock compensation expense	112		$ 112
Stock option exercises net of taxes, shares			(1)
Stock option exercises net of taxes, value	(110)		$ (110)
Other, shares			0
Other	15		$ 5	10			0
Balance, shares at Dec. 31, 2023			513
Balance at Dec. 31, 2023	$ 24,145		$ 3,154	$ 23,465		$ (2,487)	$ 13

Consolidated Statements Of Sh_2

Consolidated Statements Of Shareholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Stockholders' Equity [Abstract]
Cash dividends paid (dollars per share)	$ 1.80	$ 1.60	$ 1.48

Summary Of Significant Accounti

Summary Of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Summary Of Significant Accounting Policies	Summary of Significant Accounting Policies Nature of Business ADM unlocks the power of nature to enrich the quality of life for people and animals. ADM’s innovation and expertise are helping people live healthier lives and support a healthier planet. The Company’s globally-integrated footprint combined with local insight give ADM capabilities few other companies have to meet critical and global needs. With a foundation in nature and nutrition, the Company is a leader in sustainability, scaling across entire value chains to help decarbonize the industry, and safeguard the planet. ADM has three business segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The Company is an essential global agricultural supply chain manager and processor supporting food security by connecting local needs with global capabilities. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated. The Company consolidates all entities, including variable interest entities (VIEs), in which it has a controlling financial interest. For VIEs, the Company assesses whether it is the primary beneficiary as defined under the applicable accounting standard. Investments in affiliates, including VIEs through which the Company exercises significant influence but does not control the investee and is not the primary beneficiary of the investee’s activities, are carried at cost plus equity in undistributed earnings since acquisition and are adjusted, where appropriate, for basis differences between the investment balance and the underlying net assets of the investee. The Company’s portion of the results of certain affiliates and results of certain VIEs are included using the most recent available financial statements. In each case, the financial statements are within 93 days of the Company’s year-end and are consistent from period to period. Use of Estimates The preparation of consolidated financial statements in conformity with generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect amounts reported in its consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Cash Equivalents The Company considers all non-segregated, highly-liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Segregated Cash and Investments The Company segregates certain cash, cash equivalents, and investment balances in accordance with regulatory requirements, commodity exchange requirements, and insurance arrangements. These balances represent deposits received from customers of the Company’s registered futures commission merchant and commodity brokerage services, cash margins and securities pledged to commodity exchange clearinghouses, and cash pledged as security under certain insurance arrangements. Segregated cash and investments also include restricted cash collateral for the various insurance programs of the Company’s captive insurance business. To the degree these segregated balances are comprised of cash and cash equivalents, they are considered restricted cash and cash equivalents on the statement of cash flows. Receivables The Company records accounts receivable at net realizable value. This value includes an allowance for estimated uncollectible accounts to reflect any loss anticipated on the accounts receivable balances including any accrued interest receivables thereon. The Company estimates uncollectible accounts by pooling receivables according to type, region, credit risk rating, and age. Each pool is assigned an expected loss co-efficient to arrive at a general reserve based on historical write-offs adjusted, as needed, for regional, economic, and other forward-looking factors. The Company minimizes credit risk due to the large and diversified nature of its worldwide customer base. ADM manages its exposure to counter-party credit risk through credit analysis and approvals, credit limits, and monitoring procedures. Long-term receivables recorded in other assets were not material to the Company’s overall receivables portfolio. The Company recorded bad debt expense in selling, general, and administrative expenses of $6 million, $88 million, and $32 million in the years ended December 31, 2023, 2022, and 2021, respectively. Changes to the allowance for estimated uncollectible accounts are as follows: Year Ended December 31 2023 2022 (In millions) Beginning, January 1 $ 199 $ 122 Current year provisions 6 88 Recoveries 2 2 Write-offs against allowance (28) (12) Foreign exchange translation adjustment — (2) Other 36 1 Ending, December 31 $ 215 $ 199 Current year provisions in the year ended December 31, 2023 is net of reversals of prior year general provisions for economic factors related to the pandemic and provision for a certain customer. Write-offs against allowance in the year ended December 31, 2023 were related to a customer in Brazil and allowance on receivables that were subsequently sold in the current year. Other in the year ended December 31, 2023 is due primarily to reclassifications. Inventories Certain merchandisable agricultural commodity inventories, which include inventories acquired under deferred pricing contracts, are stated at market value. In addition, the Company values certain inventories using the first-in, first-out (FIFO) method at the lower of cost or net realizable value. The following table sets forth the Company’s inventories as of December 31, 2023 and 2022. December 31, 2023 December 31, 2022 (In millions) Raw materials and supplies $ 5,475 $ 6,975 Finished goods 6,482 7,796 Total inventories $ 11,957 $ 14,771 Included in raw materials and supplies are work in process inventories which were not material as of December 31, 2023 and 2022. Fair Value Measurements The Company determines fair value based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company uses the market approach valuation technique to measure the majority of its assets and liabilities carried at fair value. Three levels are established within the fair value hierarchy that may be used to report fair value: Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Observable inputs, including Level 1 prices that have been adjusted; quoted prices for similar assets or liabilities; quoted prices in markets that are less active than traded exchanges; and other inputs that are observable or can be substantially corroborated by observable market data. Level 3: Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities. In evaluating the significance of fair value inputs, the Company generally classifies assets or liabilities as Level 3 when their fair value is determined using unobservable inputs that individually or when aggregated with other unobservable inputs, represent more than 10% of the fair value of the assets or liabilities. Judgment is required in evaluating both quantitative and qualitative factors in the determination of significance for purposes of fair value level classification. Level 3 amounts can include assets and liabilities whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as assets and liabilities for which the determination of fair value requires significant management judgment or estimation. Based on historical experience with the Company’s suppliers and customers, the Company’s own credit risk and knowledge of current market conditions, the Company does not view nonperformance risk to be a significant input to fair value for the majority of its forward commodity purchase and sale contracts. However, in certain cases, if the Company believes the nonperformance risk to be a significant input, the Company records estimated fair value adjustments, and classifies the measurement in Level 3. In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy. The lowest level of input that is a significant component of the fair value measurement determines the placement of the entire fair value measurement in the hierarchy. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the classification of fair value assets and liabilities within the fair value hierarchy levels. The Company’s policy regarding the timing of transfers between levels, including both transfers into and transfers out of Level 3, is to measure and record the transfers at the end of the reporting period. Derivatives The Company recognizes all of its derivative instruments as either assets or liabilities at fair value in its consolidated balance sheet. Unrealized gains are reported as other current assets and unrealized losses are reported as accrued expenses and other payables. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and on the type of hedging relationship. The majority of the Company’s derivatives have not been designated as hedging instruments, and as such, changes in fair value of these derivatives are recognized in earnings immediately. For those derivative instruments that are designated and qualify as hedging instruments, the Company designates the hedging instrument, based upon the exposure being hedged, as a cash flow hedge or a net investment hedge. For derivative instruments that are designated and qualify as highly-effective cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) (AOCI) and as an operating activity in the statement of cash flows and reclassified into earnings in the same line item affected by the hedged transaction and in the same period or periods during which the hedged transaction affects earnings. Hedge components excluded from the assessment of effectiveness and gains and losses related to discontinued hedges are recognized in the consolidated statement of earnings during the current period. For derivative instruments that are designated and qualify as net investment hedges, foreign exchange gains and losses related to changes in foreign currency exchange rates are deferred in AOCI until the underlying investment is divested. Cost Method Investments Cost method investments of $438 million and $488 million as of December 31, 2023 and 2022, respectively, are included in Other Assets in the Company’s consolidated balance sheets. Revaluation losses of $76 million for the year ended December 31, 2023 were related to investments in the alternative protein category and precision fermentation. Revaluation gains of $37 million and $49 million for the years ended December 31, 2022 and 2021, respectively, were in connection with observable third-party transactions (a level 2 measurement under applicable accounting standards). Revaluation gains and losses are recorded in interest and investment income in the Company’s consolidated statements of earnings. As of December 31, 2023, the cumulative amounts of upward and downward adjustments were $113 million and $76 million, respectively. Property, Plant, and Equipment Property, plant, and equipment are recorded at cost. Repair and maintenance costs are expensed as incurred. The Company uses the straight-line method in computing depreciation for financial reporting purposes and generally uses accelerated methods for income tax purposes. The annual provisions for depreciation have been computed principally in accordance with the following ranges of asset lives: buildings - 15 to 40 years; machinery and equipment - 3 to 40 years. The Company capitalized interest on major construction projects in progress of $32 million, $20 million, and $17 million for the years ended December 31, 2023, 2022, and 2021, respectively. Income Taxes The Company accounts for income taxes in accordance with the liability method. Deferred tax assets and liabilities are recorded for temporary differences between the tax basis of assets and liabilities and reported amounts in the consolidated financial statements using statutory rates in effect for the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recorded in the results of operations in the period that includes the enactment date under the law. Applicable accounting standards prescribe a minimum threshold a tax position is required to meet before being recognized in the consolidated financial statements. The Company recognizes in its consolidated financial statements tax positions determined more likely than not to be sustained upon examination, based on the technical merits of the position. The Company classifies interest on income tax-related balances as interest expense and classifies tax-related penalties as selling, general, and administrative expenses. Income tax effects from AOCI are released when the individual units of account are sold, terminated, or extinguished. Goodwill and other intangible assets Goodwill and other intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. Definite-lived intangible assets, including capitalized expenses related to the Company’s 1ADM program such as third-party configuration costs and internal labor, are amortized over their estimated useful lives of 1 to 50 years and are reviewed for impairment whenever there are indicators the carrying value of the assets may not be fully recoverable. The Company’s accounting policy is to evaluate goodwill and other intangible assets with indefinite lives for impairment on October 1 of each fiscal year or whenever there are indicators the carrying value of the assets may not be fully recoverable. The Company recorded impairment charges totaling $201 million related to goodwill, customer list, and discontinued animal nutrition trademarks, $2 million related to customer list, and $52 million related to goodwill and other intangibles during the years ended December 31, 2023, 2022, and 2021, respectively (see Note 9 for additional information). The goodwill impairment charge recorded during the year ended December 31, 2023 of $137 million was related to the Animal Nutrition reporting unit that was evaluated for impairment using a quantitative assessment. The Company utilized a third-party valuation specialist to assist management in determining the fair value of the Animal Nutrition reporting unit. The fair value of the Animal Nutrition reporting unit was estimated based on a combination of discounted cash flows (income approach) and the use of pricing multiples derived from an analysis of comparable public companies multiplied against historical and or anticipated financial metrics (market approach). As a result of the impairment testing in the fourth quarter of 2023, the Company determined the fair value of the Animal Nutrition reporting unit was below its carrying value. The decline in the fair value of the Animal Nutrition reporting unit was primarily driven by a higher discount rate due to changes in the underlying business performance and industry conditions as well as the macroeconomic environment, causing a decline in projected cash flows. Asset Abandonments and Write-Downs The Company evaluates long-lived assets for impairment whenever indicators of impairment exist. In addition, assets are written down to fair value after consideration of the Company’s ability to utilize the assets for their intended purpose, employ the assets in alternative uses, or sell the assets to recover the carrying value. Fair value is generally based on discounted cash flow analysis which relies on management’s estimate of market participant assumptions or estimated selling price for assets considered held for sale (a Level 3 measurement under applicable accounting standards). During 2023, 2022 and 2021, the Company temporarily idled certain assets which were not material. During the years ended December 31, 2023, 2022, and 2021, asset abandonment and impairment charges were $108 million, $35 million, and $73 million, respectively. Payables to Brokerage Customers Payables to brokerage customers represent the total of customer accounts at the Company’s futures commission merchant with credit or positive balances. Customer accounts are used primarily in connection with commodity transactions and include gains and losses on open commodity trades as well as securities and other deposits made for margins or other purposes as required by the Company or the exchange-clearing organizations or counterparties. Payables to brokerage customers have a corresponding balance in segregated cash and investments and customer omnibus receivable in other current assets. Revenues The Company follows a policy of recognizing revenue at a single point in time when it satisfies its performance obligation by transferring control over a product or service to a customer. For transportation service contracts, the Company recognizes revenue over time as the mode of transportation moves towards its destination in accordance with the transfer of control guidance of ASC Topic 606, Revenue from Contracts with Customers (“Topic 606”). For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by ASC 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets (“Topic 610-20”). Stock Compensation The Company recognizes expense for its stock compensation based on the fair value of the awards that are granted. The Company’s stock compensation plans provide for the granting of restricted stock, restricted stock units, performance stock units, and stock options. The fair values of stock options and performance stock units are estimated at the date of grant using the Black-Scholes option valuation model and a lattice valuation model, respectively. These valuation models require the input of subjective assumptions. Measured compensation cost, net of forfeitures, is recognized ratably over the vesting period of the related stock compensation award. Research and Development Costs associated with research and development are expensed as incurred and recorded within selling, general, and administrative expenses. Such costs incurred, net of expenditures subsequently reimbursed by government grants, were $256 million, $216 million, and $171 million for the years ended December 31, 2023, 2022, and 2021, respectively. Per Share Data Basic earnings per common share are determined by dividing net earnings attributable to controlling interests by the weighted average number of common shares outstanding. In computing diluted earnings per share, average number of common shares outstanding is increased by common stock options outstanding with exercise prices lower than the average market price of common shares using the treasury share method. Business Combinations The Company’s acquisitions are accounted for in accordance with ASC Topic 805, Business Combinations, as amended . The consideration transferred is allocated to various assets acquired and liabilities assumed at their estimated fair values as of the acquisition date with the residual allocated to goodwill. Fair values allocated to assets acquired and liabilities assumed in business combinations require management to make significant judgments, estimates, and assumptions, especially with respect to intangible assets. Management makes estimates of fair values based upon assumptions it believes to be reasonable. These estimates are based upon historical experience and information obtained from the management of the acquired companies and are inherently uncertain. The estimated fair values related to intangible assets primarily consist of customer relationships, trademarks, and developed technology which are determined primarily using discounted cash flow models. Estimates in the discounted cash flow models include, but are not limited to, certain assumptions that form the basis of the forecasted results (e.g. revenue growth rates, customer attrition rates, and royalty rates). These significant assumptions are forward looking and could be affected by future economic and market conditions. During the measurement period, which may take up to one year from the acquisition date, adjustments due to changes in the estimated fair value of assets acquired and liabilities assumed may be recorded as adjustments to the consideration transferred and the related allocations. Upon the conclusion of the measurement period or the final determination of the values of assets acquired and liabilities assumed, whichever comes first, any such adjustments are charged to the consolidated statements of earnings. Redeemable Noncontrolling Interest The Company accounts for any redeemable noncontrolling interest in temporary equity - redeemable noncontrolling interest at redemption value with periodic changes recorded in retained earnings. Operations in Ukraine and Russia ADM employs approximately 630 people in Ukraine and operates an oilseeds crushing plant, a grain port terminal, inland and river silos, and a trading office. The Company’s footprint in Russia is limited to operations related to the production and transport of essential food commodities and ingredients. As a result of the ongoing conflict in Ukraine, the Company reviewed the valuation of its assets and concluded that as of December 31, 2023, receivables, net of allowances, are deemed collectible and market inventories are valued appropriately. The Company also evaluated the impact of Russia’s announcement of its purported annexation of four Ukrainian regions on the valuation of ADM’s assets in those regions and concluded the assets are appropriately valued. As the conflict in Ukraine evolves, the Company will continue to review the valuation of these assets and make any required adjustments, which are not expected to be material to the Company’s consolidated financial statements. New Accounting Standards Effective January 1, 2023, the Company adopted the amended guidance of Accounting Standards Codification (ASC) Topic 805, Business Combinations , which improves comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. The amended guidance requires an entity (acquirer) to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers , (Topic 606). The Company’s adoption of this amended guidance did not have an impact on its consolidated financial statements. Effective January 1, 2023, the Company adopted the amended guidance of ASC Subtopic 405-50, Liabilities - Supplier Finance Programs , which enhances the transparency of supplier finance programs. The amended guidance requires an entity (buyer) in a supplier finance program to disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. ADM has Supplier Payable Programs (“SPP”) with financial institutions which act as its paying agents for payables due to certain of its suppliers. The Company has neither an economic interest in a supplier’s participation in the SPP nor a direct financial relationship with the financial institutions, and has concluded its obligations to the suppliers, including amounts due and scheduled payment terms, are not impacted by their participation in the SPP. Accordingly, amounts associated with the SPP continue to be classified in current liabilities Year Ended December 31 2023 (In millions) Beginning, January 1 $ 196 Obligations confirmed 1,100 Obligations paid (1,022) Ending, December 31 $ 274 Through December 31, 2024, the Company has the option to adopt the amended guidance of ASC Topic 848, Reference Rate Reform , which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by the reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. The expedients and exceptions provided by the amended guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2024, except for hedging relationships existing as of December 31, 2024, that an entity has elected certain optional expedients for and are retained through the end of the hedging relationship. The Company’s adoption of the amended guidance will not have an impact on its consolidated financial statements. Effective December 31, 2024, the Company will be required to adopt the amended guidance of ASC 280, Segment Reporting , which improves disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for more detailed information about a reportable segment’s expenses. The amended guidance improves reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and permits entities to disclose more than one measure of a reportable segment’s profitability used by the Chief Operating Decision Maker. The adoption of the amended guidance will result in expanded disclosures in the Company’s segment and geographic information footnote but will not have an impact on the consolidated financial statements. Effective December 31, 2025, the Company will be required to adopt the amended guidance of ASC 740, Income Taxes , which enhances the transparency and decision usefulness of income tax disclosures. The amendments address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The adoption of the amended guidance will result in expanded disclosures in the Company’s income taxes footnote but will not have an impact on the consolidated financial statements.

Revenues Revenues

Revenues Revenues	12 Months Ended
	Dec. 31, 2023
Revenues [Abstract]
Revenue from Contract with Customer [Text Block]	Revenues Revenue Recognition The Company principally generates revenue from merchandising and transporting agricultural commodities, and manufacturing products for use in food, beverages, feed, energy, and industrial applications, and ingredients and solutions for human and animal nutrition. Revenue is measured based on the consideration specified in the contract with a customer. The Company follows a policy of recognizing revenue at a single point in time when it satisfies its performance obligation by transferring control over a product or service to a customer. The majority of the Company’s contracts with customers have one performance obligation and a contract duration of one year or less. The Company applies the practical expedient in paragraph 10-50-14 of Topic 606 and does not disclose information about remaining performance obligations that have original expected durations of one year or less. For transportation service contracts, the Company recognizes revenue over time as the mode of transportation moves towards its destination in accordance with the transfer of control guidance of Topic 606. The Company recognized revenue from transportation service contracts of $761 million, $818 million, and $606 million for the years ended December 31, 2023, 2022, and 2021, respectively. For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by ASC 610-20. Shipping and Handling Costs Shipping and handling costs related to contracts with customers for the sale of goods are accounted for as a fulfillment activity and are included in cost of products sold. Accordingly, amounts billed to customers for such costs are included as a component of revenues. Taxes Collected from Customers and Remitted to Governmental Authorities The Company does not include taxes assessed by governmental authorities that are (i) imposed on and concurrent with a specific revenue-producing transaction and (ii) collected from customers, in the measurement of transactions prices or as a component of revenues and cost of products sold. Contract Liabilities Contract liabilities relate to advance payments from customers for goods and services the Company has yet to provide. Contract liabilities of $626 million and $694 million as of December 31, 2023 and 2022, respectively, were recorded in accrued expenses and other payables in the consolidated balance sheet. Revenues recognized in the year ended December 31, 2023 from the December 31, 2022 contract liabilities were $469 million. Disaggregation of Revenues The following tables present revenue disaggregated by timing of recognition and major product lines for the years ended December 31, 2023, 2022, and 2021. Year Ended December 31, 2023 Topic 606 Revenue Topic 815 (1) Total Point in Time Over Time Total Revenue Revenues (In millions) Ag Services and Oilseeds Ag Services $ 4,110 $ 761 $ 4,871 $ 42,549 $ 47,420 Crushing 470 — 470 13,550 14,020 Refined Products and Other 2,295 — 2,295 9,691 11,986 Total Ag Services and Oilseeds 6,875 761 7,636 65,790 73,426 Carbohydrate Solutions Starches and Sweeteners 7,431 — 7,431 2,454 9,885 Vantage Corn Processors 2,989 — 2,989 — 2,989 Total Carbohydrate Solutions 10,420 — 10,420 2,454 12,874 Nutrition Human Nutrition 3,634 — 3,634 — 3,634 Animal Nutrition 3,577 — 3,577 — 3,577 Total Nutrition 7,211 — 7,211 — 7,211 Other Business 424 — 424 — 424 Total Revenues $ 24,930 $ 761 $ 25,691 $ 68,244 $ 93,935 Year Ended December 31, 2022 Topic 606 Revenue Topic 815 (1) Total Point in Time Over Time Total Revenue Revenues (In millions) Ag Services and Oilseeds Ag Services $ 4,053 $ 818 $ 4,871 $ 48,310 $ 53,181 Crushing 573 — 573 12,566 13,139 Refined Products and Other 2,724 — 2,724 10,519 13,243 Total Ag Services and Oilseeds 7,350 818 8,168 71,395 79,563 Carbohydrate Solutions Starches and Sweeteners 7,696 — 7,696 2,555 10,251 Vantage Corn Processors 3,710 — 3,710 — 3,710 Total Carbohydrate Solutions 11,406 — 11,406 2,555 13,961 Nutrition Human Nutrition 3,769 — 3,769 — 3,769 Animal Nutrition 3,867 — 3,867 — 3,867 Total Nutrition 7,636 — 7,636 — 7,636 Other Business 396 — 396 — 396 Total Revenues $ 26,788 $ 818 $ 27,606 $ 73,950 $ 101,556 Year Ended December 31, 2021 Topic 606 Revenue Topic 815 (1) Total Point in Time Over Time Total Revenue Revenues (In millions) Ag Services and Oilseeds Ag Services $ 2,831 $ 606 $ 3,437 $ 41,580 $ 45,017 Crushing 441 — 441 10,927 11,368 Refined Products and Other 2,458 — 2,458 8,204 10,662 Total Ag Services and Oilseeds 5,730 606 6,336 60,711 67,047 Carbohydrate Solutions Starches and Sweeteners 5,866 — 5,866 1,745 7,611 Vantage Corn Processors 3,499 — 3,499 — 3,499 Total Carbohydrate Solutions 9,365 — 9,365 1,745 11,110 Nutrition Human Nutrition 3,189 — 3,189 — 3,189 Animal Nutrition 3,523 — 3,523 — 3,523 Total Nutrition 6,712 — 6,712 — 6,712 Other Business 380 — 380 — 380 Total Revenues $ 22,187 $ 606 $ 22,793 $ 62,456 $ 85,249 (1) Topic 815 revenue relates to the physical delivery or the settlement of the Company’s sales contracts accounted for as derivatives and are outside the scope of Topic 606. Ag Services and Oilseeds The Ag Services and Oilseeds segment generates revenue from the sale of commodities, from service fees for the transportation of goods, from the sale of products manufactured in its global processing facilities, and from its structured trade finance activities. Revenue is measured based on the consideration specified in the contract. Revenue is recognized when a performance obligation is satisfied by transferring control over a product or providing service to a customer. For transportation service contracts, the Company recognizes revenue over time as the mode of transportation moves towards its destination in accordance with the transfer of control guidance of Topic 606. The amount of revenue recognized follows the contractually specified price which may include freight or other contractually specified cost components. For physically settled derivative sales contracts outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by Topic 610-20. The Company engages in various structured trade finance activities to leverage its global trade flows whereby the Company obtains letters of credit (LCs) to guarantee payments on both global purchases and sales of grain. LCs guaranteeing payment on grain sales are sold on a non-recourse basis with no continuing involvement. The Company earns returns from the difference in interest rates between the LCs that guarantee payment on the underlying purchases and sales of grain given the differing risk profiles of the underlying transactions. The net return related to structured trade finance activities is included in revenue and is not significant for the years ended December 31, 2023, 2022, and 2021. Carbohydrate Solutions The Carbohydrate Solutions segment generates revenue from the sale of products manufactured at the Company’s global corn and wheat milling facilities around the world. Revenue is recognized when control over products is transferred to the customer. Products are shipped to customers from the Company’s various facilities and from its network of storage terminals. The amount of revenue recognized is based on the consideration specified in the contract which could include freight and other costs depending on the specific shipping terms of each contract. For physically settled derivative sales contracts outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by Topic 610-20. Nutrition The Nutrition segment sells ingredients and solutions including plant-based proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, enzymes, botanical extracts, edible beans, formula feeds, animal health and nutrition products, pet food and treats, and other specialty food and feed ingredients. Revenue is recognized when control over products is transferred to the customer. The amount of revenue recognized follows the contracted price or the mutually agreed price of the product. Freight and shipping are recognized as a component of revenue at the same time control transfers to the customer. Other Business Other Business includes the Company’s futures commission business whose primary sources of revenue are commissions and brokerage income generated from executing orders and clearing futures contracts and options on futures contracts on behalf of its customers. Commissions and brokerage revenue are recognized on the date the transaction is executed. Other Business also includes the Company’s captive insurance business which generates third party revenue through its proportionate share of premiums from third-party reinsurance pools. Reinsurance premiums are recognized on a straight-line basis over the period underlying the policy.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2023
Business Combinations [Abstract]
Acquisitions	Acquisitions Fiscal year 2023 acquisitions During the year ended December 31, 2023, the Company acquired Prairie Pulse Inc., an 83% majority stake in Buckminster Química, and D.C.A. Finance B.V. for an aggregate cash consideration of $25 million. The aggregate cash consideration of these acquisitions, net of $2 million in cash acquired, was preliminarily allocated as follows: (In millions) Property, plant, and equipment $ 18 Goodwill 20 Other long-term assets 2 Long-term liabilities (17) Aggregate cash consideration $ 23 Fiscal year 2022 acquisitions During the year ended December 31, 2022, the Company acquired Kansas Protein Foods LLC for cash consideration of $23 million. The cash consideration of this acquisition, net of $1 million in cash acquired, was allocated as follows: (In millions) Property, plant, and equipment $ 9 Goodwill 13 Cash consideration $ 22 Fiscal year 2021 acquisitions During the year ended December 31, 2021, the Company’s Nutrition segment acquired five businesses including, a 75% majority stake in U.S.-based PetDine, Pedigree Ovens, The Pound Bakery, and NutraDine (collectively, “P4”), premier providers of private label pet treats and supplements; Deerland Probiotics & Enzymes (“Deerland”), a leader in probiotic, prebiotic, and enzyme technology; and Sojaprotein, a leading European provider of non-GMO soy ingredients, for an aggregate consideration of $1.6 billion using cash on hand. The aggregate cash consideration of these acquisitions, net of $21 million in cash acquired, was allocated as follows. In 2022, the Company made immaterial adjustments to the purchase price allocations related to these acquisitions. These adjustments have been reflected in the table below. (In millions) P4 Deerland Sojaprotein Others Total Working capital $ 11 $ 27 $ 35 $ 7 $ 80 Property, plant, and equipment 73 43 85 6 207 Goodwill 317 396 192 35 940 Other intangible assets 245 252 42 18 557 Other long-term assets — — 12 2 14 Long-term liabilities — (74) (10) — (84) Temporary equity - redeemable noncontrolling interest (150) — — — (150) Aggregate cash consideration $ 496 $ 644 $ 356 $ 68 $ 1,564 The Company has the option to acquire the remaining 25% interest in P4 from December 31, 2023 to March 31, 2025, based on a fixed multiple of earnings before interest, taxes, depreciation, and amortization for the twelve months prior to the exercise of this option. The noncontrolling interest holders also have the option to put the 25% interest to the Company on the same terms. The Company records the 25% remaining interest in temporary equity - redeemable noncontrolling interest. Of the $940 million allocated to goodwill, $313 million is expected to be deductible for tax purposes. The 2021 acquisitions advance ADM’s growth strategy by expanding the Company’s capabilities in pet treat and supplements and the fast-growing global demand for plant-based proteins as well as capabilities in the high-value flavor segment and the fast growing demand for food, beverages, and supplements. The post-acquisition financial results of these acquisitions are reported in the Nutrition segment. The following table sets forth the fair values and the useful lives of the other intangible assets acquired. Useful Lives P4 Deerland Sojaprotein Others Total (In years) (In millions) Intangible assets with finite lives: Trademarks/brands 7 to 15 $ 9 $ 18 $ 5 $ 1 $ 33 Customer lists 15 to 20 220 176 37 14 447 Recipes and others 7 16 58 — 3 77 Total other intangible assets acquired $ 245 $ 252 $ 42 $ 18 $ 557

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following tables set forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2023 and 2022. Fair Value Measurements at December 31, 2023 Quoted Prices in Significant Significant Total (In millions) Assets: Inventories carried at market $ — $ 4,274 $ 2,713 $ 6,987 Unrealized derivative gains: Commodity contracts — 628 731 1,359 Foreign exchange contracts — 187 — 187 Cash equivalents 209 — — 209 Segregated investments 1,362 — — 1,362 Total Assets $ 1,571 $ 5,089 $ 3,444 $ 10,104 Liabilities: Unrealized derivative losses: Commodity contracts $ — $ 500 $ 457 $ 957 Foreign exchange contracts — 144 — 144 Inventory-related payables — 1,219 101 1,320 Total Liabilities $ — $ 1,863 $ 558 $ 2,421 Fair Value Measurements at December 31, 2022 Quoted Prices in Significant Significant Total (In millions) Assets: Inventories carried at market $ — $ 6,281 $ 2,760 $ 9,041 Unrealized derivative gains: Commodity contracts — 796 541 1,337 Foreign currency contracts — 258 — 258 Interest rate contracts — 109 — 109 Cash equivalents 405 — — 405 Segregated investments 1,453 — — 1,453 Total Assets $ 1,858 $ 7,444 $ 3,301 $ 12,603 Liabilities: Unrealized derivative losses: Commodity contracts $ — $ 665 $ 603 $ 1,268 Foreign currency contracts — 275 — 275 Debt conversion option — — 6 6 Inventory-related payables — 1,181 89 1,270 Total Liabilities $ — $ 2,121 $ 698 $ 2,819 Estimated fair values of inventories and inventory-related payables stated at market are based on exchange-quoted prices, adjusted for differences in local markets and quality, referred to as basis. Market valuations for the Company’s inventories are adjusted for location and quality (basis) because the exchange-quoted prices represent contracts that have standardized terms for commodity, quantity, future delivery period, delivery location, and commodity quality or grade. The basis adjustments are generally determined using inputs from competitor and broker quotations or market transactions and are considered observable. Basis adjustments are impacted by specific local supply and demand characteristics at each facility and the overall market. Factors such as substitute products, weather, fuel costs, contract terms, and futures prices also impact the movement of these basis adjustments. In some cases, the basis adjustments are unobservable because they are supported by little to no market activity. When unobservable inputs have a significant impact (more than 10%) on the measurement of fair value, the inventory is classified in Level 3. Changes in the fair value of inventories and inventory-related payables are recognized in the consolidated statements of earnings as a component of cost of products sold. Derivative contracts include exchange-traded commodity futures and options contracts, forward commodity purchase and sale contracts, and OTC instruments related primarily to agricultural commodities, energy, interest rates, and foreign currencies. Exchange-traded futures and options contracts are valued based on unadjusted quoted prices in active markets and are classified in Level 1. The majority of the Company’s exchange-traded futures and options contracts are cash-settled on a daily basis and, therefore, are not included in these tables. Fair value for forward commodity purchase and sale contracts is estimated based on exchange-quoted prices adjusted for differences in local markets. Market valuations for the Company’s forward commodity purchase and sale contracts are adjusted for location (basis) because the exchange-quoted prices represent contracts that have standardized terms for commodity, quantity, future delivery period, delivery location, and commodity quality or grade. The basis adjustments are generally determined using inputs from competitor and broker quotations or market transactions and are considered observable. Basis adjustments are impacted by specific local supply and demand characteristics at each facility and the overall market. Factors such as substitute products, weather, fuel costs, contract terms, and futures prices also impact the movement of these basis adjustments. In some cases, the basis adjustments are unobservable because they are supported by little to no market activity. When observable inputs are available for substantially the full term of the contract, it is classified in Level 2. When unobservable inputs have a significant impact (more than 10%) on the measurement of fair value, the contract is classified in Level 3. Except for certain derivatives designated as cash flow hedges, changes in the fair value of commodity-related derivatives are recognized in the consolidated statements of earnings as a component of cost of products sold. Changes in the fair value of foreign currency-related derivatives are recognized in the consolidated statements of earnings as a component of revenues, cost of products sold, and other (income) expense - net, depending upon the purpose of the contract. The changes in the fair value of derivatives designated as effective cash flow hedges are recognized in the consolidated balance sheets as a component of AOCI until the hedged items are recorded in earnings or it is probable the hedged transaction will no longer occur. The Company’s cash equivalents are comprised of money market funds valued using quoted market prices and are classified as Level 1. The Company’s segregated investments are comprised of U.S. Treasury securities. U.S. Treasury securities are valued using quoted market prices and are classified in Level 1. The debt conversion option was the equity linked embedded derivative related to the exchangeable bonds. The fair value of the embedded derivative was included in long-term debt, with changes in fair value recognized as interest, and was valued with the assistance of a third-party pricing service (a level 3 measurement). The following tables present a rollforward of the activity of all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the years ended December 31, 2023 and 2022. Level 3 Fair Value Assets Measurements at Inventories Commodity Total (In millions) Balance, December 31, 2022 $ 2,760 $ 541 $ 3,301 Total increase (decrease) in net realized/unrealized gains included in cost of products sold 432 1,460 1,892 Purchases 29,929 — 29,929 Sales (30,038) — (30,038) Settlements (4) (1,559) (1,563) Transfers into Level 3 1,584 371 1,955 Transfers out of Level 3 (1,950) (82) (2,032) Ending balance, December 31, 2023 (1) $ 2,713 $ 731 $ 3,444 (1) Includes increase in unrealized gains Level 3 Fair Value Liabilities Measurements at Inventory- Commodity Debt Conversion Option Total (In millions) Balance, December 31, 2022 $ 89 $ 603 $ 6 $ 698 Total increase (decrease) in net realized/unrealized losses included in cost of products sold and interest expense 5 1,303 (6) 1,302 Purchases 49 — — 49 Settlements (35) (1,583) — (1,618) Transfers into Level 3 1 157 — 158 Transfers out of Level 3 (8) (23) — (31) Ending balance, December 31, 2023 (1) $ 101 $ 457 $ — $ 558 (1) Includes increase in unrealized losses Level 3 Fair Value Assets Measurements at Inventories Commodity Total (In millions) Balance, December 31, 2021 $ 3,004 $ 460 $ 3,464 Total increase (decrease) in net realized/unrealized gains included in cost of products sold 867 1,648 2,515 Purchases 49,735 — 49,735 Sales (50,414) — (50,414) Settlements — (1,672) (1,672) Transfers into Level 3 1,088 400 1,488 Transfers out of Level 3 (1,520) (295) (1,815) Ending balance, December 31, 2022 (1) $ 2,760 $ 541 $ 3,301 (1) Includes increase in unrealized gains Level 3 Fair Value Liabilities Measurements at Inventory- Commodity Debt Conversion Option Total (In millions) Balance, December 31, 2021 $ 106 $ 815 $ 15 $ 936 Total increase (decrease) in net realized/unrealized losses included in cost of products sold and interest expense 3 2,483 (9) 2,477 Purchases 183 — — 183 Sales (203) — — (203) Settlements — (2,844) — (2,844) Transfers into Level 3 — 401 — 401 Transfers out of Level 3 — (252) — (252) Ending balance, December 31, 2022 (1) $ 89 $ 603 $ 6 $ 698 (1) Includes increase in unrealized losses Transfers into Level 3 of assets and liabilities previously classified in Level 2 were due to the relative value of unobservable inputs to the total fair value measurement of certain products and derivative contracts rising above the 10% threshold. Transfers out of Level 3 were primarily due to the relative value of unobservable inputs to the total fair value measurement of certain products and derivative contracts falling below the 10% threshold and thus permitting reclassification to Level 2. In some cases, the price components that result in differences between exchange-traded prices and local prices for inventories and commodity purchase and sale contracts are observable based upon available quotations for these pricing components, and in some cases, the differences are unobservable. These price components primarily include transportation costs and other adjustments required due to location, quality, or other contract terms. In the table below, these other adjustments are referred to as basis. The following table sets forth the weighted average percentage of the unobservable price components included in the Company’s Level 3 valuations as of December 31, 2023 and 2022. The Company’s Level 3 measurements may include basis only, transportation cost only, or both price components. As an example, for Level 3 inventories with basis, the unobservable component as of December 31, 2023 is a weighted average 25.0% of the total price for assets and 33.2% of the total price for liabilities. Weighted Average % of Total Price December 31, 2023 December 31, 2022 Component Type Assets Liabilities Assets Liabilities Inventories and Related Payables Basis 25.0% 33.2% 19.4% 15.2% Transportation cost 11.5% —% 10.5% —% Commodity Derivative Contracts Basis 24.2% 24.9% 22.7% 26.5% Transportation cost 9.3% 3.2% 13.5% 3.7% In certain of the Company’s principal markets, the Company relies on price quotes from third parties to value its inventories and physical commodity purchase and sale contracts. These price quotes are generally not further adjusted by the Company in determining the applicable market price. In some cases, availability of third-party quotes is limited to only one or two independent sources. In these situations, absent other corroborating evidence, the Company considers these price quotes as 100% unobservable and, therefore, the fair value of these items is reported in Level 3.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments & Hedging Activities	Derivative Instruments & Hedging Activities Derivatives Not Designated as Hedging Instruments The majority of the Company’s derivative instruments have not been designated as hedging instruments. The Company uses exchange-traded futures and exchange-traded and OTC options contracts to manage its net position of merchandisable agricultural product inventories and forward cash purchase and sales contracts to reduce price risk caused by market fluctuations in agricultural commodities and foreign currencies. The Company also uses exchange-traded futures and exchange-traded and OTC options contracts as components of merchandising strategies designed to enhance margins. The results of these strategies can be significantly impacted by factors such as the correlation between the value of exchange-traded commodities futures contracts and the value of the underlying commodities, counterparty contract defaults, and volatility of freight markets. Derivatives, including exchange traded contracts and forward commodity purchase or sale contracts, and inventories of certain merchandisable agricultural products, which include amounts acquired under deferred pricing contracts, are stated at fair value or market value. Inventory is not a derivative and therefore fair values of and changes in fair values of inventories are not included in the tables below. The following table sets forth the fair value of derivatives not designated as hedging instruments as of December 31, 2023 and 2022. December 31, 2023 December 31, 2022 Assets Liabilities Assets Liabilities (In millions) Foreign Currency Contracts $ 187 $ 122 $ 154 $ 275 Commodity Contracts 1,343 957 1,337 1,248 Debt Conversion Option — — — 6 Total $ 1,530 $ 1,079 $ 1,491 $ 1,529 The following table sets forth the pre-tax gains (losses) on derivatives not designated as hedging instruments that have been included in the consolidated statements of earnings for the years ended December 31, 2023, 2022, and 2021. Cost of Other expense (income) - net products Interest (In millions) Revenues sold Expense For the Year Ended December 31, 2023 Consolidated Statement of Earnings $ 93,935 $ 86,422 $ 647 $ (176) Pre-tax gains (losses) on: Foreign Currency Contracts $ (33) $ 322 $ — $ 43 Commodity Contracts — 619 — — Debt Conversion Option — — 6 Total gain (loss) recognized in earnings $ (33) $ 941 $ 6 $ 43 $ 957 For the Year Ended December 31, 2022 Consolidated Statement of Earnings $ 101,556 $ 93,986 $ 396 $ (358) Pre-tax gains (losses) on: Foreign Currency Contracts $ (42) $ 367 $ — $ 194 Commodity Contracts — (120) — — Debt Conversion Option — — 9 — Total gain (loss) recognized in earnings $ (42) $ 247 $ 9 $ 194 $ 408 For the Year Ended December 31, 2021 Consolidated Statement of Earnings $ 85,249 $ 79,262 $ 265 $ (94) Pre-tax gains (losses) on: Foreign Currency Contracts $ 3 $ (140) $ — $ 189 Commodity Contracts — (1,606) — — Debt Conversion Option — — 19 — Total gain (loss) recognized in earnings $ 3 $ (1,746) $ 19 $ 189 $ (1,535) Changes in the market value of inventories of certain merchandisable agricultural commodities, inventory-related payables, forward cash purchase and sales contracts, exchange-traded futures, and exchange-traded and OTC options contracts are recognized in earnings immediately as a component of cost of products sold. Changes in the fair value of foreign currency-related derivatives are recognized in the consolidated statements of earnings as a component of revenues, cost of products sold, and other (income) expense - net depending on the purpose of the contract. Derivatives Designated as Cash Flow or Net Investment Hedging Instruments The Company had certain derivatives designated as cash flow and net investment hedges as of December 31, 2023 and 2022. For derivative instruments that are designated and qualify as highly-effective cash flow hedges (i.e., hedging the exposure to variability in expected future cash flow that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of AOCI and as an operating activity in the statement of cash flows and reclassified into earnings in the same line item affected by the hedged transaction and in the same period or periods during which the hedged transaction affects earnings. Hedge components excluded from the assessment of effectiveness and gains and losses related to discontinued hedges are recognized in the consolidated statement of earnings during the current period. Commodity Contracts For each of the hedge programs described below, the derivatives are designated as cash flow hedges. The changes in the market value of such derivative contracts have historically been, and are expected to continue to be, highly effective at offsetting changes in price movements of the hedged item. Once the hedged item is recognized in earnings, the gains and losses arising from the hedge are reclassified from AOCI to either revenues or cost of products sold, as applicable. The Company uses futures or options contracts to hedge the purchase price of anticipated volumes of corn to be purchased and processed in a future month. The objective of this hedging program is to reduce the variability of cash flows associated with the Company’s forecasted purchases of corn. The Company’s corn processing plants normally grind approximately 59 million bushels per month. During the past 12 months, the Company hedged between 18% and 34% of its monthly grind. At December 31, 2023, the Company had designated hedges representing between 4% to 28% of its anticipated monthly grind of corn for the next 12 months. The Company, from time to time, also uses futures, options, and swaps to hedge the sales price of certain ethanol sales contracts. The Company has established hedging programs for ethanol sales contracts that are indexed to unleaded gasoline prices and to various exchange-traded ethanol contracts. The objective of these hedging programs is to reduce the variability of cash flows associated with the Company’s sales of ethanol. During the past 12 months and as of December 31, 2023, the Company had no hedges related to ethanol sales. The Company uses futures and options contracts to hedge the purchase price of anticipated volumes of soybeans to be purchased and processed in a future month for certain of its U.S. soybean crush facilities, subject to certain program limits. The Company also uses futures or options contracts to hedge the sales prices of anticipated soybean meal and soybean oil sales proportionate to the soybean crushing process at these facilities, subject to certain program limits. During the past 12 months, the Company hedged between 77% and 100% of the anticipated monthly soybean crush for soybean purchases and soybean meal and oil sales at the designated facilities. At December 31, 2023, the Company had designated hedges representing between 0% and 100% of the anticipated monthly soybean crush for soybean purchases and soybean meal and oil sales at the designated facilities over the next 12 months. The Company uses futures and OTC swaps to hedge the purchase price of anticipated volumes of natural gas consumption in a future month for certain of its facilities in North America and Europe, subject to certain program limits. During the past 12 months, the Company hedged between 54% and 85% of the anticipated monthly natural gas consumption at the designated facilities. At December 31, 2023, the Company had designated hedges representing between 38% and 64% of the anticipated monthly natural gas consumption over the next 12 months. As of December 31, 2023 and 2022, the Company had after-tax gains of $42 million and after-tax losses of $17 million in AOCI, respectively, related to gains and losses from these programs. The Company expects to recognize $42 million of the 2023 after-tax gains in its consolidated statement of earnings during the next 12 months. Interest Rate Contracts The Company used swap locks designated as cash flow hedges to hedge the changes in the forecasted interest payments due to changes in the benchmark rate leading up to future bond issuance dates. The terms of the swap locks matched the terms of the forecasted interest payments. The deferred gains and losses will be recognized in interest expense over the period in which the related interest payments will be paid. As of December 31, 2022, the Company executed swap locks maturing on various dates with an aggregate notional amount of $400 million. During the quarter ended March 31, 2023, the Company unwound the swap locks in anticipation of the April 3, 2023 debt issuance. Foreign Currency Contracts The Company uses cross-currency swaps and foreign exchange forwards designated as net investment hedges to protect the Company’s investment in a foreign subsidiary against changes in foreign currency exchange rates. The Company executed USD-fixed to Euro-fixed cross-currency swaps with an aggregate notional amount of $0.8 billion as of December 31, 2023 and 2022, and foreign exchange forwards with an aggregate notional amount of $2.1 billion and $2.5 billion as of December 31, 2023 and 2022, respectively. Amounts excluded from the assessment of hedge effectiveness are immaterial for all periods presented. As of December 31, 2023 and 2022, the Company had after-tax losses of $5 million and after-tax gains of $79 million in AOCI, respectively, related to foreign exchange gains and losses from net investment hedge transactions. The amount is deferred in AOCI until the underlying investment is divested. The following table sets forth the fair value of derivatives designated as hedging instruments as of December 31, 2023 and 2022. December 31, 2023 December 31, 2022 Assets Liabilities Assets Liabilities (In millions) Commodity Contracts $ 16 $ — $ — $ 20 Interest Rate Contracts — — 109 — Foreign Currency Contracts — 22 104 — Total $ 16 $ 22 $ 213 $ 20 The following table sets forth the pre-tax gains (losses) on derivatives designated as hedging instruments that have been included in the consolidated statement of earnings for the years ended December 31, 2023, 2022, and 2021. Cost of products sold (In millions) Revenues For the Year Ended December 31, 2023 Consolidated Statement of Earnings $ 93,935 $ 86,422 Effective amounts recognized in earnings Pre-tax gains (losses) on: Commodity Contracts — 322 Total gain (loss) recognized in earnings $ — $ 322 $ 322 For the Year Ended December 31, 2022 Consolidated Statement of Earnings $ 101,556 $ 93,986 Effective amounts recognized in earnings Pre-tax gains (losses) on: Commodity Contracts $ — $ 351 Interest Rate Contracts 1 — Total gain (loss) recognized in earnings $ 1 $ 351 $ 352 For the Year Ended December 31, 2021 Consolidated Statement of Earnings $ 85,249 $ 79,262 Effective amounts recognized in earnings Pre-tax gains (losses) on: Commodity Contracts $ — $ 490 Interest Rate Contracts (16) — Total gain (loss) recognized in earnings $ (16) $ 490 $ 474 Other Net Investment Hedging Strategies The Company has designated €0.7 billion and €1.3 billion of its outstanding long-term debt and commercial paper borrowings at December 31, 2023 and 2022, respectively, as hedges of its net investment in a foreign subsidiary. As of December 31, 2023 and 2022, the Company had after-tax gains of $212 million and $228 million in AOCI, respectively, related to foreign exchange gains and losses from the net investment hedge transactions. The amount is deferred in AOCI until the underlying investment is divested.

Other Current Assets

Other Current Assets	12 Months Ended
	Dec. 31, 2023
Other Assets [Abstract]
Other Current Assets	Other Current Assets The following table sets forth the items in other current assets: December 31, 2023 December 31, 2022 (In millions) Unrealized gains on derivative contracts $ 1,546 $ 1,704 Margin deposits and grain accounts 560 723 Customer omnibus receivable 1,052 1,309 Financing receivables - net (1) 237 235 Insurance premiums receivable 61 54 Prepaid expenses 445 443 Biodiesel tax credit 119 68 Tax receivables 491 616 Non-trade receivables 304 361 Other current assets 167 153 $ 4,982 $ 5,666 (1) The Company provides financing to suppliers, primarily Brazilian farmers, to finance a portion of the suppliers’ production costs. The amounts are reported net of allowances of $6 million and $3 million at December 31, 2023 and 2022, respectively. Interest earned on financing receivables of $21 million, $15 million, and $11 million for the years ended December 31, 2023, 2022, and 2021, respectively, is included in interest and investment income in the consolidated statements of earnings.

Accrued Expenses And Other Paya

Accrued Expenses And Other Payables	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses And Other Payables	Accrued Expenses and Other Payables The following table sets forth the items in accrued expenses and other payables: December 31, 2023 December 31, 2022 (In millions) Unrealized losses on derivative contracts $ 1,101 $ 1,543 Accrued compensation 439 475 Income tax payable 284 248 Other taxes payable 172 136 Insurance claims payable 73 223 Contract liability 626 694 Other accruals and payables 1,381 1,476 $ 4,076 $ 4,795

Investments In And Advances To

Investments In And Advances To Affiliates	12 Months Ended
	Dec. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]
Investments In And Advances To Affiliates	Investments in and Advances to Affiliates The Company applies the equity method of accounting for investments in investees over which ADM has the ability to exercise significant influence, including the Company’s 22.5% share ownership in Wilmar as of December 31, 2023 and 2022. As of December 31, 2023, the Company also holds equity method investments in Pacificor (32.2%), Stratas Foods LLC (50.0%), Edible Oils Limited (50.0%), Olenex (37.5%), SoyVen (50.0%), Hungrana Ltd (50.0%), Almidones Mexicanos S.A. (50.0%), Aston Foods and Food Ingredients (50.0%), Red Star Yeast Company, LLC (40.0%), LSCP, LLLP (22.1%), Vimison S.A. de C.V. (45.3%), ADM Matsutani LLC (50%), Matsutani Singapore Pte. Ltd. (50%), ADM Vland Biotech Shandong Co., Ltd. (50%), Dusial S.A. (42.8%), and Vitafort ZRT (34.3%). The Company had 73 and 67 unconsolidated domestic and foreign affiliates as of December 31, 2023 and 2022, respectively. The following table summarizes the combined balance sheets as of December 31, 2023 and 2022, and the combined statements of earnings of the Company’s unconsolidated affiliates for the years ended December 31, 2023, 2022, and 2021. December 31 (In millions) 2023 2022 Current assets $ 41,032 $ 41,407 Non-current assets 29,773 30,589 Current liabilities (33,812) (36,091) Non-current liabilities (8,973) (9,300) Noncontrolling interests (2,489) (2,641) Net assets $ 25,531 $ 23,964 Year Ended December 31 (In millions) 2023 2022 2021 Revenues $ 85,754 $ 109,448 $ 87,528 Gross profit 4,261 8,946 7,719 Net income 2,452 3,140 2,315 The Company’s share of the undistributed earnings of its unconsolidated affiliates as of December 31, 2023 is $5.9 billion. The Company’s investment in Wilmar has a carrying value of $4.1 billion as of December 31, 2023, and a market value of $3.8 billion based on quoted market price converted to U.S. dollars at the applicable exchange rate at December 31, 2023. The Company evaluated the near-term prospects of Wilmar in relation to the severity and duration of the decline in fair value. Based on that evaluation, the Company does not consider the investment to be other-than-temporarily impaired at December 31, 2023. The Company provides credit facilities totaling $121 million to six unconsolidated affiliates. One facility that bears interest at 5.97% has an outstanding balance of $2 million while the other five facilities have no outstanding balance as of December 31, 2023. The outstanding balance is included in other current assets in the accompanying consolidated balance sheet. Net sales to unconsolidated affiliates during the years ended December 31, 2023, 2022, and 2021 were $7.0 billion, $7.8 billion, and $6.6 billion, respectively. Accounts receivable due from unconsolidated affiliates as of December 31, 2023 and 2022 was $167 million and $286 million, respectively.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill balances attributable to consolidated businesses, by segment, are set forth in the following table. December 31, 2023 December 31, 2022 (In millions) Ag Services and Oilseeds $ 235 $ 193 Carbohydrate Solutions 224 224 Nutrition 3,640 3,731 Other Business 4 14 Total $ 4,103 $ 4,162 The changes in goodwill during the year ended December 31, 2023 were primarily related to impairment of $137 million in the Animal Nutrition reporting unit of Nutrition, partially offset by an increase due to an acquisition of $20 million principally in the Ag Services and Oilseeds segment and foreign currency translation gains of $65 million primarily in the Nutrition segment. As of December 31, 2023 and 2022, accumulated amortization loss was $156 million and $19 million, respectively. The following table sets forth the other intangible assets: December 31, 2023 December 31, 2022 Useful Gross Accumulated Gross Accumulated Life Amount Amortization Net Amount Amortization Net (In years) (In millions) Intangible assets with indefinite lives: Trademarks/brands $ 375 $ — $ 375 $ 397 $ — $ 397 Other 58 — 58 — — — Intangible assets with definite lives: Trademarks/brands 5 to 20 53 (35) 18 70 (28) 42 Customer lists 1 to 30 1,544 (627) 917 1,544 (542) 1,002 Capitalized software and related costs 5 to 8 950 (523) 427 721 (449) 272 Land rights 2 to 50 107 (30) 77 109 (25) 84 Other intellectual property 6 to 20 211 (135) 76 228 (112) 116 Recipes and other 1 to 35 511 (304) 207 547 (274) 273 Intangible assets in process 83 — 83 196 — 196 Total $ 3,892 $ (1,654) $ 2,238 $ 3,812 $ (1,430) $ 2,382 The changes in the gross amounts during the year ended December 31, 2023 were primarily related to additions to capitalized software and related costs, net of the decrease in intangible assets in process and increases related to foreign currency translation of $53 million, partially offset by impairments of $64 million and reclassifications. The changes in accumulated amortization during the year ended December 31, 2023 were related to amortization expense and foreign currency translation of $15 million, partially offset by reclassifications. Aggregate amortization expense was $234 million, $235 million, and $177 million for the years ended December 31, 2023, 2022, and 2021, respectively, of which $72 million, $69 million, and $33 million, respectively, were for amortization of capitalized software and related costs. The estimated future aggregate amortization expense for the next five years is $338 million, $345 million, $337 million, $330 million, and $310 million, respectively.

Debt Financing Arrangements

Debt Financing Arrangements	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Debt Financing Arrangements	Debt Financing Arrangements The Company’s long-term debt consisted of the following: Debt Instrument Interest Rate Face Amount Due Date December 31, 2023 December 31, 2022 (In millions) 2.5% Notes $1 billion 2026 $ 998 $ 997 3.25% Notes $1 billion 2030 991 989 2.900% Notes $750 million 2032 744 744 2.700% Notes $750 million 2051 732 731 1% Notes €650 million 2025 717 691 4.5% Notes $600 million 2049 589 589 4.500% Notes $500 million 2033 492 — 5.375% Debentures $432 million 2035 426 425 3.75% Notes $408 million 2047 403 403 5.935% Debentures $336 million 2032 334 334 5.765% Debentures $297 million 2041 297 297 4.535% Debentures $383 million 2042 288 286 4.016% Debentures $371 million 2043 263 260 7% Debentures $160 million 2031 159 159 6.95% Debentures $157 million 2097 154 154 7.5% Debentures $147 million 2027 147 147 6.625% Debentures $144 million 2029 144 144 6.75% Debentures $103 million 2027 103 103 6.45% Debentures $103 million 2038 102 102 1.750% Notes €600 million 2023 — 641 0% Bonds $300 million 2023 — 304 Other 177 177 Total long-term debt including current maturities 8,260 8,677 Current maturities (1) (942) Total long-term debt $ 8,259 $ 7,735 On April 3, 2023, the Company issued $500 million aggregate principal amount of 4.500% Notes due August 15, 2033. Net proceeds before expenses were $493 million. Proceeds from the borrowings were used for general corporate purposes. In June 2023, the Company redeemed €600 million aggregate principal amount of 1.750% Notes due 2023. In August 2023, the Company redeemed $300 million aggregate principal amount of zero coupon exchangeable bonds due 2023. During the year ended December 31, 2023, Archer Daniels Midland Singapore, Pte. Ltd., a wholly-owned subsidiary of the Company, increased its revolving credit facility from $500 million to $750 million at an interest rate of Secured Overnight Financing Rate plus a fixed spread. The facility is used to finance working capital requirements and for general corporate purposes. On February 28, 2022, the Company issued its first sustainability bond of $750 million aggregate principal amount of 2.900% notes due March 1, 2032. Net proceeds before expenses were $745 million. Proceeds from the borrowings were used to finance investments and expenditures in eligible green projects that contribute to environmental objectives and/or eligible social projects that aim to address or mitigate a specific social issue and/or seek to achieve positive social outcomes. In September 2022, the Company redeemed €500 million aggregate principal amount of Fixed-to-Floating Rate Senior Notes due 2022 issued in a private placement on March 25, 2021. Discount amortization expense, net of premium amortization, of $15 million, $6 million, and $10 million for the years ended December 31, 2023, 2022, and 2021, respectively, are included in interest expense related to the Company’s long-term debt. At December 31, 2023, the fair value of the Company’s long-term debt exceeded the carrying value by $0.3 billion, as estimated using quoted market prices (a Level 2 measurement under applicable accounting standards). The aggregate maturities of long-term debt for the five years after December 31, 2023, are $1 million, $718 million, $999 million, $251 million, and $1 million, respectively. At December 31, 2023, the Company had lines of credit, including the accounts receivable securitization programs described below, totaling $13.2 billion, of which $11.5 billion was unused. The weighted average interest rates on short-term borrowings outstanding at December 31, 2023 and 2022, were 7.44% and 6.21%, respectively. Of the Company’s total lines of credit, $5.0 billion supported the combined U.S. and European commercial paper borrowing programs, against which there was $5 million commercial paper outstanding at December 31, 2023. The Company’s credit facilities and certain debentures require the Company to comply with specified financial and non-financial covenants including maintenance of minimum tangible net worth as well as limitations related to incurring liens, secured debt, and certain other financing arrangements. The Company is in compliance with these covenants as of December 31, 2023. The Company had outstanding standby letters of credit and surety bonds at December 31, 2023 and 2022, totaling $1.6 billion. The Company has accounts receivable securitization programs (the “Programs”). The Programs provide the Company with up to $3.0 billion in funding resulting from the sale of accounts receivable. As of December 31, 2023, the Company utilized $1.6 billion of its facility under the Programs (see Note 19 for more information on the Programs).

Stock Compensation

Stock Compensation	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Stock Compensation	Stock Compensation The Company’s employee stock compensation plans provide for the granting of options to employees to purchase common stock of the Company pursuant to the Company’s 2020 Incentive Compensation Plan. These options are issued at market value on the date of grant, vest incrementally over one year to five years, and expire ten years after the date of grant. The fair value of each option grant is estimated as of the date of grant using the Black-Scholes single option pricing model. The volatility assumption used in the Black-Scholes single option pricing model is based on the historical volatility of the Company’s stock. The volatility of the Company’s stock was calculated based upon the monthly closing price of the Company’s stock for the period immediately prior to the date of grant corresponding to the average expected life of the grant. The average expected life represents the period of time that option grants are expected to be outstanding. The risk-free rate is based on the rate of U.S. Treasury zero-coupon issues with a remaining term equal to the expected life of option grants. No options were granted in 2023, 2022, and 2021. A summary of option activity during 2023 is presented below: Shares Weighted-Average (In thousands, except per share amounts) Shares under option at December 31, 2022 2,097 $38.27 Exercised (483) 42.15 Forfeited or expired — 0.00 Shares under option at December 31, 2023 1,614 $37.11 Exercisable at December 31, 2023 1,614 $37.11 The weighted-average remaining contractual term of options outstanding and exercisable at December 31, 2023, is 2 years. The aggregate intrinsic value of options outstanding and exercisable at December 31, 2023, is $59 million. The total intrinsic values of options exercised during the years ended December 31, 2023, 2022, and 2021, were $20 million, $117 million, and $37 million, respectively. Cash proceeds received from options exercised during the years ended December 31, 2023, 2022, and 2021, were $20 million, $90 million, and $64 million, respectively. At December 31, 2023, unrecognized compensation expense related to option grants to be recognized as compensation expense during the next year was immaterial. The Company’s 2020 Incentive Compensation Plan provides for the granting of restricted stock and restricted stock units (Restricted Stock Awards) at no cost to certain officers and key employees. In addition, the Company’s 2020 Incentive Compensation Plan also provides for the granting of performance stock units (PSUs) at no cost to certain officers and key employees. Restricted Stock Awards are made in common stock or stock units with equivalent rights and vest at the end of a restriction period of three years. Starting with the February 2023 grant, Restricted Stock Awards have a three-year graded vesting schedule and vest at 33.33% each year. The awards for PSUs are made in common stock units and vest at the end of a vesting period of three years subject to the attainment of certain future service and performance criteria based on the Company’s adjusted return on invested capital (ROIC) and adjusted earnings per share (EPS) with a modifier for gender parity and GHG emissions. During the years ended December 31, 2023, 2022, and 2021, 1.7 million, 2.3 million, and 2.7 million common stock or stock units, respectively, were granted as Restricted Stock Awards and PSUs. At December 31, 2023, there were 13.5 million shares available for future grants pursuant to the 2020 plan. The fair value of Restricted Stock Awards and PSUs is determined based on the market value of the Company’s shares on the grant date. The weighted-average grant-date fair values of awards granted during the years ended December 31, 2023, 2022, and 2021 were $78.90, $70.13, and $53.28, respectively. A summary of Restricted Stock Awards and PSUs activity during 2023 is presented below: Restricted Weighted Average (In thousands, except per share amounts) Non-vested at December 31, 2022 6,408 $57.22 Granted 1,663 78.90 Vested (2,559) 45.66 Forfeited (180) 71.22 Non-vested at December 31, 2023 5,332 $69.82 At December 31, 2023, there was $91 million of total unrecognized compensation expense related to Restricted Stock Awards and PSUs. Amounts to be recognized as compensation expense during the next three years are $58 million, $30 million, and $3 million, respectively. The total grant-date fair value of Restricted Stock Awards that vested during the year ended December 31, 2023 was $153 million. Compensation expense for option grants, Restricted Stock Awards, and PSUs granted to employees is generally recognized on a straight-line basis during the service period of the respective grant. Certain of the Company’s option grants, Restricted Stock Awards, and PSUs continue to vest upon the recipient’s retirement from the Company and compensation expense related to option grants and Restricted Stock Awards granted to retirement-eligible employees is recognized in earnings on the date of grant. Compensation expense for PSUs is based on the probability of meeting the performance criteria. The Company recognizes forfeitures as they occur. Total compensation expense for option grants, Restricted Stock Awards, and PSUs recognized during the years ended December 31, 2023, 2022, and 2021 was $112 million, $147 million, and $161 million, respectively. Changes in incentive compensation expense are primarily caused by the level of attainment of the PSU performance criteria described above.

Other (Income) Expense - Net

Other (Income) Expense - Net	12 Months Ended
	Dec. 31, 2023
Other Income and Expenses [Abstract]
Other (Income) Expense - Net	Other (Income) Expense – Net The following table sets forth the items in other (income) expense: (In millions) Year Ended December 31 2023 2022 2021 Gains on sale of assets $ (38) $ (78) $ (100) Pension settlement — — 83 Other – net (138) (280) (77) $ (176) $ (358) $ (94) Individually significant items included in the table above are: Gains on sale of assets for the year ended December 31, 2023 and 2022 consisted of gains on sales of certain assets and disposals of individually insignificant assets in the ordinary course of business. Gains on sale of assets for the year ended December 31, 2021 consisted of gains on the sale of the Company’s ethanol production complex in Peoria, Illinois of $22 million, the sale of certain other assets, and disposals of individually insignificant assets in the ordinary course of business. Pension settlement for the year ended December 31, 2021 was related to the purchase of group annuity contracts that irrevocably transferred the future benefit obligations and annuity administration for certain salaried and hourly retirees and terminated vested participants under the Company’s ADM Retirement Plan and ADM Pension Plan for Hourly-Wage Employees to independent third parties. Other - net Other - net

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The following table sets forth the geographic split of earnings before income taxes: Year Ended (In millions) December 31 2023 2022 2021 United States $ 1,844 $ 2,725 $ 2,140 Foreign 2,450 2,508 1,173 $ 4,294 $ 5,233 $ 3,313 Significant components of income taxes are as follows: (In millions) Year Ended December 31 2023 2022 2021 Current Federal $ 291 $ 379 $ 404 State 47 97 79 Foreign 513 481 224 Deferred Federal (52) 23 (59) State (10) 7 (12) Foreign 39 (119) (58) $ 828 $ 868 $ 578 Significant components of deferred tax liabilities and assets are as follows: December 31, 2023 December 31, 2022 (In millions) Deferred tax liabilities Property, plant, and equipment $ 827 $ 811 Intangibles 358 417 Right of use assets 263 237 Equity in earnings of affiliates 214 191 Inventory reserves — 11 Debt exchange 50 52 Reserves and other accruals 49 86 Other 137 108 $ 1,898 $ 1,913 Deferred tax assets Pension and postretirement benefits $ 111 $ 104 Inventories 20 — Lease liabilities 268 244 Stock compensation 42 51 Foreign tax loss carryforwards 494 496 Capital loss carryforwards 42 42 State tax attributes 25 21 Reserves and other accruals 5 22 Other 93 77 Gross deferred tax assets 1,100 1,057 Valuation allowances (216) (209) Net deferred tax assets $ 884 $ 848 Net deferred tax liabilities $ 1,014 $ 1,065 The net deferred tax liabilities are classified as follows: Noncurrent assets (foreign) $ 295 $ 337 Noncurrent liabilities (1,106) (1,183) Noncurrent liabilities (foreign) (203) (219) $ (1,014) $ (1,065) During 2023, the Company increased valuation allowances primarily related to net operating loss carryforwards. Reconciliation of the statutory federal income tax rate to the Company’s effective income tax rate on earnings is as follows: Year Ended December 31 2023 2022 2021 Statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal tax benefit 0.9 1.4 1.5 Foreign earnings taxed at rates other than the U.S. statutory rate (0.2) (3.8) (2.8) Foreign currency effects/remeasurement 0.5 0.6 — Income tax adjustment to filed returns (0.4) (0.1) 0.7 Tax benefit on U.S. biodiesel credits (1.7) (1.2) (1.9) Tax benefit on U.S. railroad credits (1.5) (1.2) (2.0) U.S. tax on foreign earnings 1.2 0.2 — Valuation allowances (0.2) — 0.7 Other (0.3) (0.3) 0.2 Effective income tax rate 19.3 % 16.6 % 17.4 % The effective tax rates for 2023 and 2022 were impacted by the geographic mix of earnings. The effective tax rate for 2022 was also impacted by discrete tax items. The effective tax rate for 2021 was impacted by the geographic mix of earnings and U.S. tax credits, including the biodiesel tax credit and the railroad maintenance tax credit. ADM’s operations in foreign jurisdictions accounted for 57%, 48%, and 35% of the Company’s total pre-tax earnings in fiscal years 2023, 2022, and 2021, respectively. The foreign rate differential was primarily due to various tax rates applicable to the income earned from the Company’s operations in Switzerland, Asia, South America and the Caribbean. On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (“Inflation Act”), which includes, among other provisions, changes to the U.S. corporate income tax system, including a 15% minimum tax based on “adjusted financial statement income,” and a one percent excise tax on net repurchases of stock for tax years beginning after December 31, 2022. While the Inflation Act has no immediate impact and is not expected to have a material adverse effect on ADM’s results of operations going forward, the Company will continue to evaluate its impact as further information becomes available. Undistributed earnings of the Company’s foreign subsidiaries and corporate joint ventures were approximately $17.9 billion at December 31, 2023. Because these undistributed earnings continue to be indefinitely reinvested in foreign operations, no income taxes, other than the transition tax, the U.S. tax on undistributed Subpart F, and the minimum tax on Global Intangible Low Taxed Income (GILTI), have been provided after the Tax Cuts and Jobs Act (the “Act”) was enacted on December 22, 2017. It is not practicable to determine the amount of unrecognized deferred tax liability related to any remaining undistributed earnings of foreign subsidiaries and corporate joint ventures not subject to the transition tax. The Company has elected to pay the one-time transition tax on accumulated foreign earnings over eight years. As of December 31, 2023, the Company’s remaining transition tax liability was $85 million, which will be paid in installments through 2025. The Company incurred U.S. taxable income of $425 million, $684 million, and $244 million related to GILTI and deducted $77 million, $67 million, and $87 million related to Foreign Derived Intangible Income Deduction in fiscal years 2023, 2022, and 2021 respectively. The Company made an accounting policy election to treat GILTI as a period cost. The Company has recorded and will continue to record the impact of tax reform items as U.S. tax authorities issue Treasury Regulations and other guidance addressing tax reform-related changes. The additional guidance, along with the potential for additional global tax legislation changes, may affect significant deductions and income inclusions and could have a material adverse effect on the Company’s net income or cash flow. The Company had $494 million and $496 million of tax assets related to net operating loss carryforwards of certain international subsidiaries at December 31, 2023 and 2022, respectively. As of December 31, 2023, approximately $412 million of these assets have no expiration date, and the remaining $82 million expire at various times through fiscal 2033. The annual usage of certain of these assets is limited to a percentage of taxable income of the respective foreign subsidiary for the year. The Company has recorded a valuation allowance of $160 million and $142 million against these tax assets at December 31, 2023 and 2022, respectively, due to the uncertainty of their realization. The Company had $42 million of tax assets related to foreign capital loss carryforwards at December 31, 2023 and 2022. The Company has recorded a valuation allowance of $42 million against these tax assets at December 31, 2023 and 2022 due to the uncertainty of their realization. The Company had $25 million and $21 million of tax assets related to state income tax attributes (incentive credits and net operating loss carryforwards), net of federal tax benefit, at December 31, 2023 and 2022, respectively, a majority of which will expire between 2024 and 2028. Due to the uncertainty of realization, the Company recorded a valuation allowance of $14 million and $15 million related to state income tax assets net of federal tax benefit as of December 31, 2023 and 2022, respectively. The change in the valuation allowance was related to the expiration of certain state income tax attributes which were fully reserved in prior years. The Company remains subject to federal examination in the U.S. for the calendar tax years 2018 through 2023. The following table sets forth a rollforward of activity of unrecognized tax benefits for the year ended December 31, 2023 and 2022 as follows: Unrecognized Tax Benefits December 31, 2023 December 31, 2022 (In millions) Beginning balance $ 151 $ 157 Additions related to current year’s tax positions 2 6 Additions related to prior years’ tax positions 28 26 Additions (adjustments) related to acquisitions — 11 Reductions related to lapse of statute of limitations (6) (6) Settlements with tax authorities (7) (43) Ending balance $ 168 $ 151 The additions and reductions in unrecognized tax benefits shown in the table included effects related to net income and shareholders’ equity. The changes in unrecognized tax benefits did not have a material effect on the Company’s net income or cash flow. At December 31, 2023 and 2022, the Company had accrued interest and penalties on unrecognized tax benefits of $52 million and $39 million, respectively. The Company is subject to income taxation and routine examinations in many jurisdictions around the world and frequently faces challenges regarding the amount of taxes due. These challenges include positions taken by the Company related to the timing, nature, and amount of deductions and the allocation of income among various jurisdictions. In its routine evaluations of the exposure associated with various tax filing positions, the Company recognizes a liability, when necessary, for estimated potential tax owed by the Company in accordance with applicable accounting standards. Resolution of the related tax positions, through negotiations with relevant tax authorities or through litigation, may take years to complete. Therefore, it is difficult to predict the timing for resolution of tax positions and the Company cannot predict or provide assurance as to the ultimate outcome of these ongoing or future examinations. However, the Company does not anticipate that the total amount of unrecognized tax benefits will increase or decrease significantly in the next twelve months. Given the long periods of time involved in resolving tax positions, the Company does not expect that the recognition of unrecognized tax benefits will have a material impact on the Company’s effective income tax rate in any given period. If the total amount of unrecognized tax benefits were recognized by the Company at one time, there would be a reduction of $165 million on the tax expense for that period. In 2014, the Company’s wholly-owned subsidiary in the Netherlands, ADM Europe B.V., received a tax assessment from the Netherlands tax authority challenging the transfer pricing aspects of a 2009 business reorganization, which involved two of its subsidiary companies in the Netherlands. As of December 31, 2023, this assessment was $90 million in tax and $34 million in interest (adjusted for variation in currency exchange rates). On April 23, 2020, the court issued an unfavorable ruling and in October 2020, assigned a third party expert to establish a valuation. During the second quarter of 2021, the third party expert issued a final valuation. On September 30, 2022, the court issued a ruling consistent with the valuation report, and the Dutch tax authorities have filed an appeal. During the quarter ended March 31, 2023, ADM filed a cross-appeal. As of December 31, 2023, the Company has accrued its best estimate of what it believes will be the likely outcome of the litigation.

Leases

Leases	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Lessee, Operating Leases	Leases Lessee Accounting The Company leases certain transportation equipment, plant equipment, office equipment, land, buildings, and storage facilities. Most leases include options to renew, with renewal terms that can extend the lease term from 6 months to 49 years. The renewal options are not included in the measurement of the right of use assets and lease liabilities unless the Company is reasonably certain to exercise the optional renewal periods. Certain leases also include index and non-index escalation clauses and options to purchase the leased property. Leases accounted for as finance leases were immaterial at December 31, 2023. As an accounting policy election, the Company does not apply the recognition requirements of Topic 842 to short-term leases in all of its underlying asset categories. The Company recognizes short-term lease payments in earnings on a straight-line basis over the lease term, and variable lease payments in the period in which the obligation for those payments is incurred. The Company also combines lease and non-lease contract components in all of its underlying asset categories as an accounting policy election. The following table sets forth the amounts relating to the Company’s total lease cost and other information. Year Ended December 31 2023 2022 2021 (In millions) Lease cost: Operating lease cost $ 390 $ 356 $ 336 Short-term lease cost 126 127 117 Total lease cost $ 516 $ 483 $ 453 Other information: Operating lease liability principal payments $ 374 $ 339 $ 325 Right-of-use assets obtained in exchange for new operating lease liabilities $ 327 $ 357 $ 197 December 31 2023 2022 Weighted-average remaining lease term - operating leases (in years) 7 7 Weighted average discount rate - operating leases 4.1 % 3.7 % Below is a tabular disclosure of the future annual undiscounted cash flows for operating lease liabilities as of December 31, 2023. Undiscounted Cash Flows (In millions) 2024 $ 334 2025 260 2026 186 2027 146 2028 101 Thereafter 339 Total 1,366 Less interest (1) (135) Lease liability $ 1,231 (1) Calculated using the implicit rate of the lease, if available, or the incremental borrowing rate that is appropriate for the tenor and geography of the lease.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2023
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans The Company provides substantially all U.S. employees and employees at certain foreign subsidiaries with retirement benefits including defined benefit pension plans and defined contribution plans. The Company also provides certain eligible U.S. employees who retire under qualifying conditions with subsidized postretirement health care coverage or Health Care Reimbursement Accounts. In 2021, the Company amended the ADM Retirement Plan and the ADM Pension Plan for Hourly-Wage Employees (collectively, the “Plans”) and entered into two binding agreements to purchase: (1) a group annuity contract from Principal Life Insurance Company (“Principal”) and (2) two group annuity contracts, separately from American General Life Insurance Company (“AGL”) and from AGL’s affiliate, The United States Life Insurance Company in the City of New York (“USL”), irrevocably transferring the future benefit obligations and annuity administration for approximately 6,000 retirees and terminated vested participants from the Plans to Principal, AGL, and USL. The purchase of the group annuity contracts was funded directly by the Plans’ assets and reduced the Company’s pension obligations by approximately $0.7 billion. As a result of the transactions, the Company recognized a non-cash pretax pension settlement charge of $83 million for the year ended December 31, 2021. On July 31, 2017, the Company announced that all participants in the Company’s U.S. salaried pension plan and the Supplemental Executive Retirement Plan (SERP) began accruing benefits under the cash balance formula effective January 1, 2022. Benefits for participants who were accruing under the final average pay formula were frozen as of December 31, 2021, including pay and service through that date. The Company maintains 401(k) plans covering substantially all U.S. employees. The Company contributes cash to the plans to match qualifying employee contributions, and also provides a non-matching employer contribution of 1% of pay to eligible participants. Under an employee stock ownership component of the 401(k) plans, employees may choose to invest in the Company’s stock as part of their own investment elections. Assets of the Company’s 401(k) plans consist primarily of listed common stocks and pooled funds. The Company’s 401(k) plans held 5.7 million shares of Company common stock at December 31, 2023, with a market value of $414 million. Cash dividends received on shares of Company common stock by these plans during the year ended December 31, 2023 were $10 million. The following table sets forth the components of retirement plan expense for the years ended December 31, 2023, 2022, and 2021: Pension Benefits Postretirement Benefits (In millions) Year Ended December 31 Year Ended December 31 2023 2022 2021 2023 2022 2021 Retirement plan expense Defined benefit plans: Service cost (benefits earned during the period) $ 41 $ 48 $ 64 $ — $ 1 $ 1 Interest cost 76 48 48 6 3 2 Expected return on plan assets (83) (79) (95) — — — Settlement charges — — 83 — — — Curtailments — (2) — — — — Amortization of actuarial loss 3 17 33 2 5 6 Amortization of prior service cost (credit) (20) (20) (20) — — (2) Net periodic defined benefit plan expense 17 12 113 8 9 7 Defined contribution plans 73 67 61 — — — Total retirement plan expense $ 90 $ 79 $ 174 $ 8 $ 9 $ 7 The following tables set forth changes in the defined benefit obligation and the fair value of defined benefit plan assets for the years ended December 31, 2023 and 2022: Pension Benefits Postretirement Benefits December 31 December 31 December 31 December 31 (In millions) (In millions) Benefit obligation, beginning $ 1,587 $ 2,178 $ 118 $ 154 Service cost 41 48 — 1 Interest cost 76 48 6 3 Actuarial loss (gain) 83 (575) 6 (24) Employee contributions 3 3 — — Curtailments — (2) — — Business combinations (1) — — — Settlements (1) (1) — — Benefits paid (53) (47) (17) (16) Foreign currency effects 30 (65) — — Benefit obligation, ending $ 1,765 $ 1,587 $ 113 $ 118 Fair value of plan assets, beginning $ 1,269 $ 1,742 $ — $ — Actual return on plan assets 121 (438) — — Employer contributions 54 60 17 16 Employee contributions 3 3 — — Settlements (1) (1) — — Benefits paid (53) (47) (17) (16) Foreign currency effects 22 (50) — — Fair value of plan assets, ending $ 1,415 $ 1,269 $ — $ — Funded status $ (350) $ (318) $ (113) $ (118) Prepaid benefit cost $ 63 $ 60 $ — $ — Accrued benefit liability – current (19) (18) (14) (14) Accrued benefit liability – long-term (394) (360) (99) (104) Net amount recognized in the balance sheet $ (350) $ (318) $ (113) $ (118) In 2023, the actuarial loss in the pension plans was primarily due to decreases in the global bond yields while actual return on plan assets was related to favorable asset performance in countries with material assets including the U.S., the U.K., Canada, and Switzerland. The Company uses the corridor approach when amortizing actuarial losses. Under the corridor approach, net unrecognized actuarial losses in excess of 10% of the greater of the projected benefit obligation or the market related value of plan assets are amortized over future periods. For plans with little to no active participants, the amortization period is the remaining average life expectancy of the participants. For plans with active participants, the amortization period is the remaining average service period of the active participants. The amortization periods range from 4 to 27 years for the Company’s defined benefit pension plans and from 5 to 18 years for the Company’s postretirement benefit plans. Included in AOCI for pension benefits at December 31, 2023, are the following amounts that have not yet been recognized in net periodic pension cost: unrecognized prior service credit of $56 million and unrecognized actuarial loss of $272 million. Included in AOCI for postretirement benefits at December 31, 2023, are the following amounts that have not yet been recognized in net periodic postretirement benefit cost: unrecognized prior service cost of $1 million and unrecognized actuarial loss of $20 million. The following table sets forth the principal assumptions used in developing net periodic benefit cost: Pension Benefits Postretirement Benefits December 31 December 31 December 31 December 31 Discount rate 4.8% 2.5% 5.1% 2.7% Expected return on plan assets 6.0% 5.0% N/A N/A Rate of compensation increase 4.3% 4.2% N/A N/A Interest crediting rate 3.9% 1.9% N/A N/A The following table sets forth the principal assumptions used in developing the year-end actuarial present value of the projected benefit obligations: Pension Benefits Postretirement Benefits December 31 December 31 December 31 December 31 Discount rate 4.5 % 4.8 % 4.9% 5.1% Rate of compensation increase 4.8 % 4.3 % N/A N/A Interest crediting rate 4.0 % 3.9 % N/A N/A The projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for the pension plans with projected benefit obligations in excess of plan assets were $1.5 billion, $1.5 billion, and $1.0 billion, respectively, as of December 31, 2023, and $1.3 billion, $1.3 billion, and $0.9 billion, respectively, as of December 31, 2022. The projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of plan assets were $1.5 billion, $1.5 billion, and $1.0 billion, respectively, as of December 31, 2023 and $1.2 billion, $1.2 billion, and $0.8 billion, respectively, as of December 31, 2022. The accumulated benefit obligation for all pension plans as of December 31, 2023 and 2022, was $1.8 billion and $1.6 billion, respectively. For postretirement benefit measurement purposes, a 6.9% annual rate of increase in the per capita cost of covered health care benefits was assumed for the year ended December 31, 2023. The rate was assumed to decrease gradually to 4.5% by 2031 and remain at that level thereafter. Plan Assets The Company’s employee benefit plan assets are principally comprised of the following types of investments: Common stock: Equity securities are valued based on quoted exchange prices and are classified within Level 1 of the valuation hierarchy. Mutual funds: Mutual funds are valued at the closing price reported on the active market on which they are traded and are classified within Level 1 of the valuation hierarchy. Common collective trust (CCT) funds: The fair values of the CCTs are valued using net asset value (NAV). The investments in CCTs are comprised of U.S. and international equity, fixed income, and other securities. The investments are valued at NAV provided by administrators of the funds. Corporate debt instruments: Corporate debt instruments are valued using third-party pricing services and are classified within Level 2 of the valuation hierarchy. U.S. Treasury instruments: U.S. Treasury instruments are valued at the closing price reported on the active market on which they are traded and are classified within Level 1 of the valuation hierarchy. U.S. government agency, state, and local government bonds: U.S. government agency obligations and state and municipal debt securities are valued using third-party pricing services and are classified within Level 2 of the valuation hierarchy. The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants’ methods, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date. The following tables set forth, by level within the fair value hierarchy, the fair value of plan assets as of December 31, 2023 and 2022. Fair Value Measurements at December 31, 2023 Quoted Prices in Significant Significant Total (In millions) Common stock $ 37 $ — $ — $ 37 Mutual funds 147 — — 147 Corporate bonds — 473 — 473 U.S. Treasury instruments 262 — — 262 U.S. government agency, state and local government bonds — 8 — 8 Other — 7 — 7 Total assets $ 446 $ 488 $ — $ 934 Common collective trust funds at NAV U.S. equity 15 International equity 60 Fixed income 330 Other 76 Total assets at fair value $ 1,415 Fair Value Measurements at December 31, 2022 Quoted Prices in Significant Significant Total (In millions) Common stock $ 68 $ — $ — $ 68 Mutual funds 245 — — 245 Corporate bonds — 318 — 318 U.S. Treasury instruments 173 — — 173 U.S. government agency, state and local government bonds — 5 — 5 Other — 9 — 9 Total assets $ 486 $ 332 $ — $ 818 Common collective trust funds at NAV U.S. equity 23 International equity 76 Fixed income 247 Other 105 Total assets at fair value $ 1,269 Level 3 Gains and Losses: There are no Plan assets classified as Level 3 in the fair value hierarchy; therefore there are no gains or losses associated with Level 3 assets. The following table sets forth the actual asset allocation for the Company’s global pension plan assets as of the measurement date: December 31 2023 (1)(2) December 31 2022 (2) Equity securities 19% 33% Debt securities 77% 62% Other 4% 5% Total 100% 100% (1) The Company’s U.S. pension plans contain approximately 67% of the Company’s global pension plan assets. The actual asset allocation for the Company’s U.S. pension plans as of the measurement date consists of 20% equity securities and 80% debt securities. The target asset allocation for the Company’s U.S. pension plans is approximately the same as the actual asset allocation. The actual asset allocation for the Company’s foreign pension plans as of the measurement date consists of 17% equity securities, 71% debt securities, and 12% other. The target asset allocation for the Company’s foreign pension plans is approximately the same as the actual asset allocation. (2) The Company’s pension plans did not directly hold any shares of Company common stock as of the December 31, 2023 and 2022 measurement dates. Investment objectives for the Company’s plan assets are to: • Optimize the long-term return on plan assets in consideration of funded status risk. • Maintain a broad diversification of assets and appropriate risk exposure across asset classes. • Maintain careful control of the risk level within each asset class. Asset allocation targets promote optimal expected return and volatility characteristics given the long-term time horizon for fulfilling the obligations of the pension plans. Selection of the targeted asset allocation for plan assets was based upon a review of the expected return and risk characteristics of each asset class, as well as the correlation of returns among asset classes. The U.S. pension plans target asset allocation is also based on an asset and liability study that is updated periodically. Investment guidelines are established with each investment manager. These guidelines provide the parameters within which the investment managers agree to operate, including criteria that determine eligible and ineligible securities, diversification requirements, and credit quality standards, where applicable. In some countries, derivatives may be used to gain market exposure in an efficient and timely manner; however, derivatives may not be used to leverage the portfolio beyond the market value of underlying investments. The Company uses external consultants to assist in monitoring the investment strategy and asset mix for the Company’s plan assets. To develop the Company’s expected long-term rate of return assumption on plan assets, the Company generally uses long-term historical return information for the targeted asset mix identified in asset and liability studies. Adjustments are made to the expected long-term rate of return assumption when deemed necessary based upon revised expectations of future investment performance of the overall investment markets. Contributions and Expected Future Benefit Payments Based on actuarial calculations, the Company expects to contribute $27 million to the pension plans and $14 million to the postretirement benefit plan during 2024. The Company may elect to make additional discretionary contributions during this period. The following benefit payments, which reflect expected future service, are expected to be paid by the benefit plans: Pension Postretirement (In millions) 2024 $ 69 $ 14 2025 75 13 2026 82 11 2027 88 11 2028 94 10 2029-2033 559 41

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2023
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Shareholders' Equity	Shareholders’ Equity The Company has authorized one billion shares of common stock and 500,000 shares of preferred stock, each with zero par value. No preferred stock has been issued. At December 31, 2023 and 2022, the Company had approximately 202.5 million shares and 169.0 million shares, respectively, of its common shares in treasury. Treasury stock of $4.9 billion at December 31, 2023 and 2022 is recorded at cost as a reduction of common stock, and treasury stock of $2.7 billion and $1.7 billion at December 31, 2023 and 2022, respectively, is recorded at cost as a reduction of retained earnings. The following tables set forth the changes in AOCI by component and the reclassifications out of AOCI for the years ended December 31, 2023 and 2022: Foreign Currency Translation Adjustment Deferred Gain (Loss) on Hedging Activities Pension and Unrealized Gain (Loss) on Investments Accumulated Other Comprehensive Income (Loss) (In millions) Balance at December 31, 2021 $ (2,248) $ 225 $ (147) $ (2) $ (2,172) Other comprehensive income before reclassifications (609) 268 117 (12) (236) Gain (loss) on net investment hedges 328 — — — 328 Amounts reclassified from AOCI — (352) 23 — (329) Tax effect (93) 7 (15) 1 (100) Net of tax amount (374) (77) 125 (11) (337) Balance at December 31, 2022 $ (2,622) $ 148 $ (22) $ (13) $ (2,509) Other comprehensive income before reclassifications 204 337 (46) 16 511 Gain (loss) on net investment hedges (153) — — — (153) Amounts reclassified from AOCI — (322) (42) — (364) Tax effect 32 (5) 2 (1) 28 Net of tax amount 83 10 (86) 15 22 Balance at December 31, 2023 $ (2,539) $ 158 $ (108) $ 2 $ (2,487) Amounts reclassified from AOCI Affected line item in the Details about AOCI components 2023 2022 2021 consolidated statement of earnings (In millions) Deferred loss (gain) on hedging activities $ — $ (1) $ 16 Revenues (322) (351) (490) Cost of products sold (322) (352) (474) Earnings before income taxes 77 62 118 Income tax expense $ (245) $ (290) $ (356) Net earnings Pension liability adjustment Amortization of defined benefit pension items: Prior service losses (credit) $ (26) $ (119) $ (77) Other (income) expense – net Actuarial losses (16) 142 176 Other (income) expense – net (42) 23 99 Earnings before income taxes (10) (4) (26) Income tax expense (benefit) $ (52) $ 19 $ 73 Net earnings

Segment and Geographic Informat

Segment and Geographic Information	12 Months Ended
	Dec. 31, 2023
Segment Reporting [Abstract]
Segment And Geographic Information	Segment and Geographic Information The Company’s operations are organized, managed, and classified into three reportable business segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. Each of these segments is organized based upon the nature of products and services offered. The Company’s remaining operations are not reportable segments, as defined by the applicable accounting standard , and are classified as Other Business. The Ag Services and Oilseeds segment includes global activities related to the origination, merchandising, transportation, and storage of agricultural raw materials, and the crushing and further processing of oilseeds such as soybeans and soft seeds (cottonseed, sunflower seed, canola, rapeseed, and flaxseed) into vegetable oils and protein meals. Oilseeds products produced and marketed by the segment include ingredients for food, feed, energy, and industrial customers. Crude vegetable oils produced by the segment’s crushing activities are sold “as is” to manufacturers of renewable green diesel and other customers or are further processed by refining, blending, bleaching, and deodorizing into salad oils. Salad oils are sold “as is” or are further processed by hydrogenating and/or interesterifying into margarine, shortening, and other food products. Partially refined oils are used to produce biodiesel and glycols or are sold to other manufacturers for use in chemicals, paints, and other industrial products. Oilseed protein meals are principally sold to third parties to be used as ingredients in commercial livestock and poultry feeds. The Ag Services and Oilseeds segment is also a major supplier of peanuts and peanut-derived ingredients to both the U.S. and export markets. In North America, cotton cellulose pulp is manufactured and sold to the chemical, paper, and other industrial markets. The Ag Services and Oilseeds segment’s grain sourcing, handling, and transportation network (including barge, ocean-going vessel, truck, rail, and container freight services) provides reliable and efficient services to the Company’s customers and agricultural processing operations. The Ag Services and Oilseeds segment also includes agricultural commodity and feed product import, export, and global distribution, and structured trade finance activities. The Company engages in various structured trade finance activities to leverage its global trade flows. This segment also includes the Company’s share of the results of its equity investments in Wilmar, Pacificor, SoyVen, Olenex, Stratas Foods LLC, and Edible Oils Limited. The Carbohydrate Solutions segment is engaged in corn and wheat wet and dry milling and other activities. The Carbohydrate Solutions segment converts corn and wheat into products and ingredients used in the food and beverage industry including sweeteners, corn and wheat starches, syrup, glucose, wheat flour, and dextrose. Dextrose and starch are used by the Carbohydrate Solutions segment as feedstocks in other downstream processes. By fermentation of dextrose, the Carbohydrate Solutions segment produces alcohol and other food and animal feed ingredients. Ethyl alcohol is produced by the Company for industrial use in products such as hand sanitizers and ethanol for use in gasoline due to its ability to increase octane as an extender and oxygenate. Corn gluten feed and meal, as well as distillers’ grains, are produced for use as animal feed ingredients. Corn germ, a by-product of the wet milling process, is further processed into vegetable oil and protein meal. Other Carbohydrate Solutions products include citric acids which are used in various food and industrial products. The Carbohydrate Solutions segment is a leader in carbon capture and sequestration. This segment also includes the Company’s share of the results of its equity investments in Hungrana Ltd., Almidones Mexicanos S.A., Aston Foods and Food Ingredients, Red Star Yeast Company, LLC, and LSCP, LLLP. In November 2021, the Company sold its ethanol production complex in Peoria, Illinois. The Nutrition segment serves various end markets including food, beverages, nutritional supplements, and feed and premix for livestock, aquaculture, and pet food. The segment engages in the manufacturing, sale, and distribution of a wide array of ingredients and solutions including plant-based proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, postbiotics, enzymes, botanical extracts, and other specialty food and feed ingredients. The Nutrition segment includes the activities related to the procurement, processing, and distribution of edible beans. The segment also includes activities related to the processing and distribution of formula feeds and animal health and nutrition products and the manufacture of contract and private label pet treats and foods. This segment also includes the Company’s share of the results of its equity investments in Vimison S.A. de C.V., ADM Matsutani LLC, Matsutani Singapore Pte. Ltd., ADM Vland Biotech Shandong Co., Ltd., Dusial S.A., and Vitafort ZRT. Other Business includes the Company’s financial business units related to futures commission and insurance activities. Intersegment sales have been recorded using principles consistent with ASC 606, Revenue from Contracts with Customers . Operating profit for each segment is based on net sales less identifiable operating expenses. Also included in operating profit for each segment is equity in earnings of affiliates based on the equity method of accounting. Specified items included in total segment operating profit and certain corporate items are not allocated to the Company’s individual business segments because operating performance of each business segment is evaluated by management exclusive of these items. Corporate results principally include unallocated corporate expenses, interest cost net of interest income, and revaluation gains and losses on cost method investments and the share of the results of equity investments in early-stage start-up companies. Correction of Certain Segment-Specific Historical Financial Information As previously disclosed, the Company received a voluntary document request from the SEC relating to intersegment sales between the Company’s Nutrition segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions segments. In response, the Company engaged external counsel, assisted by a forensic accounting firm, to conduct an internal investigation, overseen by the Audit Committee of the Company’s Board of Directors, which is separately advised by external counsel (the Investigation). The Company has historically disclosed in the footnotes to its financial statements that intersegment sales have been recorded at amounts approximating market. In connection with the Investigation, the Company identified certain intersegment sales for the years ended December 31, 2021 through 2023 that occurred between the Company’s Nutrition segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions segments that were not recorded at amounts approximating market. The correction of these immaterial errors does not have any impact on the Company’s previously reported Consolidated Statements of Earnings, Consolidated Statements of Comprehensive Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Cash Flows, or Consolidated Statements of Shareholders’ Equity for any of the periods presented below. The following tables present: (i) adjustments and revised gross revenues, intersegment revenues, and operating profit amounts for the Ag Services and Oilseeds segment; (ii) adjustments and revised gross revenues, intersegment revenues and operating profit amounts for the Carbohydrate Solutions segment; and (iii) adjustments and revised operating profit amounts for the Nutrition segment, in each case, for each of the years ended December 31, 2023, 2022, and 2021. No adjustments were required to the gross revenues of the Nutrition segment. Impact of the Adjustments on Ag Services and Oilseeds Segment Gross Revenues and Operating Profit Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as originally reported for 2022 and 2021 $ 77,457 $ 83,686 $ 70,455 Adjustments 1 15 24 Gross revenues, as revised $ 77,458 $ 83,701 $ 70,479 Intersegment revenues, as originally reported for 2022 and 2021 $ 4,031 $ 4,123 $ 3,408 Adjustments 1 15 24 Intersegment revenues, as revised $ 4,032 $ 4,138 $ 3,432 Segment operating profit, as originally reported for 2022 and 2021 $ 4,066 $ 4,386 $ 2,775 Adjustments 1 15 24 Segment operating profit, as revised $ 4,067 $ 4,401 $ 2,799 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Impact of the Adjustments on Carbohydrate Solutions Segment Gross Revenues and Operating Profit Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as originally reported for 2022 and 2021 $ 14,509 $ 16,336 $ 12,672 Adjustments 30 53 35 Gross revenues, as revised $ 14,539 $ 16,389 $ 12,707 Intersegment revenues, as originally reported for 2022 and 2021 $ 1,635 $ 2,375 $ 1,562 Adjustments 30 53 35 Intersegment revenues, as revised $ 1,665 $ 2,428 $ 1,597 Segment operating profit, as originally reported for 2022 and 2021 $ 1,345 $ 1,360 $ 1,283 Adjustments 30 53 35 Segment operating profit, as revised $ 1,375 $ 1,413 $ 1,318 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Impact of the Adjustments on Nutrition Segment Operating Profit Years Ended December 31 (In millions) 2023 (1) 2022 2021 Segment operating profit, as originally reported for 2022 and 2021 $ 458 $ 736 $ 691 Adjustments (31) (68) (59) Segment operating profit, as revised $ 427 $ 668 $ 632 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Separately, the Company determined that a portion of the originally reported gross revenues and intersegment revenues of each of the Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition segments included certain intrasegment revenues (resulting from sales within the segment), and should have included exclusively intersegment revenues (resulting from sales from one segment to the other). The correction of these immaterial errors does not have any impact on the Company’s previously reported Consolidated Statements of Earnings, Consolidated Statements of Comprehensive Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Cash Flows, or Consolidated Statements of Shareholders’ Equity for any of the periods presented below. The following tables present: (i) additional adjustments and further revised gross revenues and intersegment revenues amounts for the Ag Services and Oilseeds segment; (ii) additional adjustments and further revised gross revenues and intersegment revenues amounts for the Carbohydrate Solutions segment; and (iii) adjustments and revised gross revenues and intersegment revenues amounts for the Nutrition segment, for each of the years ended December 31, 2023, 2022, and 2021 . Additional Impact of the Adjustments on Ag Services and Oilseeds Segment Gross Revenues and Intersegment Revenues Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as revised $ 77,458 $ 83,701 $ 70,479 Additional adjustments (1,446) (1,579) (1,115) Gross revenues, as further revised $ 76,012 $ 82,122 $ 69,364 Intersegment revenues, as revised $ 4,032 $ 4,138 $ 3,432 Additional adjustments (1,446) (1,579) (1,115) Intersegment revenues, as further revised $ 2,586 $ 2,559 $ 2,317 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Additional Impact of the Adjustments on Carbohydrate Solutions Segment Gross Revenues and Intersegment Revenues Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as revised $ 14,539 $ 16,389 $ 12,707 Additional adjustments (11) (487) (295) Gross revenues, as further revised $ 14,528 $ 15,902 $ 12,412 Intersegment revenues, as revised $ 1,665 $ 2,428 $ 1,597 Additional adjustments (11) (487) (295) Intersegment revenues, as further revised $ 1,654 $ 1,941 $ 1,302 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Impact of the Adjustments on Nutrition Segment Gross Revenues and Intersegment Revenues Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as originally reported for 2022 and 2021 $ 7,466 $ 7,836 $ 6,933 Adjustments (141) (15) (68) Gross revenues, as revised $ 7,325 $ 7,821 $ 6,865 Intersegment revenues, as originally reported for 2022 and 2021 $ 255 $ 200 $ 221 Adjustments (141) (15) (68) Intersegment revenues, as revised $ 114 $ 185 $ 153 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Segment Information The following tables present data by segment, adjusted for the matters discussed above, for the years ended December 31, 2023, 2022 and 2021. (In millions) Year Ended December 31 2023 2022 2021 Gross revenues Ag Services and Oilseeds $ 76,012 $ 82,122 $ 69,364 Carbohydrate Solutions 14,528 15,902 12,412 Nutrition 7,325 7,821 6,865 Other 424 396 380 Intersegment elimination (4,354) (4,685) (3,772) Total $ 93,935 $ 101,556 $ 85,249 Intersegment revenues Ag Services and Oilseeds $ 2,586 $ 2,559 $ 2,317 Carbohydrate Solutions 1,654 1,941 1,302 Nutrition 114 185 153 Total $ 4,354 $ 4,685 $ 3,772 Revenues from external customers Ag Services and Oilseeds Ag Services $ 47,420 $ 53,181 $ 45,017 Crushing 14,020 13,139 11,368 Refined Products and Other 11,986 13,243 10,662 Total Ag Services and Oilseeds 73,426 79,563 67,047 Carbohydrate Solutions Starches and Sweeteners 9,885 10,251 7,611 Vantage Corn Processors 2,989 3,710 3,499 Total Carbohydrate Solutions 12,874 13,961 11,110 Nutrition Human Nutrition 3,634 3,769 3,189 Animal Nutrition 3,577 3,867 3,523 Total Nutrition 7,211 7,636 6,712 Other 424 396 380 Total $ 93,935 $ 101,556 $ 85,249 (In millions) Year Ended December 31 2023 2022 2021 Depreciation Ag Services and Oilseeds $ 350 $ 334 $ 349 Carbohydrate Solutions 304 307 322 Nutrition 132 120 101 Other 10 9 8 Corporate 29 24 27 Total $ 825 $ 794 $ 807 Long-lived asset impairments (1) Ag Services and Oilseeds $ 11 $ — $ 10 Carbohydrate Solutions 32 14 13 Nutrition 65 21 50 Total $ 108 $ 35 $ 73 Interest and investment income Ag Services and Oilseeds $ 54 $ 52 $ 27 Nutrition (18) 2 1 Other 499 185 16 Corporate (36) 54 52 Total $ 499 $ 293 $ 96 Equity in earnings of affiliates Ag Services and Oilseeds $ 459 $ 714 $ 500 Carbohydrate Solutions 76 94 70 Nutrition 21 23 24 Corporate (5) 1 1 Total $ 551 $ 832 $ 595 (1) See Note 18 for total asset impairment, exit, and restructuring costs. (In millions) Year Ended December 31 2023 2022 2021 Segment Operating Profit Ag Services and Oilseeds $ 4,067 $ 4,401 $ 2,799 Carbohydrate Solutions 1,375 1,413 1,318 Nutrition 427 668 632 Other 375 167 25 Specified Items: Gains on sales of assets and businesses (1) 17 47 77 Impairment, restructuring, and net settlement contingencies (2) (361) (147) (213) Total segment operating profit 5,900 6,549 4,638 Corporate (1,606) (1,316) (1,325) Earnings before income taxes $ 4,294 $ 5,233 $ 3,313 (1) The gains in 2023 and 2022 were related to the sale of certain assets. The gains in 2021 were related to the sale of ethanol and certain other assets. (2) The charges in 2023 were related to the impairment of certain long-lived assets, goodwill, intangibles, and an equity investment, restructuring, and a contingency related to import duties, partially offset by settlement/contingency adjustments. The charges in 2022 were related to the impairment of certain assets, restructuring, and settlement contingencies. The charges in 2021 were related to the impairment of certain long-lived assets, goodwill, and other intangibles, restructuring, and a legal settlement. (In millions) December 31 2023 2022 Investments in and advances to affiliates Ag Services and Oilseeds $ 4,888 $ 4,863 Carbohydrate Solutions 380 365 Nutrition 145 111 Corporate 87 128 Total $ 5,500 $ 5,467 Identifiable assets Ag Services and Oilseeds $ 25,473 $ 28,657 Carbohydrate Solutions 6,334 6,801 Nutrition 10,341 10,615 Other 8,701 10,569 Corporate 3,782 3,132 Total $ 54,631 $ 59,774 (In millions) Year Ended December 31 2023 2022 Gross additions to property, plant, and equipment Ag Services and Oilseeds $ 732 $ 568 Carbohydrate Solutions 351 261 Nutrition 262 314 Other 1 15 Corporate 37 53 Total $ 1,383 $ 1,211 Geographic information: The following geographic data include revenues attributed to the countries based on the location of the subsidiary making the sale and long-lived assets based on physical location. Long-lived assets represent the net book value of property, plant, and equipment. Year Ended (In millions) December 31 2023 2022 2021 Revenues United States $ 38,783 $ 43,272 $ 35,396 Switzerland 19,898 21,821 18,453 Cayman Islands 7,646 5,883 5,515 Brazil 3,361 4,004 3,213 Mexico 3,185 3,709 2,934 Canada 2,400 2,272 1,818 United Kingdom 2,219 2,231 1,848 Other Foreign 16,443 18,364 16,072 $ 93,935 $ 101,556 $ 85,249 (In millions) December 31 2023 2022 Long-lived assets United States $ 6,660 $ 6,322 Brazil 874 801 Other Foreign 2,974 2,810 $ 10,508 $ 9,933

Asset Impairment, Exit, and Res

Asset Impairment, Exit, and Restructuring Costs	12 Months Ended
	Dec. 31, 2023
Restructuring, Settlement and Impairment Provisions [Abstract]
Asset Impairment, Exit, and Restructuring Costs	Asset Impairment, Exit, and Restructuring Costs The following table sets forth the charges included in asset impairment, exit, and restructuring costs. (In millions) Year Ended December 31 2023 2022 2021 Restructuring and exit costs (1) $ 33 $ 29 $ 39 Impairment charge - goodwill and other intangible assets (2) 201 2 52 Impairment charge - other long-lived assets (3) 108 35 73 Total asset impairment, exit, and restructuring costs $ 342 $ 66 $ 164 (1) Restructuring and exit costs for the year ended December 31, 2023 consisted of several individually insignificant restructuring charges totaling $27 million presented as specified items within segment operating profit and $6 million in Corporate. Restructuring and exit costs for the year ended December 31, 2022 consisted of several individually insignificant restructuring charges totaling $28 million presented as specified items within segment operating profit and restructuring charges of $1 million in Corporate. Restructuring and exit costs for the year ended December 31, 2021 consisted of several individually insignificant restructuring charges totaling $35 million presented as specified items within segment operating profit and $4 million in Corporate. (2) Impairment charge - goodwill and other intangible assets for the year ended December 31, 2023 consisted of impairments related to goodwill of $137 million and customer list and discontinued animal nutrition trademarks totaling $64 million in Nutrition, presented as specified items within segment operating profit. Impairment charge - goodwill and other intangible assets for the year ended December 31, 2022 consisted of customer list impairment of $2 million in Nutrition presented as specified items within segment operating profit. Impairment charge - goodwill and other intangible assets for the year ended December 31, 2021 consisted of goodwill impairment of $5 million and land rights impairment customer list impairment (3) Impairment charge - other long-lived assets for the year ended December 31, 2023 consisted of impairments related to certain long-lived assets in Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition of $10 million, $33 million, and $65 million, respectively, presented as specified items within segment operating profit. Impairment charge - other long-lived assets for the year ended December 31, 2022 consisted of impairments related to certain long-lived assets in Carbohydrate Solutions and Nutrition of $15 million and $20 million, respectively, presented as specified items within segment operating profit. Impairment charge - other long-lived assets for the year ended December 31, 2021 consisted of impairments related to certain long-lived assets in Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition of $10 million, $13 million, and $50 million, respectively, presented as specified items within segment operating profit.

Sale of Accounts Receivable

Sale of Accounts Receivable	12 Months Ended
	Dec. 31, 2023
Transfers and Servicing [Abstract]
Sale of Accounts Receivable	Sale of Accounts Receivable The Company has an accounts receivable securitization program (the “First Program”) with certain commercial paper conduit purchasers and committed purchasers (collectively, the “First Purchasers”). Under the First Program, certain U.S.-originated trade accounts receivable are sold to a wholly-owned bankruptcy-remote entity, ADM Receivables, LLC (“ADM Receivables”). ADM Receivables transfers certain of the purchased accounts receivable to each of the First Purchasers together with a security interest in all of its right, title, and interest in the remaining purchased accounts receivable. In exchange, ADM Receivables receives a cash payment of up to $1.9 billion for the accounts receivable transferred. The First Program terminates on May 17, 2024, unless extended. The Company also has an accounts receivable securitization program (the “Second Program”) with certain commercial paper conduit purchasers and committed purchasers (collectively, the “Second Purchasers”). Under the Second Program, certain non-U.S.-originated trade accounts receivable are sold to a wholly-owned bankruptcy-remote entity, ADM Ireland Receivables Company (ADM Ireland Receivables). ADM Ireland Receivables transfers certain of the purchased accounts receivable to each of the Second Purchasers together with a security interest in all of its right, title, and interest in the remaining purchased accounts receivable. In exchange, ADM Ireland Receivables receives a cash payment of up to $1.1 billion (€1.0 billion) for the accounts receivables transferred. The Second Program terminates on April 19, 2024, unless extended. Under the First and Second Programs (collectively, the “Programs”), ADM Receivables and ADM Ireland Receivables use the cash proceeds from the transfer of receivables to the First Purchasers and Second Purchasers (collectively, the “Purchasers”) and other consideration, as applicable, to finance the purchase of receivables from the Company and the ADM subsidiaries originating the receivables. The Company accounts for these transfers as sales. The Company acts as a servicer for the transferred receivables. At December 31, 2023 and 2022, the Company did not record a servicing asset or liability related to its retained responsibility, based on its assessment of the servicing fee, market values for similar transactions, and its cost of servicing the receivables sold. As of December 31, 2023 and 2022, the fair value of trade receivables transferred to the Purchasers under the Programs and derecognized from the Company’s consolidated balance sheet was $1.6 billion and $2.6 billion, respectively. Total receivables sold were $54.8 billion, $59.0 billion, and $50.3 billion for the years ended December 31, 2023, 2022, and 2021, respectively. Cash collections from customers on receivables sold were $53.6 billion, $56.9 billion, and $47.3 billion for the years ended December 31, 2023, 2022, and 2021, respectively. Receivables pledged as collateral to the Purchasers were $1.1 billion and $0.6 billion as of December 31, 2023 and 2022, respectively. Transfers of receivables under the Programs during the years ended December 31, 2023, 2022, and 2021 resulted in an expense for the loss on sale of $56 million, $21 million, and $11 million, respectively, which is classified as selling, general, and administrative expenses in the consolidated statements of earnings. The Company reflects cash flows related to the Programs as operating activities because the cash received from the Purchasers upon both the sale and collection of the receivables is not subject to significant interest rate risk given the short-term nature of the Company’s trade receivables.

Legal Proceedings, Guarantees,

Legal Proceedings, Guarantees, and Commitments	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Legal Matters and Contingencies	Legal Proceedings The Company is routinely involved in a number of actual or threatened legal actions, including those involving alleged personal injuries, employment law, product liability, intellectual property, environmental issues, alleged tax liability (see Note 13 for information on income tax matters), and class actions. The Company also routinely receives inquiries from regulators and other government authorities relating to various aspects of its business, and at any given time, the Company has matters at various stages of resolution. The outcomes of these matters are not within Company’s complete control and may not be known for prolonged periods of time. In some actions, claimants seek damages, as well as other relief including injunctive relief, that could require significant expenditures or result in lost revenues. In accordance with applicable accounting standards, the Company records a liability in its consolidated financial statements for material loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a material loss contingency is reasonably possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages, with incomplete facts or legal discovery; involve unsubstantiated or indeterminate claims for damages; potentially involve penalties, fines, disgorgement, or punitive damages; or could result in a change in business practice. Commodities Class Actions On September 4, 2019, AOT Holding AG (“AOT”) filed a putative class action under the U.S. Commodities Exchange Act in federal district court in Urbana, Illinois, alleging that the Company sought to manipulate the benchmark price used to price and settle ethanol derivatives traded on futures exchanges. On March 16, 2021, AOT filed an amended complaint adding a second named plaintiff Maize Capital Group, LLC (“Maize”). AOT and Maize allege that members of the putative class collectively suffered damages calculated to be between approximately $500 million to over $2.0 billion as a result of the Company’s alleged actions. On July 14, 2020, Green Plains Inc. and its related entities (“GP”) filed a putative class action lawsuit, alleging substantially the same operative facts, in federal court in Nebraska, seeking to represent sellers of ethanol. On July 23, 2020, Midwest Renewable Energy, LLC (“MRE”) filed a putative class action in federal court in Illinois alleging substantially the same operative facts and asserting claims under the Sherman Act. On November 11, 2020, United Wisconsin Grain Producers LLC (“UWGP”) and five other ethanol producers filed a lawsuit in federal court in Illinois alleging substantially the same facts and asserting claims under the Sherman Act and Illinois, Iowa, and Wisconsin law. The court granted ADM’s motion to dismiss the MRE and UWGP complaints without prejudice on August 9, 2021 and September 28, 2021, respectively. On August 16, 2021, the court granted ADM’s motion to dismiss the GP complaint, dismissing one claim with prejudice and declining jurisdiction over the remaining state law claim. MRE filed an amended complaint on August 30, 2021, which ADM moved to dismiss on September 27, 2021. The court denied ADM’s motion to dismiss on September 26, 2023. UWGP filed an amended complaint on October 19, 2021, which the court dismissed on July 12, 2022. UWGP has appealed the dismissal to the United States Court of Appeals for the Seventh Circuit. On October 26, 2021, GP filed a new complaint in Nebraska federal district court, alleging substantially the same facts and asserting a claim for tortious interference with contractual relations. On March 18, 2022, the Nebraska federal district court granted ADM’s motion to transfer the GP case back to the Central District of Illinois for further proceedings. ADM moved to dismiss the complaint on May 20, 2022 and on December 30, 2022, the court dismissed GP’s complaint with prejudice. GP appealed the dismissal. As of December 31, 2023, the appeal was pending. The Company denies liability, and is vigorously defending itself in these actions. As these actions are in pretrial proceedings, the Company is unable at this time to predict the final outcome with any reasonable degree of certainty, but believes the outcome will not have a material adverse effect on its financial condition, results of operations, or cash flows. Intersegment Sales Investigations On June 30, 2023, the Company received a voluntary document request from the SEC relating to intersegment sales between the Company’s Nutrition reporting segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions reporting segments. The Company is cooperating with the SEC. Following the Company’s January 21, 2024 announcement of the Investigation, the Company received voluntary document requests from the DOJ focused primarily on the same subject matter, and the DOJ directed grand jury subpoenas to certain current and former Company employees. The Company is cooperating with the DOJ. The Company is unable to predict the final outcome of these investigations with any reasonable degree of certainty. Securities Litigation On January 24, 2024, following the Company’s January 21, 2024 announcement of the investigation relating to intersegment sales, a purported stockholder of the Company filed a putative class action in the U.S. District Court for the Northern District of Illinois against the Company and its Chief Executive Officer, as well as Vikram Luthar and Ray Young. The plaintiff alleges false and misleading statements in the Company’s disclosures. The Company is unable to predict the final outcome of this proceeding with any reasonable degree of certainty.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Subsequent Events In January 2024, the Company acquired Revela Foods, a Wisconsin-based developer and manufacturer of innovative dairy flavor ingredients and solutions, for $656 million, subject to working capital adjustments, and UK-based FDL, a leading developer and producer of premium flavor and functional ingredient systems, for $232 million. In February 2024, the Company acquired PT Trouw Nutrition Indonesia, a subsidiary of Nutreco and leading provider of functional and nutritional solutions for livestock farming in Indonesia, for $18 million, subject to working capital adjustments.

Valuation And Qualifying Accoun

Valuation And Qualifying Accounts And Reserves	12 Months Ended
	Dec. 31, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Valuation And Qualifying Accounts And Reserves	SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES Beginning of End of (In millions) Year Balance Additions Deductions (1) Other (2) Year Balance Allowance for doubtful accounts December 31, 2021 $ 100 32 (28) 18 $ 122 December 31, 2022 $ 122 88 (12) 1 $ 199 December 31, 2023 $ 199 6 (28) 38 $ 215 Beginning of End of (In millions) Year Balance Additions Deductions Other Year Balance Income tax valuation allowance December 31, 2021 $ 339 7 (65) — $ 281 December 31, 2022 $ 281 18 (90) — $ 209 December 31, 2023 $ 209 58 (51) — $ 216 (1) Uncollectible accounts written off (2) Impact of reclassifications, foreign exchange translation, and other adjustments

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 565	$ 821	$ 927	$ 1,170	$ 1,019	$ 1,031	$ 1,236	$ 1,054	$ 3,483	$ 4,340	$ 2,709

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	None of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated any contract, instruction, or written plan for the purchase or sale of ADM’s securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarter ended December 31, 2023.
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary Of Significant Accoun_2

Summary Of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Nature of Business	Nature of Business ADM unlocks the power of nature to enrich the quality of life for people and animals. ADM’s innovation and expertise are helping people live healthier lives and support a healthier planet. The Company’s globally-integrated footprint combined with local insight give ADM capabilities few other companies have to meet critical and global needs. With a foundation in nature and nutrition, the Company is a leader in sustainability, scaling across entire value chains to help decarbonize the industry, and safeguard the planet. ADM has three business segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The Company is an essential global agricultural supply chain manager and processor supporting food security by connecting local needs with global capabilities.
Principles Of Consolidation	Principles of Consolidation
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect amounts reported in its consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Cash Equivalents	Cash Equivalents The Company considers all non-segregated, highly-liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents.
Segregated Cash and Investments	Segregated Cash and Investments The Company segregates certain cash, cash equivalents, and investment balances in accordance with regulatory requirements, commodity exchange requirements, and insurance arrangements. These balances represent deposits received from customers of the Company’s registered futures commission merchant and commodity brokerage services, cash margins and securities pledged to commodity exchange clearinghouses, and cash pledged as security under certain insurance arrangements. Segregated cash and investments also include restricted cash collateral for the various insurance programs of the Company’s captive insurance business. To the degree these segregated balances are comprised of cash and cash equivalents, they are considered restricted cash and cash equivalents on the statement of cash flows.
Receivables	Receivables
Inventories	Inventories Certain merchandisable agricultural commodity inventories, which include inventories acquired under deferred pricing contracts, are stated at market value. In addition, the Company values certain inventories using the first-in, first-out (FIFO) method at the lower of cost or net realizable value.
Cost Method Investments	Cost Method Investments
Fair Value Measurements	Fair Value Measurements The Company determines fair value based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company uses the market approach valuation technique to measure the majority of its assets and liabilities carried at fair value. Three levels are established within the fair value hierarchy that may be used to report fair value: Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Observable inputs, including Level 1 prices that have been adjusted; quoted prices for similar assets or liabilities; quoted prices in markets that are less active than traded exchanges; and other inputs that are observable or can be substantially corroborated by observable market data. Level 3: Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities. In evaluating the significance of fair value inputs, the Company generally classifies assets or liabilities as Level 3 when their fair value is determined using unobservable inputs that individually or when aggregated with other unobservable inputs, represent more than 10% of the fair value of the assets or liabilities. Judgment is required in evaluating both quantitative and qualitative factors in the determination of significance for purposes of fair value level classification. Level 3 amounts can include assets and liabilities whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as assets and liabilities for which the determination of fair value requires significant management judgment or estimation. Based on historical experience with the Company’s suppliers and customers, the Company’s own credit risk and knowledge of current market conditions, the Company does not view nonperformance risk to be a significant input to fair value for the majority of its forward commodity purchase and sale contracts. However, in certain cases, if the Company believes the nonperformance risk to be a significant input, the Company records estimated fair value adjustments, and classifies the measurement in Level 3. In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy. The lowest level of input that is a significant component of the fair value measurement determines the placement of the entire fair value measurement in the hierarchy. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the classification of fair value assets and liabilities within the fair value hierarchy levels.
Derivatives	Derivatives The Company recognizes all of its derivative instruments as either assets or liabilities at fair value in its consolidated balance sheet. Unrealized gains are reported as other current assets and unrealized losses are reported as accrued expenses and other payables. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and on the type of hedging relationship. The majority of the Company’s derivatives have not been designated as hedging instruments, and as such, changes in fair value of these derivatives are recognized in earnings immediately. For those derivative instruments that are designated and qualify as hedging instruments, the Company designates the hedging instrument, based upon the exposure being hedged, as a cash flow hedge or a net investment hedge. For derivative instruments that are designated and qualify as highly-effective cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) (AOCI) and as an operating activity in the statement of cash flows and reclassified into earnings in the same line item affected by the hedged transaction and in the same period or periods during which the hedged transaction affects earnings. Hedge components excluded from the assessment of effectiveness and gains and losses related to discontinued hedges are recognized in the consolidated statement of earnings during the current period. For derivative instruments that are designated and qualify as net investment hedges, foreign exchange gains and losses related to changes in foreign currency exchange rates are deferred in AOCI until the underlying investment is divested.
Property, Plant, and Equipment	Property, Plant, and Equipment Property, plant, and equipment are recorded at cost. Repair and maintenance costs are expensed as incurred. The Company uses the straight-line method in computing depreciation for financial reporting purposes and generally uses accelerated methods for income tax purposes. The annual provisions for depreciation have been computed principally in accordance with the following ranges of asset lives: buildings - 15 to 40 years; machinery and equipment - 3 to 40 years. The Company capitalized interest on major construction projects in progress of $32 million, $20 million, and $17 million for the years ended December 31, 2023, 2022, and 2021, respectively.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with the liability method. Deferred tax assets and liabilities are recorded for temporary differences between the tax basis of assets and liabilities and reported amounts in the consolidated financial statements using statutory rates in effect for the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recorded in the results of operations in the period that includes the enactment date under the law. Applicable accounting standards prescribe a minimum threshold a tax position is required to meet before being recognized in the consolidated financial statements. The Company recognizes in its consolidated financial statements tax positions determined more likely than not to be sustained upon examination, based on the technical merits of the position. The Company classifies interest on income tax-related balances as interest expense and classifies tax-related penalties as selling, general, and administrative expenses. Income tax effects from AOCI are released when the individual units of account are sold, terminated, or extinguished.
Goodwill and other intangible assets	Goodwill and other intangible assets Goodwill and other intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. Definite-lived intangible assets, including capitalized expenses related to the Company’s 1ADM program such as third-party configuration costs and internal labor, are amortized over their estimated useful lives of 1 to 50 years and are reviewed for impairment whenever there are indicators the carrying value of the assets may not be fully recoverable. The Company’s accounting policy is to evaluate goodwill and other intangible assets with indefinite lives for impairment on October 1 of each fiscal year or whenever there are indicators the carrying value of the assets may not be fully recoverable. The Company recorded impairment charges totaling $201 million related to goodwill, customer list, and discontinued animal nutrition trademarks, $2 million related to customer list, and $52 million related to goodwill and other intangibles during the years ended December 31, 2023, 2022, and 2021, respectively (see Note 9 for additional information). The goodwill impairment charge recorded during the year ended December 31, 2023 of $137 million was related to the Animal Nutrition reporting unit that was evaluated for impairment using a quantitative assessment. The Company utilized a third-party valuation specialist to assist management in determining the fair value of the Animal Nutrition reporting unit. The fair value of the Animal Nutrition reporting unit was estimated based on a combination of discounted cash flows (income approach) and the use of pricing multiples derived from an analysis of comparable public companies multiplied against historical and or anticipated financial metrics (market approach). As a result of the impairment testing in the fourth quarter of 2023, the Company determined the fair value of the Animal Nutrition reporting unit was below its carrying value. The decline in the fair value of the Animal Nutrition reporting unit was primarily driven by a higher discount rate due to changes in the underlying business performance and industry conditions as well as the macroeconomic environment, causing a decline in projected cash flows.
Asset Abandonments and Write-Downs	Asset Abandonments and Write-Downs
Payables to Brokerage Customers	Payables to Brokerage Customers
Revenues	Revenues The Company follows a policy of recognizing revenue at a single point in time when it satisfies its performance obligation by transferring control over a product or service to a customer. For transportation service contracts, the Company recognizes revenue over time as the mode of transportation moves towards its destination in accordance with the transfer of control guidance of ASC Topic 606, Revenue from Contracts with Customers (“Topic 606”). For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by ASC 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets
Stock Compensation	Stock Compensation The Company recognizes expense for its stock compensation based on the fair value of the awards that are granted. The Company’s stock compensation plans provide for the granting of restricted stock, restricted stock units, performance stock units, and stock options. The fair values of stock options and performance stock units are estimated at the date of grant using the Black-Scholes option valuation model and a lattice valuation model, respectively. These valuation models require the input of subjective assumptions. Measured compensation cost, net of forfeitures, is recognized ratably over the vesting period of the related stock compensation award.
Research and Development	Research and Development Costs associated with research and development are expensed as incurred and recorded within selling, general, and administrative expenses. Such costs incurred, net of expenditures subsequently reimbursed by government grants, were $256 million, $216 million, and $171 million for the years ended December 31, 2023, 2022, and 2021, respectively.
Per Share Data	Per Share Data Basic earnings per common share are determined by dividing net earnings attributable to controlling interests by the weighted average number of common shares outstanding. In computing diluted earnings per share, average number of common shares outstanding is increased by common stock options outstanding with exercise prices lower than the average market price of common shares using the treasury share method.
Business Combinations	Business Combinations The Company’s acquisitions are accounted for in accordance with ASC Topic 805, Business Combinations, as amended . The consideration transferred is allocated to various assets acquired and liabilities assumed at their estimated fair values as of the acquisition date with the residual allocated to goodwill. Fair values allocated to assets acquired and liabilities assumed in business combinations require management to make significant judgments, estimates, and assumptions, especially with respect to intangible assets. Management makes estimates of fair values based upon assumptions it believes to be reasonable. These estimates are based upon historical experience and information obtained from the management of the acquired companies and are inherently uncertain. The estimated fair values related to intangible assets primarily consist of customer relationships, trademarks, and developed technology which are determined primarily using discounted cash flow models. Estimates in the discounted cash flow models include, but are not limited to, certain assumptions that form the basis of the forecasted results (e.g. revenue growth rates, customer attrition rates, and royalty rates). These significant assumptions are forward looking and could be affected by future economic and market conditions. During the measurement period, which may take up to one year from the acquisition date, adjustments due to changes in the estimated fair value of assets acquired and liabilities assumed may be recorded as adjustments to the consideration transferred and the related allocations. Upon the conclusion of the measurement period or the final determination of the values of assets acquired and liabilities assumed, whichever comes first, any such adjustments are charged to the consolidated statements of earnings.
Adoption of New Accounting Standards	New Accounting Standards Effective January 1, 2023, the Company adopted the amended guidance of Accounting Standards Codification (ASC) Topic 805, Business Combinations , which improves comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. The amended guidance requires an entity (acquirer) to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers , (Topic 606). The Company’s adoption of this amended guidance did not have an impact on its consolidated financial statements. Effective January 1, 2023, the Company adopted the amended guidance of ASC Subtopic 405-50, Liabilities - Supplier Finance Programs , which enhances the transparency of supplier finance programs. The amended guidance requires an entity (buyer) in a supplier finance program to disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. ADM has Supplier Payable Programs (“SPP”) with financial institutions which act as its paying agents for payables due to certain of its suppliers. The Company has neither an economic interest in a supplier’s participation in the SPP nor a direct financial relationship with the financial institutions, and has concluded its obligations to the suppliers, including amounts due and scheduled payment terms, are not impacted by their participation in the SPP. Accordingly, amounts associated with the SPP continue to be classified in current liabilities Year Ended December 31 2023 (In millions) Beginning, January 1 $ 196 Obligations confirmed 1,100 Obligations paid (1,022) Ending, December 31 $ 274 Through December 31, 2024, the Company has the option to adopt the amended guidance of ASC Topic 848, Reference Rate Reform , which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by the reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. The expedients and exceptions provided by the amended guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2024, except for hedging relationships existing as of December 31, 2024, that an entity has elected certain optional expedients for and are retained through the end of the hedging relationship. The Company’s adoption of the amended guidance will not have an impact on its consolidated financial statements. Effective December 31, 2024, the Company will be required to adopt the amended guidance of ASC 280, Segment Reporting , which improves disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for more detailed information about a reportable segment’s expenses. The amended guidance improves reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and permits entities to disclose more than one measure of a reportable segment’s profitability used by the Chief Operating Decision Maker. The adoption of the amended guidance will result in expanded disclosures in the Company’s segment and geographic information footnote but will not have an impact on the consolidated financial statements. Effective December 31, 2025, the Company will be required to adopt the amended guidance of ASC 740, Income Taxes , which enhances the transparency and decision usefulness of income tax disclosures. The amendments address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The adoption of the amended guidance will result in expanded disclosures in the Company’s income taxes footnote but will not have an impact on the consolidated financial statements.
Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy	Redeemable Noncontrolling Interest The Company accounts for any redeemable noncontrolling interest in temporary equity - redeemable noncontrolling interest at redemption value with periodic changes recorded in retained earnings.

Leases Leases (Policies)

Leases Leases (Policies)	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Short-term Leases [Policy Text Block]	As an accounting policy election, the Company does not apply the recognition requirements of Topic 842 to short-term leases in all of its underlying asset categories. The Company recognizes short-term lease payments in earnings on a straight-line basis over the lease term, and variable lease payments in the period in which the obligation for those payments is incurred. The Company also combines lease and non-lease contract components in all of its underlying asset categories as an accounting policy election.

Summary Of Significant Accoun_3

Summary Of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of inventory by costing method [Table Text Block]	The following table sets forth the Company’s inventories as of December 31, 2023 and 2022. December 31, 2023 December 31, 2022 (In millions) Raw materials and supplies $ 5,475 $ 6,975 Finished goods 6,482 7,796 Total inventories $ 11,957 $ 14,771
Accounts Receivable, Allowance for Credit Loss	Changes to the allowance for estimated uncollectible accounts are as follows: Year Ended December 31 2023 2022 (In millions) Beginning, January 1 $ 199 $ 122 Current year provisions 6 88 Recoveries 2 2 Write-offs against allowance (28) (12) Foreign exchange translation adjustment — (2) Other 36 1 Ending, December 31 $ 215 $ 199
Supplier Finance Program	Changes to the outstanding payment obligations are as follows: Year Ended December 31 2023 (In millions) Beginning, January 1 $ 196 Obligations confirmed 1,100 Obligations paid (1,022) Ending, December 31 $ 274

Revenues Revenues (Tables)

Revenues Revenues (Tables)	12 Months Ended
	Dec. 31, 2023
Revenues [Abstract]
Disaggregation of Revenue [Table Text Block]	Disaggregation of Revenues The following tables present revenue disaggregated by timing of recognition and major product lines for the years ended December 31, 2023, 2022, and 2021. Year Ended December 31, 2023 Topic 606 Revenue Topic 815 (1) Total Point in Time Over Time Total Revenue Revenues (In millions) Ag Services and Oilseeds Ag Services $ 4,110 $ 761 $ 4,871 $ 42,549 $ 47,420 Crushing 470 — 470 13,550 14,020 Refined Products and Other 2,295 — 2,295 9,691 11,986 Total Ag Services and Oilseeds 6,875 761 7,636 65,790 73,426 Carbohydrate Solutions Starches and Sweeteners 7,431 — 7,431 2,454 9,885 Vantage Corn Processors 2,989 — 2,989 — 2,989 Total Carbohydrate Solutions 10,420 — 10,420 2,454 12,874 Nutrition Human Nutrition 3,634 — 3,634 — 3,634 Animal Nutrition 3,577 — 3,577 — 3,577 Total Nutrition 7,211 — 7,211 — 7,211 Other Business 424 — 424 — 424 Total Revenues $ 24,930 $ 761 $ 25,691 $ 68,244 $ 93,935 Year Ended December 31, 2022 Topic 606 Revenue Topic 815 (1) Total Point in Time Over Time Total Revenue Revenues (In millions) Ag Services and Oilseeds Ag Services $ 4,053 $ 818 $ 4,871 $ 48,310 $ 53,181 Crushing 573 — 573 12,566 13,139 Refined Products and Other 2,724 — 2,724 10,519 13,243 Total Ag Services and Oilseeds 7,350 818 8,168 71,395 79,563 Carbohydrate Solutions Starches and Sweeteners 7,696 — 7,696 2,555 10,251 Vantage Corn Processors 3,710 — 3,710 — 3,710 Total Carbohydrate Solutions 11,406 — 11,406 2,555 13,961 Nutrition Human Nutrition 3,769 — 3,769 — 3,769 Animal Nutrition 3,867 — 3,867 — 3,867 Total Nutrition 7,636 — 7,636 — 7,636 Other Business 396 — 396 — 396 Total Revenues $ 26,788 $ 818 $ 27,606 $ 73,950 $ 101,556 Year Ended December 31, 2021 Topic 606 Revenue Topic 815 (1) Total Point in Time Over Time Total Revenue Revenues (In millions) Ag Services and Oilseeds Ag Services $ 2,831 $ 606 $ 3,437 $ 41,580 $ 45,017 Crushing 441 — 441 10,927 11,368 Refined Products and Other 2,458 — 2,458 8,204 10,662 Total Ag Services and Oilseeds 5,730 606 6,336 60,711 67,047 Carbohydrate Solutions Starches and Sweeteners 5,866 — 5,866 1,745 7,611 Vantage Corn Processors 3,499 — 3,499 — 3,499 Total Carbohydrate Solutions 9,365 — 9,365 1,745 11,110 Nutrition Human Nutrition 3,189 — 3,189 — 3,189 Animal Nutrition 3,523 — 3,523 — 3,523 Total Nutrition 6,712 — 6,712 — 6,712 Other Business 380 — 380 — 380 Total Revenues $ 22,187 $ 606 $ 22,793 $ 62,456 $ 85,249 (1) Topic 815 revenue relates to the physical delivery or the settlement of the Company’s sales contracts accounted for as derivatives and are outside the scope of Topic 606.

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Business Combinations [Abstract]
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]			The following table sets forth the fair values and the useful lives of the other intangible assets acquired. Useful Lives P4 Deerland Sojaprotein Others Total (In years) (In millions) Intangible assets with finite lives: Trademarks/brands 7 to 15 $ 9 $ 18 $ 5 $ 1 $ 33 Customer lists 15 to 20 220 176 37 14 447 Recipes and others 7 16 58 — 3 77 Total other intangible assets acquired $ 245 $ 252 $ 42 $ 18 $ 557
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	During the year ended December 31, 2023, the Company acquired Prairie Pulse Inc., an 83% majority stake in Buckminster Química, and D.C.A. Finance B.V. for an aggregate cash consideration of $25 million. The aggregate cash consideration of these acquisitions, net of $2 million in cash acquired, was preliminarily allocated as follows: (In millions) Property, plant, and equipment $ 18 Goodwill 20 Other long-term assets 2 Long-term liabilities (17) Aggregate cash consideration $ 23	During the year ended December 31, 2022, the Company acquired Kansas Protein Foods LLC for cash consideration of $23 million. The cash consideration of this acquisition, net of $1 million in cash acquired, was allocated as follows: (In millions) Property, plant, and equipment $ 9 Goodwill 13 Cash consideration $ 22	During the year ended December 31, 2021, the Company’s Nutrition segment acquired five businesses including, a 75% majority stake in U.S.-based PetDine, Pedigree Ovens, The Pound Bakery, and NutraDine (collectively, “P4”), premier providers of private label pet treats and supplements; Deerland Probiotics & Enzymes (“Deerland”), a leader in probiotic, prebiotic, and enzyme technology; and Sojaprotein, a leading European provider of non-GMO soy ingredients, for an aggregate consideration of $1.6 billion using cash on hand. The aggregate cash consideration of these acquisitions, net of $21 million in cash acquired, was allocated as follows. In 2022, the Company made immaterial adjustments to the purchase price allocations related to these acquisitions. These adjustments have been reflected in the table below. (In millions) P4 Deerland Sojaprotein Others Total Working capital $ 11 $ 27 $ 35 $ 7 $ 80 Property, plant, and equipment 73 43 85 6 207 Goodwill 317 396 192 35 940 Other intangible assets 245 252 42 18 557 Other long-term assets — — 12 2 14 Long-term liabilities — (74) (10) — (84) Temporary equity - redeemable noncontrolling interest (150) — — — (150) Aggregate cash consideration $ 496 $ 644 $ 356 $ 68 $ 1,564

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The following tables set forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2023 and 2022. Fair Value Measurements at December 31, 2023 Quoted Prices in Significant Significant Total (In millions) Assets: Inventories carried at market $ — $ 4,274 $ 2,713 $ 6,987 Unrealized derivative gains: Commodity contracts — 628 731 1,359 Foreign exchange contracts — 187 — 187 Cash equivalents 209 — — 209 Segregated investments 1,362 — — 1,362 Total Assets $ 1,571 $ 5,089 $ 3,444 $ 10,104 Liabilities: Unrealized derivative losses: Commodity contracts $ — $ 500 $ 457 $ 957 Foreign exchange contracts — 144 — 144 Inventory-related payables — 1,219 101 1,320 Total Liabilities $ — $ 1,863 $ 558 $ 2,421 Fair Value Measurements at December 31, 2022 Quoted Prices in Significant Significant Total (In millions) Assets: Inventories carried at market $ — $ 6,281 $ 2,760 $ 9,041 Unrealized derivative gains: Commodity contracts — 796 541 1,337 Foreign currency contracts — 258 — 258 Interest rate contracts — 109 — 109 Cash equivalents 405 — — 405 Segregated investments 1,453 — — 1,453 Total Assets $ 1,858 $ 7,444 $ 3,301 $ 12,603 Liabilities: Unrealized derivative losses: Commodity contracts $ — $ 665 $ 603 $ 1,268 Foreign currency contracts — 275 — 275 Debt conversion option — — 6 6 Inventory-related payables — 1,181 89 1,270 Total Liabilities $ — $ 2,121 $ 698 $ 2,819
Reconciliation Of Assets Measured At Fair Value On A Recurring Basis	Level 3 Fair Value Assets Measurements at Inventories Commodity Total (In millions) Balance, December 31, 2022 $ 2,760 $ 541 $ 3,301 Total increase (decrease) in net realized/unrealized gains included in cost of products sold 432 1,460 1,892 Purchases 29,929 — 29,929 Sales (30,038) — (30,038) Settlements (4) (1,559) (1,563) Transfers into Level 3 1,584 371 1,955 Transfers out of Level 3 (1,950) (82) (2,032) Ending balance, December 31, 2023 (1) $ 2,713 $ 731 $ 3,444 (1) Includes increase in unrealized gains	Level 3 Fair Value Assets Measurements at Inventories Commodity Total (In millions) Balance, December 31, 2021 $ 3,004 $ 460 $ 3,464 Total increase (decrease) in net realized/unrealized gains included in cost of products sold 867 1,648 2,515 Purchases 49,735 — 49,735 Sales (50,414) — (50,414) Settlements — (1,672) (1,672) Transfers into Level 3 1,088 400 1,488 Transfers out of Level 3 (1,520) (295) (1,815) Ending balance, December 31, 2022 (1) $ 2,760 $ 541 $ 3,301 (1) Includes increase in unrealized gains
Reconciliation Of Liabilities Measured At Fair Value On A Recurring Basis	Level 3 Fair Value Liabilities Measurements at Inventory- Commodity Debt Conversion Option Total (In millions) Balance, December 31, 2022 $ 89 $ 603 $ 6 $ 698 Total increase (decrease) in net realized/unrealized losses included in cost of products sold and interest expense 5 1,303 (6) 1,302 Purchases 49 — — 49 Settlements (35) (1,583) — (1,618) Transfers into Level 3 1 157 — 158 Transfers out of Level 3 (8) (23) — (31) Ending balance, December 31, 2023 (1) $ 101 $ 457 $ — $ 558 (1) Includes increase in unrealized losses	Level 3 Fair Value Liabilities Measurements at Inventory- Commodity Debt Conversion Option Total (In millions) Balance, December 31, 2021 $ 106 $ 815 $ 15 $ 936 Total increase (decrease) in net realized/unrealized losses included in cost of products sold and interest expense 3 2,483 (9) 2,477 Purchases 183 — — 183 Sales (203) — — (203) Settlements — (2,844) — (2,844) Transfers into Level 3 — 401 — 401 Transfers out of Level 3 — (252) — (252) Ending balance, December 31, 2022 (1) $ 89 $ 603 $ 6 $ 698 (1) Includes increase in unrealized losses
Unobservable Price Components Present in the Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table sets forth the weighted average percentage of the unobservable price components included in the Company’s Level 3 valuations as of December 31, 2023 and 2022. The Company’s Level 3 measurements may include basis only, transportation cost only, or both price components. As an example, for Level 3 inventories with basis, the unobservable component as of December 31, 2023 is a weighted average 25.0% of the total price for assets and 33.2% of the total price for liabilities. Weighted Average % of Total Price December 31, 2023 December 31, 2022 Component Type Assets Liabilities Assets Liabilities Inventories and Related Payables Basis 25.0% 33.2% 19.4% 15.2% Transportation cost 11.5% —% 10.5% —% Commodity Derivative Contracts Basis 24.2% 24.9% 22.7% 26.5% Transportation cost 9.3% 3.2% 13.5% 3.7%

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Other Derivatives Not Designated as Hedging Instruments	The following table sets forth the fair value of derivatives not designated as hedging instruments as of December 31, 2023 and 2022. December 31, 2023 December 31, 2022 Assets Liabilities Assets Liabilities (In millions) Foreign Currency Contracts $ 187 $ 122 $ 154 $ 275 Commodity Contracts 1,343 957 1,337 1,248 Debt Conversion Option — — — 6 Total $ 1,530 $ 1,079 $ 1,491 $ 1,529 The following table sets forth the pre-tax gains (losses) on derivatives not designated as hedging instruments that have been included in the consolidated statements of earnings for the years ended December 31, 2023, 2022, and 2021. Cost of Other expense (income) - net products Interest (In millions) Revenues sold Expense For the Year Ended December 31, 2023 Consolidated Statement of Earnings $ 93,935 $ 86,422 $ 647 $ (176) Pre-tax gains (losses) on: Foreign Currency Contracts $ (33) $ 322 $ — $ 43 Commodity Contracts — 619 — — Debt Conversion Option — — 6 Total gain (loss) recognized in earnings $ (33) $ 941 $ 6 $ 43 $ 957 For the Year Ended December 31, 2022 Consolidated Statement of Earnings $ 101,556 $ 93,986 $ 396 $ (358) Pre-tax gains (losses) on: Foreign Currency Contracts $ (42) $ 367 $ — $ 194 Commodity Contracts — (120) — — Debt Conversion Option — — 9 — Total gain (loss) recognized in earnings $ (42) $ 247 $ 9 $ 194 $ 408 For the Year Ended December 31, 2021 Consolidated Statement of Earnings $ 85,249 $ 79,262 $ 265 $ (94) Pre-tax gains (losses) on: Foreign Currency Contracts $ 3 $ (140) $ — $ 189 Commodity Contracts — (1,606) — — Debt Conversion Option — — 19 — Total gain (loss) recognized in earnings $ 3 $ (1,746) $ 19 $ 189 $ (1,535)
Schedule Of Derivatives Designated As Hedging Instruments	The following table sets forth the fair value of derivatives designated as hedging instruments as of December 31, 2023 and 2022. December 31, 2023 December 31, 2022 Assets Liabilities Assets Liabilities (In millions) Commodity Contracts $ 16 $ — $ — $ 20 Interest Rate Contracts — — 109 — Foreign Currency Contracts — 22 104 — Total $ 16 $ 22 $ 213 $ 20 The following table sets forth the pre-tax gains (losses) on derivatives designated as hedging instruments that have been included in the consolidated statement of earnings for the years ended December 31, 2023, 2022, and 2021. Cost of products sold (In millions) Revenues For the Year Ended December 31, 2023 Consolidated Statement of Earnings $ 93,935 $ 86,422 Effective amounts recognized in earnings Pre-tax gains (losses) on: Commodity Contracts — 322 Total gain (loss) recognized in earnings $ — $ 322 $ 322 For the Year Ended December 31, 2022 Consolidated Statement of Earnings $ 101,556 $ 93,986 Effective amounts recognized in earnings Pre-tax gains (losses) on: Commodity Contracts $ — $ 351 Interest Rate Contracts 1 — Total gain (loss) recognized in earnings $ 1 $ 351 $ 352 For the Year Ended December 31, 2021 Consolidated Statement of Earnings $ 85,249 $ 79,262 Effective amounts recognized in earnings Pre-tax gains (losses) on: Commodity Contracts $ — $ 490 Interest Rate Contracts (16) — Total gain (loss) recognized in earnings $ (16) $ 490 $ 474

Other Current Assets (Tables)

Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2023
Other Assets [Abstract]
Other Current Assets	The following table sets forth the items in other current assets: December 31, 2023 December 31, 2022 (In millions) Unrealized gains on derivative contracts $ 1,546 $ 1,704 Margin deposits and grain accounts 560 723 Customer omnibus receivable 1,052 1,309 Financing receivables - net (1) 237 235 Insurance premiums receivable 61 54 Prepaid expenses 445 443 Biodiesel tax credit 119 68 Tax receivables 491 616 Non-trade receivables 304 361 Other current assets 167 153 $ 4,982 $ 5,666

Accrued Expenses And Other Pa_2

Accrued Expenses And Other Payables (Tables)	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses And Other Payables	The following table sets forth the items in accrued expenses and other payables: December 31, 2023 December 31, 2022 (In millions) Unrealized losses on derivative contracts $ 1,101 $ 1,543 Accrued compensation 439 475 Income tax payable 284 248 Other taxes payable 172 136 Insurance claims payable 73 223 Contract liability 626 694 Other accruals and payables 1,381 1,476 $ 4,076 $ 4,795

Investments In And Advances T_2

Investments In And Advances To Affiliates (Tables)	12 Months Ended
	Dec. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]
Combined Balance Sheets And Statements Of Earnings Of The Company's Unconsolidated Affiliates	The following table summarizes the combined balance sheets as of December 31, 2023 and 2022, and the combined statements of earnings of the Company’s unconsolidated affiliates for the years ended December 31, 2023, 2022, and 2021. December 31 (In millions) 2023 2022 Current assets $ 41,032 $ 41,407 Non-current assets 29,773 30,589 Current liabilities (33,812) (36,091) Non-current liabilities (8,973) (9,300) Noncontrolling interests (2,489) (2,641) Net assets $ 25,531 $ 23,964 Year Ended December 31 (In millions) 2023 2022 2021 Revenues $ 85,754 $ 109,448 $ 87,528 Gross profit 4,261 8,946 7,719 Net income 2,452 3,140 2,315

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill Balances Attributable To Consolidated Businesses And Investments In Affiliates, By Segment	Goodwill balances attributable to consolidated businesses, by segment, are set forth in the following table. December 31, 2023 December 31, 2022 (In millions) Ag Services and Oilseeds $ 235 $ 193 Carbohydrate Solutions 224 224 Nutrition 3,640 3,731 Other Business 4 14 Total $ 4,103 $ 4,162
Schedule of other intangible assets	The following table sets forth the other intangible assets: December 31, 2023 December 31, 2022 Useful Gross Accumulated Gross Accumulated Life Amount Amortization Net Amount Amortization Net (In years) (In millions) Intangible assets with indefinite lives: Trademarks/brands $ 375 $ — $ 375 $ 397 $ — $ 397 Other 58 — 58 — — — Intangible assets with definite lives: Trademarks/brands 5 to 20 53 (35) 18 70 (28) 42 Customer lists 1 to 30 1,544 (627) 917 1,544 (542) 1,002 Capitalized software and related costs 5 to 8 950 (523) 427 721 (449) 272 Land rights 2 to 50 107 (30) 77 109 (25) 84 Other intellectual property 6 to 20 211 (135) 76 228 (112) 116 Recipes and other 1 to 35 511 (304) 207 547 (274) 273 Intangible assets in process 83 — 83 196 — 196 Total $ 3,892 $ (1,654) $ 2,238 $ 3,812 $ (1,430) $ 2,382

Debt Financing Arrangements (Ta

Debt Financing Arrangements (Tables)	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Long-Term Debt	The Company’s long-term debt consisted of the following: Debt Instrument Interest Rate Face Amount Due Date December 31, 2023 December 31, 2022 (In millions) 2.5% Notes $1 billion 2026 $ 998 $ 997 3.25% Notes $1 billion 2030 991 989 2.900% Notes $750 million 2032 744 744 2.700% Notes $750 million 2051 732 731 1% Notes €650 million 2025 717 691 4.5% Notes $600 million 2049 589 589 4.500% Notes $500 million 2033 492 — 5.375% Debentures $432 million 2035 426 425 3.75% Notes $408 million 2047 403 403 5.935% Debentures $336 million 2032 334 334 5.765% Debentures $297 million 2041 297 297 4.535% Debentures $383 million 2042 288 286 4.016% Debentures $371 million 2043 263 260 7% Debentures $160 million 2031 159 159 6.95% Debentures $157 million 2097 154 154 7.5% Debentures $147 million 2027 147 147 6.625% Debentures $144 million 2029 144 144 6.75% Debentures $103 million 2027 103 103 6.45% Debentures $103 million 2038 102 102 1.750% Notes €600 million 2023 — 641 0% Bonds $300 million 2023 — 304 Other 177 177 Total long-term debt including current maturities 8,260 8,677 Current maturities (1) (942) Total long-term debt $ 8,259 $ 7,735

Stock Compensation (Tables)

Stock Compensation (Tables)	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Summary Of Option Activity During The Period	A summary of option activity during 2023 is presented below: Shares Weighted-Average (In thousands, except per share amounts) Shares under option at December 31, 2022 2,097 $38.27 Exercised (483) 42.15 Forfeited or expired — 0.00 Shares under option at December 31, 2023 1,614 $37.11 Exercisable at December 31, 2023 1,614 $37.11
Summary Of Restricted Stock Awards And PSUs Activity During The Period	A summary of Restricted Stock Awards and PSUs activity during 2023 is presented below: Restricted Weighted Average (In thousands, except per share amounts) Non-vested at December 31, 2022 6,408 $57.22 Granted 1,663 78.90 Vested (2,559) 45.66 Forfeited (180) 71.22 Non-vested at December 31, 2023 5,332 $69.82

Other (Income) Expense - Net (T

Other (Income) Expense - Net (Tables)	12 Months Ended
	Dec. 31, 2023
Other Income and Expenses [Abstract]
Other (Income) Expense - Net	The following table sets forth the items in other (income) expense: (In millions) Year Ended December 31 2023 2022 2021 Gains on sale of assets $ (38) $ (78) $ (100) Pension settlement — — 83 Other – net (138) (280) (77) $ (176) $ (358) $ (94)

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Components Of Earnings Before Income Taxes by Geographic Region	The following table sets forth the geographic split of earnings before income taxes: Year Ended (In millions) December 31 2023 2022 2021 United States $ 1,844 $ 2,725 $ 2,140 Foreign 2,450 2,508 1,173 $ 4,294 $ 5,233 $ 3,313
Significant Components Of Income Taxes	Significant components of income taxes are as follows: (In millions) Year Ended December 31 2023 2022 2021 Current Federal $ 291 $ 379 $ 404 State 47 97 79 Foreign 513 481 224 Deferred Federal (52) 23 (59) State (10) 7 (12) Foreign 39 (119) (58) $ 828 $ 868 $ 578
Significant Components Of Deferred Tax Liabilities And Assets	Significant components of deferred tax liabilities and assets are as follows: December 31, 2023 December 31, 2022 (In millions) Deferred tax liabilities Property, plant, and equipment $ 827 $ 811 Intangibles 358 417 Right of use assets 263 237 Equity in earnings of affiliates 214 191 Inventory reserves — 11 Debt exchange 50 52 Reserves and other accruals 49 86 Other 137 108 $ 1,898 $ 1,913 Deferred tax assets Pension and postretirement benefits $ 111 $ 104 Inventories 20 — Lease liabilities 268 244 Stock compensation 42 51 Foreign tax loss carryforwards 494 496 Capital loss carryforwards 42 42 State tax attributes 25 21 Reserves and other accruals 5 22 Other 93 77 Gross deferred tax assets 1,100 1,057 Valuation allowances (216) (209) Net deferred tax assets $ 884 $ 848 Net deferred tax liabilities $ 1,014 $ 1,065 The net deferred tax liabilities are classified as follows: Noncurrent assets (foreign) $ 295 $ 337 Noncurrent liabilities (1,106) (1,183) Noncurrent liabilities (foreign) (203) (219) $ (1,014) $ (1,065)
Reconciliation Of The Statutory Federal Income Tax Rate To The Company's Effective Tax Rate On Earnings	Reconciliation of the statutory federal income tax rate to the Company’s effective income tax rate on earnings is as follows: Year Ended December 31 2023 2022 2021 Statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal tax benefit 0.9 1.4 1.5 Foreign earnings taxed at rates other than the U.S. statutory rate (0.2) (3.8) (2.8) Foreign currency effects/remeasurement 0.5 0.6 — Income tax adjustment to filed returns (0.4) (0.1) 0.7 Tax benefit on U.S. biodiesel credits (1.7) (1.2) (1.9) Tax benefit on U.S. railroad credits (1.5) (1.2) (2.0) U.S. tax on foreign earnings 1.2 0.2 — Valuation allowances (0.2) — 0.7 Other (0.3) (0.3) 0.2 Effective income tax rate 19.3 % 16.6 % 17.4 %
Unrecognized Tax Benefits	The following table sets forth a rollforward of activity of unrecognized tax benefits for the year ended December 31, 2023 and 2022 as follows: Unrecognized Tax Benefits December 31, 2023 December 31, 2022 (In millions) Beginning balance $ 151 $ 157 Additions related to current year’s tax positions 2 6 Additions related to prior years’ tax positions 28 26 Additions (adjustments) related to acquisitions — 11 Reductions related to lapse of statute of limitations (6) (6) Settlements with tax authorities (7) (43) Ending balance $ 168 $ 151

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Lease, Cost [Table Text Block]	The following table sets forth the amounts relating to the Company’s total lease cost and other information. Year Ended December 31 2023 2022 2021 (In millions) Lease cost: Operating lease cost $ 390 $ 356 $ 336 Short-term lease cost 126 127 117 Total lease cost $ 516 $ 483 $ 453 Other information: Operating lease liability principal payments $ 374 $ 339 $ 325 Right-of-use assets obtained in exchange for new operating lease liabilities $ 327 $ 357 $ 197 December 31 2023 2022 Weighted-average remaining lease term - operating leases (in years) 7 7 Weighted average discount rate - operating leases 4.1 % 3.7 %
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	Below is a tabular disclosure of the future annual undiscounted cash flows for operating lease liabilities as of December 31, 2023. Undiscounted Cash Flows (In millions) 2024 $ 334 2025 260 2026 186 2027 146 2028 101 Thereafter 339 Total 1,366 Less interest (1) (135) Lease liability $ 1,231 (1) Calculated using the implicit rate of the lease, if available, or the incremental borrowing rate that is appropriate for the tenor and geography of the lease.

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2023
Retirement Benefits [Abstract]
Retirement Plan Expense	The following table sets forth the components of retirement plan expense for the years ended December 31, 2023, 2022, and 2021: Pension Benefits Postretirement Benefits (In millions) Year Ended December 31 Year Ended December 31 2023 2022 2021 2023 2022 2021 Retirement plan expense Defined benefit plans: Service cost (benefits earned during the period) $ 41 $ 48 $ 64 $ — $ 1 $ 1 Interest cost 76 48 48 6 3 2 Expected return on plan assets (83) (79) (95) — — — Settlement charges — — 83 — — — Curtailments — (2) — — — — Amortization of actuarial loss 3 17 33 2 5 6 Amortization of prior service cost (credit) (20) (20) (20) — — (2) Net periodic defined benefit plan expense 17 12 113 8 9 7 Defined contribution plans 73 67 61 — — — Total retirement plan expense $ 90 $ 79 $ 174 $ 8 $ 9 $ 7
Changes In Defined Benefit Obligation And Fair Value Of Defined Benefit Plan Assets	The following tables set forth changes in the defined benefit obligation and the fair value of defined benefit plan assets for the years ended December 31, 2023 and 2022: Pension Benefits Postretirement Benefits December 31 December 31 December 31 December 31 (In millions) (In millions) Benefit obligation, beginning $ 1,587 $ 2,178 $ 118 $ 154 Service cost 41 48 — 1 Interest cost 76 48 6 3 Actuarial loss (gain) 83 (575) 6 (24) Employee contributions 3 3 — — Curtailments — (2) — — Business combinations (1) — — — Settlements (1) (1) — — Benefits paid (53) (47) (17) (16) Foreign currency effects 30 (65) — — Benefit obligation, ending $ 1,765 $ 1,587 $ 113 $ 118 Fair value of plan assets, beginning $ 1,269 $ 1,742 $ — $ — Actual return on plan assets 121 (438) — — Employer contributions 54 60 17 16 Employee contributions 3 3 — — Settlements (1) (1) — — Benefits paid (53) (47) (17) (16) Foreign currency effects 22 (50) — — Fair value of plan assets, ending $ 1,415 $ 1,269 $ — $ — Funded status $ (350) $ (318) $ (113) $ (118) Prepaid benefit cost $ 63 $ 60 $ — $ — Accrued benefit liability – current (19) (18) (14) (14) Accrued benefit liability – long-term (394) (360) (99) (104) Net amount recognized in the balance sheet $ (350) $ (318) $ (113) $ (118)
Principal Assumptions In Developing Net Periodic Pension Cost	The following table sets forth the principal assumptions used in developing net periodic benefit cost: Pension Benefits Postretirement Benefits December 31 December 31 December 31 December 31 Discount rate 4.8% 2.5% 5.1% 2.7% Expected return on plan assets 6.0% 5.0% N/A N/A Rate of compensation increase 4.3% 4.2% N/A N/A Interest crediting rate 3.9% 1.9% N/A N/A The following table sets forth the principal assumptions used in developing the year-end actuarial present value of the projected benefit obligations: Pension Benefits Postretirement Benefits December 31 December 31 December 31 December 31 Discount rate 4.5 % 4.8 % 4.9% 5.1% Rate of compensation increase 4.8 % 4.3 % N/A N/A Interest crediting rate 4.0 % 3.9 % N/A N/A
Schedule Of Fair Value Of Plan Assets	The following tables set forth, by level within the fair value hierarchy, the fair value of plan assets as of December 31, 2023 and 2022. Fair Value Measurements at December 31, 2023 Quoted Prices in Significant Significant Total (In millions) Common stock $ 37 $ — $ — $ 37 Mutual funds 147 — — 147 Corporate bonds — 473 — 473 U.S. Treasury instruments 262 — — 262 U.S. government agency, state and local government bonds — 8 — 8 Other — 7 — 7 Total assets $ 446 $ 488 $ — $ 934 Common collective trust funds at NAV U.S. equity 15 International equity 60 Fixed income 330 Other 76 Total assets at fair value $ 1,415 Fair Value Measurements at December 31, 2022 Quoted Prices in Significant Significant Total (In millions) Common stock $ 68 $ — $ — $ 68 Mutual funds 245 — — 245 Corporate bonds — 318 — 318 U.S. Treasury instruments 173 — — 173 U.S. government agency, state and local government bonds — 5 — 5 Other — 9 — 9 Total assets $ 486 $ 332 $ — $ 818 Common collective trust funds at NAV U.S. equity 23 International equity 76 Fixed income 247 Other 105 Total assets at fair value $ 1,269
Actual Asset Allocation For Global Pension Plan Assets	The following table sets forth the actual asset allocation for the Company’s global pension plan assets as of the measurement date: December 31 2023 (1)(2) December 31 2022 (2) Equity securities 19% 33% Debt securities 77% 62% Other 4% 5% Total 100% 100% (1) The Company’s U.S. pension plans contain approximately 67% of the Company’s global pension plan assets. The actual asset allocation for the Company’s U.S. pension plans as of the measurement date consists of 20% equity securities and 80% debt securities. The target asset allocation for the Company’s U.S. pension plans is approximately the same as the actual asset allocation. The actual asset allocation for the Company’s foreign pension plans as of the measurement date consists of 17% equity securities, 71% debt securities, and 12% other. The target asset allocation for the Company’s foreign pension plans is approximately the same as the actual asset allocation. (2)
Expected Future Benefit Payments To Be Paid	The following benefit payments, which reflect expected future service, are expected to be paid by the benefit plans: Pension Postretirement (In millions) 2024 $ 69 $ 14 2025 75 13 2026 82 11 2027 88 11 2028 94 10 2029-2033 559 41

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2023
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Accumulated Other Comprehensive Income (Loss)	The following tables set forth the changes in AOCI by component and the reclassifications out of AOCI for the years ended December 31, 2023 and 2022: Foreign Currency Translation Adjustment Deferred Gain (Loss) on Hedging Activities Pension and Unrealized Gain (Loss) on Investments Accumulated Other Comprehensive Income (Loss) (In millions) Balance at December 31, 2021 $ (2,248) $ 225 $ (147) $ (2) $ (2,172) Other comprehensive income before reclassifications (609) 268 117 (12) (236) Gain (loss) on net investment hedges 328 — — — 328 Amounts reclassified from AOCI — (352) 23 — (329) Tax effect (93) 7 (15) 1 (100) Net of tax amount (374) (77) 125 (11) (337) Balance at December 31, 2022 $ (2,622) $ 148 $ (22) $ (13) $ (2,509) Other comprehensive income before reclassifications 204 337 (46) 16 511 Gain (loss) on net investment hedges (153) — — — (153) Amounts reclassified from AOCI — (322) (42) — (364) Tax effect 32 (5) 2 (1) 28 Net of tax amount 83 10 (86) 15 22 Balance at December 31, 2023 $ (2,539) $ 158 $ (108) $ 2 $ (2,487)
Reclassification Out of Accumulated Other Comprehensive Income [Table Text Block]	Amounts reclassified from AOCI Affected line item in the Details about AOCI components 2023 2022 2021 consolidated statement of earnings (In millions) Deferred loss (gain) on hedging activities $ — $ (1) $ 16 Revenues (322) (351) (490) Cost of products sold (322) (352) (474) Earnings before income taxes 77 62 118 Income tax expense $ (245) $ (290) $ (356) Net earnings Pension liability adjustment Amortization of defined benefit pension items: Prior service losses (credit) $ (26) $ (119) $ (77) Other (income) expense – net Actuarial losses (16) 142 176 Other (income) expense – net (42) 23 99 Earnings before income taxes (10) (4) (26) Income tax expense (benefit) $ (52) $ 19 $ 73 Net earnings

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2023
Segment Reporting [Abstract]
Segment Information	The following tables present: (i) adjustments and revised gross revenues, intersegment revenues, and operating profit amounts for the Ag Services and Oilseeds segment; (ii) adjustments and revised gross revenues, intersegment revenues and operating profit amounts for the Carbohydrate Solutions segment; and (iii) adjustments and revised operating profit amounts for the Nutrition segment, in each case, for each of the years ended December 31, 2023, 2022, and 2021. No adjustments were required to the gross revenues of the Nutrition segment. Impact of the Adjustments on Ag Services and Oilseeds Segment Gross Revenues and Operating Profit Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as originally reported for 2022 and 2021 $ 77,457 $ 83,686 $ 70,455 Adjustments 1 15 24 Gross revenues, as revised $ 77,458 $ 83,701 $ 70,479 Intersegment revenues, as originally reported for 2022 and 2021 $ 4,031 $ 4,123 $ 3,408 Adjustments 1 15 24 Intersegment revenues, as revised $ 4,032 $ 4,138 $ 3,432 Segment operating profit, as originally reported for 2022 and 2021 $ 4,066 $ 4,386 $ 2,775 Adjustments 1 15 24 Segment operating profit, as revised $ 4,067 $ 4,401 $ 2,799 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Impact of the Adjustments on Carbohydrate Solutions Segment Gross Revenues and Operating Profit Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as originally reported for 2022 and 2021 $ 14,509 $ 16,336 $ 12,672 Adjustments 30 53 35 Gross revenues, as revised $ 14,539 $ 16,389 $ 12,707 Intersegment revenues, as originally reported for 2022 and 2021 $ 1,635 $ 2,375 $ 1,562 Adjustments 30 53 35 Intersegment revenues, as revised $ 1,665 $ 2,428 $ 1,597 Segment operating profit, as originally reported for 2022 and 2021 $ 1,345 $ 1,360 $ 1,283 Adjustments 30 53 35 Segment operating profit, as revised $ 1,375 $ 1,413 $ 1,318 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Impact of the Adjustments on Nutrition Segment Operating Profit Years Ended December 31 (In millions) 2023 (1) 2022 2021 Segment operating profit, as originally reported for 2022 and 2021 $ 458 $ 736 $ 691 Adjustments (31) (68) (59) Segment operating profit, as revised $ 427 $ 668 $ 632 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Separately, the Company determined that a portion of the originally reported gross revenues and intersegment revenues of each of the Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition segments included certain intrasegment revenues (resulting from sales within the segment), and should have included exclusively intersegment revenues (resulting from sales from one segment to the other). The correction of these immaterial errors does not have any impact on the Company’s previously reported Consolidated Statements of Earnings, Consolidated Statements of Comprehensive Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Cash Flows, or Consolidated Statements of Shareholders’ Equity for any of the periods presented below. The following tables present: (i) additional adjustments and further revised gross revenues and intersegment revenues amounts for the Ag Services and Oilseeds segment; (ii) additional adjustments and further revised gross revenues and intersegment revenues amounts for the Carbohydrate Solutions segment; and (iii) adjustments and revised gross revenues and intersegment revenues amounts for the Nutrition segment, for each of the years ended December 31, 2023, 2022, and 2021 . Additional Impact of the Adjustments on Ag Services and Oilseeds Segment Gross Revenues and Intersegment Revenues Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as revised $ 77,458 $ 83,701 $ 70,479 Additional adjustments (1,446) (1,579) (1,115) Gross revenues, as further revised $ 76,012 $ 82,122 $ 69,364 Intersegment revenues, as revised $ 4,032 $ 4,138 $ 3,432 Additional adjustments (1,446) (1,579) (1,115) Intersegment revenues, as further revised $ 2,586 $ 2,559 $ 2,317 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Additional Impact of the Adjustments on Carbohydrate Solutions Segment Gross Revenues and Intersegment Revenues Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as revised $ 14,539 $ 16,389 $ 12,707 Additional adjustments (11) (487) (295) Gross revenues, as further revised $ 14,528 $ 15,902 $ 12,412 Intersegment revenues, as revised $ 1,665 $ 2,428 $ 1,597 Additional adjustments (11) (487) (295) Intersegment revenues, as further revised $ 1,654 $ 1,941 $ 1,302 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Impact of the Adjustments on Nutrition Segment Gross Revenues and Intersegment Revenues Years Ended December 31 (In millions) 2023 (1) 2022 2021 Gross revenues, as originally reported for 2022 and 2021 $ 7,466 $ 7,836 $ 6,933 Adjustments (141) (15) (68) Gross revenues, as revised $ 7,325 $ 7,821 $ 6,865 Intersegment revenues, as originally reported for 2022 and 2021 $ 255 $ 200 $ 221 Adjustments (141) (15) (68) Intersegment revenues, as revised $ 114 $ 185 $ 153 (1) The adjustments set forth in the table above for the year ended December 31, 2023 reflect adjustments effected for the period January 1, 2023 through September 30, 2023. Given the timing of the Investigation, no adjustments were effected in the fourth quarter of 2023. Segment Information The following tables present data by segment, adjusted for the matters discussed above, for the years ended December 31, 2023, 2022 and 2021. (In millions) Year Ended December 31 2023 2022 2021 Gross revenues Ag Services and Oilseeds $ 76,012 $ 82,122 $ 69,364 Carbohydrate Solutions 14,528 15,902 12,412 Nutrition 7,325 7,821 6,865 Other 424 396 380 Intersegment elimination (4,354) (4,685) (3,772) Total $ 93,935 $ 101,556 $ 85,249 Intersegment revenues Ag Services and Oilseeds $ 2,586 $ 2,559 $ 2,317 Carbohydrate Solutions 1,654 1,941 1,302 Nutrition 114 185 153 Total $ 4,354 $ 4,685 $ 3,772 Revenues from external customers Ag Services and Oilseeds Ag Services $ 47,420 $ 53,181 $ 45,017 Crushing 14,020 13,139 11,368 Refined Products and Other 11,986 13,243 10,662 Total Ag Services and Oilseeds 73,426 79,563 67,047 Carbohydrate Solutions Starches and Sweeteners 9,885 10,251 7,611 Vantage Corn Processors 2,989 3,710 3,499 Total Carbohydrate Solutions 12,874 13,961 11,110 Nutrition Human Nutrition 3,634 3,769 3,189 Animal Nutrition 3,577 3,867 3,523 Total Nutrition 7,211 7,636 6,712 Other 424 396 380 Total $ 93,935 $ 101,556 $ 85,249 (In millions) Year Ended December 31 2023 2022 2021 Depreciation Ag Services and Oilseeds $ 350 $ 334 $ 349 Carbohydrate Solutions 304 307 322 Nutrition 132 120 101 Other 10 9 8 Corporate 29 24 27 Total $ 825 $ 794 $ 807 Long-lived asset impairments (1) Ag Services and Oilseeds $ 11 $ — $ 10 Carbohydrate Solutions 32 14 13 Nutrition 65 21 50 Total $ 108 $ 35 $ 73 Interest and investment income Ag Services and Oilseeds $ 54 $ 52 $ 27 Nutrition (18) 2 1 Other 499 185 16 Corporate (36) 54 52 Total $ 499 $ 293 $ 96 Equity in earnings of affiliates Ag Services and Oilseeds $ 459 $ 714 $ 500 Carbohydrate Solutions 76 94 70 Nutrition 21 23 24 Corporate (5) 1 1 Total $ 551 $ 832 $ 595 (1) See Note 18 for total asset impairment, exit, and restructuring costs. (In millions) Year Ended December 31 2023 2022 2021 Segment Operating Profit Ag Services and Oilseeds $ 4,067 $ 4,401 $ 2,799 Carbohydrate Solutions 1,375 1,413 1,318 Nutrition 427 668 632 Other 375 167 25 Specified Items: Gains on sales of assets and businesses (1) 17 47 77 Impairment, restructuring, and net settlement contingencies (2) (361) (147) (213) Total segment operating profit 5,900 6,549 4,638 Corporate (1,606) (1,316) (1,325) Earnings before income taxes $ 4,294 $ 5,233 $ 3,313 (1) The gains in 2023 and 2022 were related to the sale of certain assets. The gains in 2021 were related to the sale of ethanol and certain other assets. (2) The charges in 2023 were related to the impairment of certain long-lived assets, goodwill, intangibles, and an equity investment, restructuring, and a contingency related to import duties, partially offset by settlement/contingency adjustments. The charges in 2022 were related to the impairment of certain assets, restructuring, and settlement contingencies. The charges in 2021 were related to the impairment of certain long-lived assets, goodwill, and other intangibles, restructuring, and a legal settlement. (In millions) December 31 2023 2022 Investments in and advances to affiliates Ag Services and Oilseeds $ 4,888 $ 4,863 Carbohydrate Solutions 380 365 Nutrition 145 111 Corporate 87 128 Total $ 5,500 $ 5,467 Identifiable assets Ag Services and Oilseeds $ 25,473 $ 28,657 Carbohydrate Solutions 6,334 6,801 Nutrition 10,341 10,615 Other 8,701 10,569 Corporate 3,782 3,132 Total $ 54,631 $ 59,774 (In millions) Year Ended December 31 2023 2022 Gross additions to property, plant, and equipment Ag Services and Oilseeds $ 732 $ 568 Carbohydrate Solutions 351 261 Nutrition 262 314 Other 1 15 Corporate 37 53 Total $ 1,383 $ 1,211
Geographic Information	Geographic information: The following geographic data include revenues attributed to the countries based on the location of the subsidiary making the sale and long-lived assets based on physical location. Long-lived assets represent the net book value of property, plant, and equipment. Year Ended (In millions) December 31 2023 2022 2021 Revenues United States $ 38,783 $ 43,272 $ 35,396 Switzerland 19,898 21,821 18,453 Cayman Islands 7,646 5,883 5,515 Brazil 3,361 4,004 3,213 Mexico 3,185 3,709 2,934 Canada 2,400 2,272 1,818 United Kingdom 2,219 2,231 1,848 Other Foreign 16,443 18,364 16,072 $ 93,935 $ 101,556 $ 85,249 (In millions) December 31 2023 2022 Long-lived assets United States $ 6,660 $ 6,322 Brazil 874 801 Other Foreign 2,974 2,810 $ 10,508 $ 9,933

Asset Impairment, Exit, And R_2

Asset Impairment, Exit, And Restructuring Costs (Tables)	12 Months Ended
	Dec. 31, 2023
Restructuring, Settlement and Impairment Provisions [Abstract]
Asset Impairment, Exit, and Restructuring Costs	The following table sets forth the charges included in asset impairment, exit, and restructuring costs. (In millions) Year Ended December 31 2023 2022 2021 Restructuring and exit costs (1) $ 33 $ 29 $ 39 Impairment charge - goodwill and other intangible assets (2) 201 2 52 Impairment charge - other long-lived assets (3) 108 35 73 Total asset impairment, exit, and restructuring costs $ 342 $ 66 $ 164 (1) Restructuring and exit costs for the year ended December 31, 2023 consisted of several individually insignificant restructuring charges totaling $27 million presented as specified items within segment operating profit and $6 million in Corporate. Restructuring and exit costs for the year ended December 31, 2022 consisted of several individually insignificant restructuring charges totaling $28 million presented as specified items within segment operating profit and restructuring charges of $1 million in Corporate. Restructuring and exit costs for the year ended December 31, 2021 consisted of several individually insignificant restructuring charges totaling $35 million presented as specified items within segment operating profit and $4 million in Corporate. (2) Impairment charge - goodwill and other intangible assets for the year ended December 31, 2023 consisted of impairments related to goodwill of $137 million and customer list and discontinued animal nutrition trademarks totaling $64 million in Nutrition, presented as specified items within segment operating profit. Impairment charge - goodwill and other intangible assets for the year ended December 31, 2022 consisted of customer list impairment of $2 million in Nutrition presented as specified items within segment operating profit. Impairment charge - goodwill and other intangible assets for the year ended December 31, 2021 consisted of goodwill impairment of $5 million and land rights impairment customer list impairment (3) Impairment charge - other long-lived assets for the year ended December 31, 2023 consisted of impairments related to certain long-lived assets in Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition of $10 million, $33 million, and $65 million, respectively, presented as specified items within segment operating profit. Impairment charge - other long-lived assets for the year ended December 31, 2022 consisted of impairments related to certain long-lived assets in Carbohydrate Solutions and Nutrition of $15 million and $20 million, respectively, presented as specified items within segment operating profit. Impairment charge - other long-lived assets for the year ended December 31, 2021 consisted of impairments related to certain long-lived assets in Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition of $10 million, $13 million, and $50 million, respectively, presented as specified items within segment operating profit.

Quarterly Financial Data (Table

Quarterly Financial Data (Tables)	12 Months Ended
	Dec. 31, 2023
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Data	Quarter Ended March 31 June 30 September 30 December 31 Year (In millions, except per share amounts) Fiscal Year Ended December 31, 2023 Revenues $ 24,072 $ 25,190 $ 21,695 $ 22,978 $ 93,935 Gross Profit 2,080 1,883 1,810 1,740 7,513 Net Earnings Attributable to Controlling Interests 1,170 927 821 565 3,483 Basic Earnings Per Common Share 2.13 1.70 1.52 1.07 6.44 Diluted Earnings Per Common Share 2.12 1.70 1.52 1.06 6.43 Fiscal Year Ended December 31, 2022 Revenues $ 23,650 $ 27,284 $ 24,683 $ 25,939 $ 101,556 Gross Profit 1,897 2,100 1,811 1,762 7,570 Net Earnings Attributable to Controlling Interests 1,054 1,236 1,031 1,019 4,340 Basic Earnings Per Common Share 1.86 2.18 1.84 1.84 7.72 Diluted Earnings Per Common Share 1.86 2.18 1.83 1.84 7.71

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023 USD ($) employee $ / shares	Sep. 30, 2023 USD ($) $ / shares	Jun. 30, 2023 USD ($) $ / shares	Mar. 31, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($) $ / shares	Sep. 30, 2022 USD ($) $ / shares	Jun. 30, 2022 USD ($) $ / shares	Mar. 31, 2022 USD ($) $ / shares	Dec. 31, 2023 USD ($) employee $ / shares	Dec. 31, 2022 USD ($) $ / shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2020 USD ($)
Reclassifications
Intangible Assets, Gross (Excluding Goodwill)	$ 3,892				$ 3,812				$ 3,892	$ 3,812
Receivables
Accounts Receivable, Allowance for Credit Loss	215				199				215	199	$ 122
Accounts Receivable, Credit Loss Expense (Reversal)									6	88	32
Accounts Receivable, Allowance for Credit Loss, Recovery									2	2
Accounts Receivable, Allowance for Credit Loss, Writeoff									(28)	(12)
Accounts receivable, allowance for credit loss, foreign exchange translation difference									0	(2)
Accounts receivable, allowance for credit loss, other adjustments									36	1
Inventory Disclosure [Abstract]
Cost of products sold									(86,422)	(93,986)	(79,262)
Net Income (Loss) Attributable to Parent	$ 565	$ 821	$ 927	$ 1,170	$ 1,019	$ 1,031	$ 1,236	$ 1,054	$ 3,483	$ 4,340	$ 2,709
Diluted earnings per common share (dollars per share) | $ / shares	$ 1.06	$ 1.52	$ 1.70	$ 2.12	$ 1.84	$ 1.83	$ 2.18	$ 1.86	$ 6.43	$ 7.71	$ 4.79
Cost Method Investments
Equity Securities, FV-NI	$ 438				$ 488				$ 438	$ 488
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount										37	$ 49
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount	113								113
Property, Plant, and Equipment
Capitalized interest on major construction projects									32	20	17
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Asset Impairment									201	2	52
Goodwill, Impairment Loss									137
Asset Abandonments and Write-Downs
Asset Abandonments and Impairments									108	35	73
Research and Development
Research and development expenses, net of expenditures subsequently reimbursed by government grants									256	216	171
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(24,145)				(24,317)				(24,145)	(24,317)	(22,508)	$ (20,022)
Supplier Finance Program, Obligation	274				196				274	196
Supplier Finance Program, Obligation, Addition									1,100
Supplier Finance Program, Obligation, Settlement									(1,022)
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount									76
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount	$ 76								$ 76
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]	Liabilities, Current								Liabilities, Current
UKRAINE
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Entity Number of Employees | employee	630								630
In Process Software
Reclassifications
Intangible Assets, Gross (Excluding Goodwill)	$ 83				$ 196				$ 83	$ 196
Reinvested Earnings [Member]
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ (23,465)								$ (23,465)		$ (21,655)	$ (19,780)
Minimum [Member]
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Asset, Useful Life	1 year								1 year
Minimum [Member] | Building [Member]
Property, Plant, and Equipment
Property, Plant and Equipment, Useful Life	15 years								15 years
Minimum [Member] | Machinery And Equipment [Member]
Property, Plant, and Equipment
Property, Plant and Equipment, Useful Life	3 years								3 years
Maximum [Member]
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Asset, Useful Life	50 years								50 years
Maximum [Member] | Building [Member]
Property, Plant, and Equipment
Property, Plant and Equipment, Useful Life	40 years								40 years
Maximum [Member] | Machinery And Equipment [Member]
Property, Plant, and Equipment
Property, Plant and Equipment, Useful Life	40 years								40 years

Summary Of Significant Accoun_5

Summary Of Significant Accounting Policies (Schedule Of Inventories) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
LIFO inventories
Inventory, Finished Goods, Net of Reserves	$ 6,482	$ 7,796
Total inventories	11,957	14,771
Inventory, Raw Materials and Supplies, Net of Reserves	$ 5,475	$ 6,975

Revenues Revenues (Details)

Revenues Revenues (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Revenues	$ 22,978	$ 21,695	$ 25,190	$ 24,072	$ 25,939	$ 24,683	$ 27,284	$ 23,650	$ 93,935	$ 101,556	$ 85,249
Contract with Customer, Liability, Current	$ 626				$ 694				626	694
Contract with Customer, Liability, Revenue Recognized									469
Ag Services and Oilseeds [Member]
Disaggregation of Revenue [Line Items]
Revenues									73,426	79,563	67,047
Carbohydrate Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenues									12,874	13,961	11,110
Nutrition [Member]
Disaggregation of Revenue [Line Items]
Revenues									7,211	7,636	6,712
Other Segments [Member]
Disaggregation of Revenue [Line Items]
Revenues									424	396	380
Non MTM Products and Services [Member]
Disaggregation of Revenue [Line Items]
Revenues									25,691	27,606	22,793
Non MTM Products and Services [Member] | Ag Services and Oilseeds [Member]
Disaggregation of Revenue [Line Items]
Revenues									7,636	8,168	6,336
Non MTM Products and Services [Member] | Ag Services [Member]
Disaggregation of Revenue [Line Items]
Revenues									4,871	4,871	3,437
Non MTM Products and Services [Member] | Crushing [Member]
Disaggregation of Revenue [Line Items]
Revenues									470	573	441
Non MTM Products and Services [Member] | Refined Products and Other [Member]
Disaggregation of Revenue [Line Items]
Revenues									2,295	2,724	2,458
Non MTM Products and Services [Member] | Carbohydrate Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenues									10,420	11,406	9,365
Non MTM Products and Services [Member] | Starches and sweeteners [Member]
Disaggregation of Revenue [Line Items]
Revenues									7,431	7,696	5,866
Non MTM Products and Services [Member] | Vantage Corn Processors
Disaggregation of Revenue [Line Items]
Revenues									2,989	3,710	3,499
Non MTM Products and Services [Member] | Nutrition [Member]
Disaggregation of Revenue [Line Items]
Revenues									7,211	7,636	6,712
Non MTM Products and Services [Member] | Human Nutrition
Disaggregation of Revenue [Line Items]
Revenues									3,634	3,769	3,189
Non MTM Products and Services [Member] | Animal Nutrition [Member]
Disaggregation of Revenue [Line Items]
Revenues									3,577	3,867	3,523
Non MTM Products and Services [Member] | Other Segments [Member]
Disaggregation of Revenue [Line Items]
Revenues									424	396	380
Non MTM Products and Services [Member] | Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Revenues									24,930	26,788	22,187
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Ag Services and Oilseeds [Member]
Disaggregation of Revenue [Line Items]
Revenues									6,875	7,350	5,730
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Ag Services [Member]
Disaggregation of Revenue [Line Items]
Revenues									4,110	4,053	2,831
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Crushing [Member]
Disaggregation of Revenue [Line Items]
Revenues									470	573	441
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Refined Products and Other [Member]
Disaggregation of Revenue [Line Items]
Revenues									2,295	2,724	2,458
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Carbohydrate Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenues									10,420	11,406	9,365
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Starches and sweeteners [Member]
Disaggregation of Revenue [Line Items]
Revenues									7,431	7,696	5,866
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Vantage Corn Processors
Disaggregation of Revenue [Line Items]
Revenues									2,989	3,710	3,499
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Nutrition [Member]
Disaggregation of Revenue [Line Items]
Revenues									7,211	7,636	6,712
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Human Nutrition
Disaggregation of Revenue [Line Items]
Revenues									3,634	3,769	3,189
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Animal Nutrition [Member]
Disaggregation of Revenue [Line Items]
Revenues									3,577	3,867	3,523
Non MTM Products and Services [Member] | Transferred at Point in Time [Member] | Other Segments [Member]
Disaggregation of Revenue [Line Items]
Revenues									424	396	380
Non MTM Products and Services [Member] | Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Revenues									761	818	606
Non MTM Products and Services [Member] | Transferred over Time [Member] | Ag Services and Oilseeds [Member]
Disaggregation of Revenue [Line Items]
Revenues									761	818	606
Non MTM Products and Services [Member] | Transferred over Time [Member] | Ag Services [Member]
Disaggregation of Revenue [Line Items]
Revenues									761	818	606
Mark-to-Market Products [Member]
Disaggregation of Revenue [Line Items]
Revenues									68,244	73,950	62,456
Mark-to-Market Products [Member] | Ag Services and Oilseeds [Member]
Disaggregation of Revenue [Line Items]
Revenues									65,790	71,395	60,711
Mark-to-Market Products [Member] | Ag Services [Member]
Disaggregation of Revenue [Line Items]
Revenues									42,549	48,310	41,580
Mark-to-Market Products [Member] | Crushing [Member]
Disaggregation of Revenue [Line Items]
Revenues									13,550	12,566	10,927
Mark-to-Market Products [Member] | Refined Products and Other [Member]
Disaggregation of Revenue [Line Items]
Revenues									9,691	10,519	8,204
Mark-to-Market Products [Member] | Carbohydrate Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenues									2,454	2,555	1,745
Mark-to-Market Products [Member] | Starches and sweeteners [Member]
Disaggregation of Revenue [Line Items]
Revenues									2,454	2,555	1,745
Ag Services [Member] | Ag Services and Oilseeds [Member]
Disaggregation of Revenue [Line Items]
Revenues									47,420	53,181	45,017
Crushing [Member] | Ag Services and Oilseeds [Member]
Disaggregation of Revenue [Line Items]
Revenues									14,020	13,139	11,368
Refined Products and Other [Member] | Ag Services and Oilseeds [Member]
Disaggregation of Revenue [Line Items]
Revenues									11,986	13,243	10,662
Starches and sweeteners [Member] | Carbohydrate Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenues									9,885	10,251	7,611
Vantage Corn Processors | Carbohydrate Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenues									2,989	3,710	3,499
Human Nutrition | Nutrition [Member]
Disaggregation of Revenue [Line Items]
Revenues									3,634	3,769	3,189
Animal Nutrition [Member] | Nutrition [Member]
Disaggregation of Revenue [Line Items]
Revenues									$ 3,577	$ 3,867	$ 3,523

Acquisitions (Details)

Acquisitions (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($) entity
Business Acquisition [Line Items]
Number of Businesses Acquired | entity			5
Payments to Acquire Businesses, Gross			$ 1,600
Cash Acquired from Acquisition			21
Purchase price allocated to working capital			80
Purchase price allocated to property, plant and equipment			207
Goodwill	$ 4,103	$ 4,162
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			557
Purchase price, net of cash acquired	23	22	1,564
Purchase price allocated to other non-current assets			14
Purchase price allocated to long-term liabilities			(84)
Business Acquisition, Goodwill, Expected Tax Deductible Amount			313
Goodwill, Acquired During Period	20		940
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value			(150)
Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	25	23
Cash Acquired from Acquisition	2	1
Purchase price allocated to working capital			7
Purchase price allocated to property, plant and equipment	18	9	6
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			18
Purchase price, net of cash acquired	23	22	68
Purchase price allocated to other non-current assets	2		2
Purchase price allocated to long-term liabilities	(17)		0
Goodwill, Acquired During Period	$ 20	$ 13	35
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value			0
P4
Business Acquisition [Line Items]
Purchase price allocated to working capital			11
Purchase price allocated to property, plant and equipment			73
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			245
Purchase price, net of cash acquired			496
Purchase price allocated to other non-current assets			0
Purchase price allocated to long-term liabilities			$ 0
Business Acquisition, Percentage of Voting Interests Acquired			75%
Goodwill, Acquired During Period			$ 317
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value			$ (150)
Period when fixed multiple of EBITDA is calculated, in months			12 months
P4 | P4
Business Acquisition [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners			25%
Sojaprotein
Business Acquisition [Line Items]
Purchase price allocated to working capital			$ 35
Purchase price allocated to property, plant and equipment			85
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			42
Purchase price, net of cash acquired			356
Purchase price allocated to other non-current assets			12
Purchase price allocated to long-term liabilities			(10)
Goodwill, Acquired During Period			192
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value			0
Deerland
Business Acquisition [Line Items]
Purchase price allocated to working capital			27
Purchase price allocated to property, plant and equipment			43
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			252
Purchase price, net of cash acquired			644
Purchase price allocated to other non-current assets			0
Purchase price allocated to long-term liabilities			(74)
Goodwill, Acquired During Period			396
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value			0
Buckminster
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired	83%
Trademarks and Brands [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			33
Trademarks and Brands [Member] | Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			1
Trademarks and Brands [Member] | P4
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			9
Trademarks and Brands [Member] | Sojaprotein
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			5
Trademarks and Brands [Member] | Deerland
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			18
Customer Lists [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			447
Customer Lists [Member] | Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			14
Customer Lists [Member] | P4
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			220
Customer Lists [Member] | Sojaprotein
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			37
Customer Lists [Member] | Deerland
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			176
Recipes
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			77
Recipes | Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			3
Recipes | P4
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			16
Recipes | Sojaprotein
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			0
Recipes | Deerland
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			$ 58
Minimum [Member] | Trademarks and Brands [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			7 years
Minimum [Member] | Customer Lists [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			15 years
Minimum [Member] | Recipes
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			7 years
Maximum [Member] | Trademarks and Brands [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			15 years
Maximum [Member] | Customer Lists [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			20 years
Maximum [Member] | Recipes
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			7 years

Fair Value Measurements (Narrat

Fair Value Measurements (Narrative) (Details) - Significant Unobservable Inputs (Level 3) [Member] - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value Measurements [Line Items]
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)	$ 2.1	$ 2.7
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	$ 1.3	$ 2.5
Assets [Member] | Weighted Average [Member] | Fair Value, Recurring [Member] | Inventories Component [Member]
Fair Value Measurements [Line Items]
Basis	25%	19.40%
Liabilities [Member] | Weighted Average [Member] | Fair Value, Recurring [Member] | Inventories Component [Member]
Fair Value Measurements [Line Items]
Basis	33.20%	15.20%

Fair Value Measurements (Fair V

Fair Value Measurements (Fair Value Measurements At Reporting Date) (Details) - Fair Value, Recurring [Member] - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Assets:
Inventories carried at market	$ 6,987	$ 9,041
Cash Equivalents	209	405
Segregated investments	1,362	1,453
Total Assets	10,104	12,603
Liabilities:
Inventory-related payables	1,320	1,270
Total Liabilities	2,421	2,819
Commodity Contracts [Member]
Assets:
Derivative Asset	1,359	1,337
Liabilities:
Derivative Liability	957	1,268
Foreign Exchange Contract [Member]
Assets:
Derivative Asset	187	258
Liabilities:
Derivative Liability	144	275
Interest Rate Contracts [Member]
Assets:
Derivative Asset		109
Embedded Derivative Financial Instruments
Liabilities:
Derivative Liability		6
Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]
Assets:
Inventories carried at market	0	0
Cash Equivalents	209	405
Segregated investments	1,362	1,453
Total Assets	1,571	1,858
Liabilities:
Inventory-related payables	0	0
Total Liabilities	0	0
Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | Commodity Contracts [Member]
Assets:
Derivative Asset	0	0
Liabilities:
Derivative Liability	0	0
Quoted Prices In Active Markets For Identical Assets (Level 1) [Member] | Foreign Exchange Contract [Member]
Assets:
Derivative Asset	0	0
Liabilities:
Derivative Liability	0	0
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Inventories carried at market	4,274	6,281
Segregated investments	0
Total Assets	5,089	7,444
Liabilities:
Inventory-related payables	1,219	1,181
Total Liabilities	1,863	2,121
Significant Other Observable Inputs (Level 2) [Member] | Commodity Contracts [Member]
Assets:
Derivative Asset	628	796
Liabilities:
Derivative Liability	500	665
Significant Other Observable Inputs (Level 2) [Member] | Foreign Exchange Contract [Member]
Assets:
Derivative Asset	187	258
Liabilities:
Derivative Liability	144	275
Significant Other Observable Inputs (Level 2) [Member] | Interest Rate Contracts [Member]
Assets:
Derivative Asset		109
Significant Unobservable Inputs (Level 3) [Member]
Assets:
Inventories carried at market	2,713	2,760
Total Assets	3,444	3,301
Liabilities:
Inventory-related payables	101	89
Total Liabilities	558	698
Significant Unobservable Inputs (Level 3) [Member] | Commodity Contracts [Member]
Assets:
Derivative Asset	731	541
Liabilities:
Derivative Liability	457	603
Significant Unobservable Inputs (Level 3) [Member] | Foreign Exchange Contract [Member]
Assets:
Derivative Asset	0	0
Liabilities:
Derivative Liability	$ 0	0
Significant Unobservable Inputs (Level 3) [Member] | Embedded Derivative Financial Instruments
Liabilities:
Derivative Liability		$ 6

Fair Value Measurements (Reconc

Fair Value Measurements (Reconciliation Of Assets Measured At Fair Value On A Recurring Basis) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	$ 3,301	$ 3,464
Total increase (decrease) in unrealized gains included in cost of products sold	1,892	2,515
Purchases	29,929	49,735
Sales	(30,038)	(50,414)
Settlements	(1,563)	(1,672)
Transfers into Level 3	1,955	1,488
Transfers out of Level 3	(2,032)	(1,815)
Balance at end of period	$ 3,444	$ 3,301
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of products sold	Cost of products sold
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of products sold	Cost of products sold
Inventories Carried At Market [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	$ 2,760	$ 3,004
Total increase (decrease) in unrealized gains included in cost of products sold	432	867
Purchases	29,929	49,735
Sales	(30,038)	(50,414)
Settlements	(4)
Transfers into Level 3	1,584	1,088
Transfers out of Level 3	(1,950)	(1,520)
Balance at end of period	2,713	2,760
Commodity Derivative Contracts Gains [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	541	460
Total increase (decrease) in unrealized gains included in cost of products sold	1,460	1,648
Settlements	(1,559)	(1,672)
Transfers into Level 3	371	400
Transfers out of Level 3	(82)	(295)
Balance at end of period	$ 731	$ 541

Fair Value Measurements (Reco_2

Fair Value Measurements (Reconciliation Of Liabilities Measured At Fair Value On A Recurring Basis) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	$ 698	$ 936
Total increase (decrease) in unrealized gains included in cost of products sold	1,302	2,477
Purchases	49	183
Sales		(203)
Settlements	(1,618)	(2,844)
Transfers into Level 3	158	401
Transfers out of Level 3	(31)	(252)
Balance at end of period	$ 558	$ 698
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of products sold, Interest Expense	Cost of products sold, Interest Expense
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of products sold	Cost of products sold, Interest Expense
Commodity Derivative Contracts Losses [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	$ 603	$ 815
Total increase (decrease) in unrealized gains included in cost of products sold	1,303	2,483
Purchases	0	0
Sales		0
Settlements	(1,583)	(2,844)
Transfers into Level 3	157	401
Transfers out of Level 3	(23)	(252)
Balance at end of period	457	603
Inventory Related Payables [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	89	106
Total increase (decrease) in unrealized gains included in cost of products sold	5	3
Purchases	49	183
Sales		(203)
Settlements	(35)	0
Transfers into Level 3	1	0
Transfers out of Level 3	(8)	0
Balance at end of period	101	89
Long-term Debt
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	6	15
Total increase (decrease) in unrealized gains included in cost of products sold		9
Purchases		0
Settlements	0
Transfers into Level 3	0
Transfers out of Level 3	0
Balance at end of period	0	$ 6
Long-term Debt | Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total increase (decrease) in unrealized gains included in cost of products sold	$ 6

Fair Value Measurements (Unobse

Fair Value Measurements (Unobservable Inputs In Level 3 Valuations Of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) - Weighted Average [Member] - Significant Unobservable Inputs (Level 3) [Member] - Fair Value, Recurring [Member]	Dec. 31, 2023	Dec. 31, 2022
Assets [Member] | Inventories Component [Member]
Unobservable inputs in Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Basis	25%	19.40%
Transportation cost	11.50%	10.50%
Assets [Member] | Commodity Derivative Contracts [Member]
Unobservable inputs in Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Basis	24.20%	22.70%
Transportation cost	9.30%	13.50%
Liabilities [Member] | Inventories Component [Member]
Unobservable inputs in Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Basis	33.20%	15.20%
Transportation cost	0%	0%
Liabilities [Member] | Commodity Derivative Contracts [Member]
Unobservable inputs in Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Basis	24.90%	26.50%
Transportation cost	3.20%	3.70%

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities (Narrative) (Details) bu in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) gal bu	Dec. 31, 2022 USD ($)
Derivative [Line Items]
Derivatives used in Net Investment Hedge, Net of Tax	$ (5)	$ 79
Notional Amount of Nonderivative Instruments	700	1,300
Foreign Debt used in Net Investment Hedge, Net of Tax	212	228
Designated As Hedging Instrument [Member]
Derivative [Line Items]
Interest Rate Derivative Assets, at Fair Value	0	109
Interest Rate Derivative Liabilities, at Fair Value	0	0
After-tax gain (losses) in AOCI from commodity cash flow hedge transactions	42	(17)
After-tax gain (losses) in AOCI from commodity cash flow hedge transactions expected to be recognized in earnings.	$ 42
Corn processed per month (in bushels) | bu	59
Soybean [Member] | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Maximum Length of Time Hedged in Price Risk Cash Flow Hedge	12 months
Soybean [Member] | Minimum [Member] | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of Anticipated Commodity Hedged During Historical Hedging Period	77%
Percentage of Anticipated Commodity Hedged over Future Hedging Period	0%
Soybean [Member] | Maximum [Member] | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of Anticipated Commodity Hedged During Historical Hedging Period	100%
Percentage of Anticipated Commodity Hedged over Future Hedging Period	100%
Currency Swap [Member] | Net Investment Hedging [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 800	800
Corn [Member] | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Maximum Length of Time Hedged in Price Risk Cash Flow Hedge	12 months
Corn [Member] | Minimum [Member] | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of Anticipated Commodity Hedged During Historical Hedging Period	18%
Percentage of Anticipated Commodity Hedged over Future Hedging Period	4%
Corn [Member] | Maximum [Member] | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of Anticipated Commodity Hedged During Historical Hedging Period	34%
Percentage of Anticipated Commodity Hedged over Future Hedging Period	28%
Foreign Exchange Forward [Member] | Net Investment Hedging [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 2,100	2,500
Ethanol [Member] | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Commodity hedged during historical hedging period (in gallons) | gal	0
Contracted hedged over future hedging period (in gallons) | gal	0
Natural Gas | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Maximum Length of Time Hedged in Price Risk Cash Flow Hedge	12 months
Natural Gas | Minimum [Member] | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of Anticipated Commodity Hedged During Historical Hedging Period	54%
Percentage of Anticipated Commodity Hedged over Future Hedging Period	38%
Natural Gas | Maximum [Member] | Designated As Hedging Instrument [Member]
Derivative [Line Items]
Percentage of Anticipated Commodity Hedged During Historical Hedging Period	85%
Percentage of Anticipated Commodity Hedged over Future Hedging Period	64%
Interest Rate Contracts [Member] | Cash Flow Hedging [Member]
Derivative [Line Items]
Derivative, Notional Amount		$ 400

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities (Pre-Tax Gains (Losses) On Derivatives Not Designated As Hedging Instruments) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Revenues	$ 22,978	$ 21,695	$ 25,190	$ 24,072	$ 25,939	$ 24,683	$ 27,284	$ 23,650	$ 93,935	$ 101,556	$ 85,249
Cost of products sold									86,422	93,986	79,262
Total gain (loss) recognized in earnings									957	408	(1,535)
Other Nonoperating Income (Expense)									(176)	(358)	(94)
Interest Expense									647	396	265
Interest Expense [Member]
Derivative [Line Items]
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net									6	9	19
Total gain (loss) recognized in earnings									6	9	19
Cost Of Products Sold [Member]
Derivative [Line Items]
FX Contracts									322	367	(140)
Commodity Contracts									619	(120)	(1,606)
Total gain (loss) recognized in earnings									941	247	(1,746)
Sales [Member]
Derivative [Line Items]
FX Contracts									(33)	(42)	3
Total gain (loss) recognized in earnings									(33)	(42)	3
Other Nonoperating Income (Expense)
Derivative [Line Items]
FX Contracts									43	194	189
Total gain (loss) recognized in earnings									$ 43	$ 194	$ 189

Derivative Instruments and He_5

Derivative Instruments and Hedging Activities (Fair Value Of Derivatives Not Designated As Hedging Instruments) (Details) - Not Designated As Hedging Instrument [Member] - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
FX Contracts Assets	$ 187	$ 154
Commodity Contracts Assets	1,343	1,337
Total fair value of derivative assets not designated as hedging instruments	1,530	1,491
FX Contracts Liabilities	122	275
Commodity Contracts Liabilities	957	1,248
Embedded Derivative, Fair Value of Embedded Derivative Liability	0	6
Embedded Derivative, Fair Value of Embedded Derivative Asset	0	0
Total fair value of derivative liabilities not designated as hedging instruments.	$ 1,079	$ 1,529

Derivative Instruments and He_6

Derivative Instruments and Hedging Activities (Pre-Tax Gains (Losses) On Derivatives Designated As Hedging Instruments) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Interest Expense									$ 647	$ 396	$ 265
Revenues	$ 22,978	$ 21,695	$ 25,190	$ 24,072	$ 25,939	$ 24,683	$ 27,284	$ 23,650	93,935	101,556	85,249
Cost of products sold									86,422	93,986	79,262
Designated As Hedging Instrument [Member]
Derivative [Line Items]
Total amount recognized in earnings									322	352	474
Designated As Hedging Instrument [Member] | Cost Of Products Sold [Member]
Derivative [Line Items]
Commodity Contracts effective amount recognized in earnings									322	351	490
Total amount recognized in earnings									$ 322	$ 351	$ 490
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]									Cost of products sold	Cost of products sold	Cost of products sold
Designated As Hedging Instrument [Member] | Sales [Member]
Derivative [Line Items]
Interest contracts effective amount recognized in earnings										$ 1	$ (16)
Commodity Contracts effective amount recognized in earnings									$ 0	0	0
Total amount recognized in earnings									$ 0	$ 1	$ (16)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]									Revenues	Revenues	Revenues

Derivative Instruments and He_7

Derivative Instruments and Hedging Activities (Fair Value Of Derivatives Designated As Hedging Instruments) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Designated As Hedging Instrument [Member]
Derivative [Line Items]
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value	$ 0	$ 104
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Liabilities, Fair Value	22	0
Price Risk Cash Flow Hedge Asset, at Fair Value	16	0
Price Risk Cash Flow Hedge Liability, at Fair Value	0	20
Interest Rate Derivative Assets, at Fair Value	0	109
Interest Rate Derivative Liabilities, at Fair Value	0	0
Derivative Instruments in Hedges, Assets, at Fair Value	16	213
Derivative Instruments in Hedges, Liabilities, at Fair Value	22	20
Not Designated As Hedging Instrument [Member]
Derivative [Line Items]
Commodity Contracts Assets	$ 1,343	$ 1,337

Other Current Assets (Details)

Other Current Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Assets [Abstract]
Unrealized gains on derivative contracts	$ 1,546	$ 1,704
Margin Deposit Assets	560	723
Customer Omnibus Receivable	1,052	1,309
Financing Receivable, after Allowance for Credit Loss	237	235
Premiums Receivable, Net	61	54
Prepaid Expense, Current	445	443
Biodiesel tax credit	119	68
Tax receivables	491	616
Other Receivables	304	361
Other current assets	167	153
Total other current assets	4,982	5,666
Financing Receivable, Allowance for Credit Loss	6	3
Interest on financing receivables	$ 21	$ 15	$ 11

Accrued Expenses And Other Pa_3

Accrued Expenses And Other Payables (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Unrealized losses on derivative contracts	$ 1,101	$ 1,543
Employee-related Liabilities	439	475
Accrued Income Taxes, Current	284	248
Accrual for Taxes Other than Income Taxes, Current	172	136
Liability for Claims and Claims Adjustment Expense	73	223
Contract with Customer, Liability, Current	626	694
Other accruals and payables	1,381	1,476
Total accrued expenses and other payables	$ 4,076	$ 4,795

Investments In And Advances T_3

Investments In And Advances To Affiliates (Narrative) (Details) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023 USD ($) facility entity	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) entity	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2023 USD ($) facility entity	Dec. 31, 2022 USD ($) entity	Dec. 31, 2021 USD ($)
Schedule Of Equity Method Investments [Line Items]
Amount of credit facility provided to unconsolidated affiliates	$ 121								$ 121
Number of unconsolidated affiliates provided with credit facilities by the entity | entity	6								6
Revenues from unconsolidated affiliates	$ 22,978	$ 21,695	$ 25,190	$ 24,072	$ 25,939	$ 24,683	$ 27,284	$ 23,650	$ 93,935	$ 101,556	$ 85,249
Accounts Receivable, after Allowance for Credit Loss, Current	4,232				4,926				4,232	4,926
Accounts Payable, Current	$ 6,313				7,803				$ 6,313	7,803
Number of facilities with no outstanding balance | facility	5								5
Other Assets, Current	$ 4,982				5,666				$ 4,982	5,666
Line of Credit Facility, Interest Rate at Period End	5.97%								5.97%
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Schedule Of Equity Method Investments [Line Items]
Revenues from unconsolidated affiliates									$ 85,754	109,448	87,528
Scale-up Bio
Schedule Of Equity Method Investments [Line Items]
Number of facilities with outstanding balance | facility	1								1
Other Assets, Current	$ 2								$ 2
Affiliated Entity
Schedule Of Equity Method Investments [Line Items]
Outstanding balance of credit facilities	0								0
Revenues from unconsolidated affiliates									7,000	7,800	$ 6,600
Accounts Receivable, after Allowance for Credit Loss, Current	$ 167				$ 286				$ 167	$ 286
Wilmar International Limited [Member]
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	22.50%				22.50%				22.50%	22.50%
Carrying value of direct investments	$ 4,100								$ 4,100
Market value of direct investments	$ 3,800								$ 3,800
Pacificor
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	32.20%								32.20%
Stratas Foods
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50%								50%
Edible Oils
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50%								50%
Olenex
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	37.50%								37.50%
SoyVen
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50%								50%
Hungrana
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50%								50%
Almidones Mexicanos
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50%								50%
Aston Foods
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50%								50%
Vimison S.A. de C.V.
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	45.30%								45.30%
LSCP
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	22.10%								22.10%
Red Star Yeast Company, LLC
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	40%								40%
ADM Matsutani LLC
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50%								50%
Matsutani Singapore
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50%								50%
Vland Biotech
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50%								50%
Dusial S.A.
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	42.80%								42.80%
Vitafort ZRT
Schedule Of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	34.30%								34.30%
Equity Method Investments [Member]
Schedule Of Equity Method Investments [Line Items]
Number of unconsolidated affiliates | entity	73				67				73	67
Undistributed earnings of unconsolidated affiliates	$ 5,900								$ 5,900

Investments In And Advances T_4

Investments In And Advances To Affiliates (Combined Balance Sheets And Statements Of Earnings Of The Company's Unconsolidated Affiliates) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Combined balance sheets and statements of earnings of the Company's unconsolidated affiliates:
Current assets	$ 29,767				$ 35,410				$ 29,767	$ 35,410
Current liabilities	(18,662)				(24,191)				(18,662)	(24,191)
Non-current liabilities	(11,504)				(10,967)				(11,504)	(10,967)
Noncontrolling interests	(13)				(33)				(13)	(33)
Revenues	22,978	$ 21,695	$ 25,190	$ 24,072	25,939	$ 24,683	$ 27,284	$ 23,650	93,935	101,556	$ 85,249
Gross Profit	1,740	$ 1,810	$ 1,883	$ 2,080	1,762	$ 1,811	$ 2,100	$ 1,897	7,513	7,570	5,987
Net earnings including noncontrolling interests									3,466	4,365	2,735
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Combined balance sheets and statements of earnings of the Company's unconsolidated affiliates:
Current assets	41,032				41,407				41,032	41,407
Non-current assets	29,773				30,589				29,773	30,589
Current liabilities	(33,812)				(36,091)				(33,812)	(36,091)
Non-current liabilities	(8,973)				(9,300)				(8,973)	(9,300)
Noncontrolling interests	(2,489)				(2,641)				(2,489)	(2,641)
Net assets	$ 25,531				$ 23,964				25,531	23,964
Revenues									85,754	109,448	87,528
Gross Profit									4,261	8,946	7,719
Net earnings including noncontrolling interests									$ 2,452	$ 3,140	$ 2,315

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Goodwill
Goodwill	$ 4,103	$ 4,162
Carbohydrate Solutions [Member]
Goodwill
Goodwill	224	224
Nutrition [Member]
Goodwill
Goodwill	3,640	3,731
Ag Services and Oilseeds [Member]
Goodwill
Goodwill	235	193
Other Segments [Member]
Goodwill
Goodwill	$ 4	$ 14

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Goodwill
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			$ 557
Goodwill	$ 4,103	$ 4,162
Goodwill and Intangible Asset Impairment	201	2	52
Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	(53)
Foreign currency translation gain (loss) on accumulated amortization of other finite-lived intangible amortization	(15)
Goodwill, Foreign Currency Translation Gain (Loss)	65
Amortization of Intangible Assets	234	235	177
Goodwill, Impairment Loss	137
Goodwill, Impaired, Accumulated Impairment Loss	156	19
Goodwill, Acquired During Period	20		940
Amortization of Intangible Assets	234	235	177
Amortization expense of intangible assets next 12 months	338
Finite-Lived Intangible Assets, Amortization Expense, Year Two	345
Finite-Lived Intangible Assets, Amortization Expense, Year Three	337
Finite-Lived Intangible Assets, Amortization Expense, Year Four	330
Finite-Lived Intangible Assets, Amortization Expense, Year Five	310
Computer Software, Intangible Asset [Member]
Goodwill
Amortization of Intangible Assets	72	69	33
Amortization of Intangible Assets	72	69	33
Nutrition [Member]
Goodwill
Goodwill	3,640	3,731
Impairment of Intangible Assets, Finite-lived	64	2	4
Goodwill, Impairment Loss			1
Series of Individually Immaterial Business Acquisitions [Member]
Goodwill
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			18
Goodwill, Acquired During Period	$ 20	$ 13	$ 35

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	$ 3,892	$ 3,812
Finite-Lived Intangible Assets, Accumulated Amortization	(1,654)	(1,430)
Intangible Assets, Net (Excluding Goodwill)	2,238	2,382
Trademarks and Brands [Member]
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	375	397
Intangible Assets, Net (Excluding Goodwill)	375	397
Recipes and Other [Member]
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	58	0
Intangible Assets, Net (Excluding Goodwill)	58	0
Use Rights [Member]
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	107	109
Finite-Lived Intangible Assets, Accumulated Amortization	(30)	(25)
Intangible Assets, Net (Excluding Goodwill)	77	84
Computer Software, Intangible Asset [Member]
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	950	721
Finite-Lived Intangible Assets, Accumulated Amortization	(523)	(449)
Intangible Assets, Net (Excluding Goodwill)	427	272
Trademarks and Brands [Member]
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	53	70
Finite-Lived Intangible Assets, Accumulated Amortization	(35)	(28)
Intangible Assets, Net (Excluding Goodwill)	18	42
Customer Lists [Member]
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	1,544	1,544
Finite-Lived Intangible Assets, Accumulated Amortization	(627)	(542)
Intangible Assets, Net (Excluding Goodwill)	917	1,002
Recipes and Other [Member]
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	511	547
Finite-Lived Intangible Assets, Accumulated Amortization	(304)	(274)
Intangible Assets, Net (Excluding Goodwill)	207	273
Technology-Based Intangible Assets [Member]
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	211	228
Finite-Lived Intangible Assets, Accumulated Amortization	(135)	(112)
Intangible Assets, Net (Excluding Goodwill)	76	116
In Process Software
Schedule of Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	83	196
Intangible Assets, Net (Excluding Goodwill)	$ 83	$ 196
Minimum [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Minimum [Member] | Use Rights [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Minimum [Member] | Computer Software, Intangible Asset [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Minimum [Member] | Trademarks and Brands [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Minimum [Member] | Customer Lists [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Minimum [Member] | Recipes and Other [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Minimum [Member] | Technology-Based Intangible Assets [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	6 years
Maximum [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	50 years
Maximum [Member] | Use Rights [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	50 years
Maximum [Member] | Computer Software, Intangible Asset [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	8 years
Maximum [Member] | Trademarks and Brands [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years
Maximum [Member] | Customer Lists [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	30 years
Maximum [Member] | Recipes and Other [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	35 years
Maximum [Member] | Technology-Based Intangible Assets [Member]
Schedule of Other Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years

Debt Financing Arrangements (Na

Debt Financing Arrangements (Narrative) (Details) € in Millions, $ in Millions			12 Months Ended
	Apr. 03, 2023 USD ($)	Feb. 28, 2022 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2023 EUR (€)	Aug. 28, 2023 USD ($)	Jun. 23, 2023 EUR (€)	Sep. 30, 2022 EUR (€)	Aug. 26, 2020 USD ($)
Debt And Financing Arrangements [Line Items]
Proceeds from notes recorded as long-term debt			$ 501	$ 752	$ 1,329
Discount amortization expense included in interest expense related to the notes			15	$ 6	10
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months			1
Long-term Debt, Maturities, Repayments of Principal in Year Two			718
Long-term Debt, Maturities, Repayments of Principal in Year Three			999
Long-term Debt, Maturities, Repayments of Principal in Year Four			251
Long-term Debt, Maturities, Repayments of Principal in Year Five			1
Lines of credit			13,200
Unused lines of credit			$ 11,500
Weighted average interest rate on short term borrowings (as a percent)			7.44%	6.21%		7.44%
Outstanding standby letters of credit and surety bonds			$ 1,600	$ 1,600
(Gain) Loss on Extinguishment of Debt			$ 0	0	$ 36
Debt Instrument, Repurchased Face Amount | €									€ 500
Line of Credit Facility, Interest Rate Description			Secured Overnight Financing Rate plus a fixed spread
Fair Value of Debt Excess over Carrying Value			$ 300
Notes Four Point Five Percent due Two Thousand Forty-Nine [Member]
Debt And Financing Arrangements [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			4.50%			4.50%
Debt instrument, maturity year			2049
Debt Instrument, Face Amount			$ 600
Notes One Percent Due in Two Thousand Twenty-Five [Member]
Debt And Financing Arrangements [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			1%			1%
Debt instrument, maturity year			2025
Debt Instrument, Face Amount | €						€ 650
Bonds Zero Percent Due in 2023 [Member]
Debt And Financing Arrangements [Line Items]
Debt Instrument, Interest Rate, Stated Percentage							0%			0%
Debt instrument, maturity year			2023
Debt Instrument, Face Amount										$ 300
Debt Instrument, Repurchased Face Amount							$ 300
Notes Two Point Twenty-Five Percent Due in 2030
Debt And Financing Arrangements [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			3.25%			3.25%
Debt instrument, maturity year			2030
Debt Instrument, Face Amount			$ 1,000
Notes Two Point Seven Percent Due in Twenty Fifty-One
Debt And Financing Arrangements [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			2.70%			2.70%
Debt instrument, maturity year			2051
Debt Instrument, Face Amount			$ 750
Notes Two Point Nine Percent due 2032
Debt And Financing Arrangements [Line Items]
Debt Instrument, Issuance Date		Feb. 28, 2022
Debt Instrument, Interest Rate, Stated Percentage		2.90%
Proceeds from notes recorded as long-term debt		$ 745
Debt Instrument, Face Amount		$ 750
Debt Instrument, Maturity Date		Mar. 01, 2032
Notes Four Point Five Percent Due in 2033
Debt And Financing Arrangements [Line Items]
Debt Instrument, Issuance Date	Apr. 03, 2023
Debt Instrument, Interest Rate, Stated Percentage	4.50%		4.50%			4.50%
Debt instrument, maturity year			2033
Proceeds from notes recorded as long-term debt	$ 493
Debt Instrument, Face Amount	$ 500		$ 500
Debt Instrument, Maturity Date	Aug. 15, 2033
Notes One Point Seventy Five Percent Due In Two Thousand Twenty-Three [Member]
Debt And Financing Arrangements [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			1.75%			1.75%		1.75%
Debt instrument, maturity year			2023
Debt Instrument, Face Amount | €						€ 600
Debt Instrument, Repurchased Face Amount | €								€ 600
Commercial Paper [Member]
Debt And Financing Arrangements [Line Items]
Lines of credit			$ 5,000
Amount utilized from lines of credit facility			5
Accounts Receivable Securitization Facility [Member]
Debt And Financing Arrangements [Line Items]
Lines of credit			3,000
Amount utilized from lines of credit facility			1,600
Foreign Line of Credit
Debt And Financing Arrangements [Line Items]
Lines of credit			$ 750	$ 500

Debt Financing Arrangements (Lo

Debt Financing Arrangements (Long-Term Debt) (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2023 EUR (€)	Aug. 28, 2023	Jun. 23, 2023	Apr. 03, 2023 USD ($)	Dec. 31, 2022 USD ($)	Aug. 26, 2020 USD ($)
Debt Instruments [Line Items]
Long-term Debt	$ 8,260					$ 8,677
Current maturities	(1)					(942)
Total long-term debt	8,259					7,735
Notes One Point Seventy Five Percent Due In Two Thousand Twenty-Three [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 0					641
Debt Instrument, Face Amount | €		€ 600
Debt Instrument, Interest Rate, Stated Percentage	1.75%	1.75%		1.75%
Debt instrument, maturity year	2023
Notes Four Point Five Percent due Two Thousand Forty-Nine [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 589					589
Debt Instrument, Face Amount	$ 600
Debt Instrument, Interest Rate, Stated Percentage	4.50%	4.50%
Debt instrument, maturity year	2049
Notes Two Point Five Percent Due in Two Thousand Twenty-Six [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 998					997
Debt Instrument, Face Amount	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	2.50%	2.50%
Debt instrument, maturity year	2026
Notes One Percent Due in Two Thousand Twenty-Five [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 717					691
Debt Instrument, Face Amount | €		€ 650
Debt Instrument, Interest Rate, Stated Percentage	1%	1%
Debt instrument, maturity year	2025
Notes Three Point Seventy-Five Percent Due in Two Thousand Forty-Seven [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 403					403
Debt Instrument, Face Amount	$ 408
Debt Instrument, Interest Rate, Stated Percentage	3.75%	3.75%
Debt instrument, maturity year	2047
Debentures five point three seven five percent due in two thousand thirty five [Member}
Debt Instruments [Line Items]
Long-term Debt	$ 426					425
Debt Instrument, Face Amount	$ 432
Debt Instrument, Interest Rate, Stated Percentage	5.375%	5.375%
Debt instrument, maturity year	2035
Debentures five point seven six five percent due in two thousand forty one [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 297					297
Debt Instrument, Face Amount	$ 297
Debt Instrument, Interest Rate, Stated Percentage	5.765%	5.765%
Debt instrument, maturity year	2041
Debentures five point nine three five percent due in two thousand thirty two [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 334					334
Debt Instrument, Face Amount	$ 336
Debt Instrument, Interest Rate, Stated Percentage	5.935%	5.935%
Debt instrument, maturity year	2032
Debentures four point zero one six percent due in two thousand forty three [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 263					260
Debt Instrument, Face Amount	$ 371
Debt Instrument, Interest Rate, Stated Percentage	4.016%	4.016%
Debt instrument, maturity year	2043
Debentures four point five three five percent due in two thousand forty two [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 288					286
Debt Instrument, Face Amount	$ 383
Debt Instrument, Interest Rate, Stated Percentage	4.535%	4.535%
Debt instrument, maturity year	2042
Debentures seven percent due in two thousand thirty one [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 159					159
Debt Instrument, Face Amount	$ 160
Debt Instrument, Interest Rate, Stated Percentage	7%	7%
Debt instrument, maturity year	2031
Debentures six point six two five percent due in two thousand twenty nine [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 144					144
Debt Instrument, Face Amount	$ 144
Debt Instrument, Interest Rate, Stated Percentage	6.625%	6.625%
Debt instrument, maturity year	2029
Debentures six point ninety-five due in two thousand ninety seven [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 154					154
Debt Instrument, Face Amount	$ 157
Debt Instrument, Interest Rate, Stated Percentage	6.95%	6.95%
Debt instrument, maturity year	2097
Debentures seven point five percent due in two thousand twenty seven [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 147					147
Debt Instrument, Face Amount	$ 147
Debt Instrument, Interest Rate, Stated Percentage	7.50%	7.50%
Debt instrument, maturity year	2027
Debentures six point forty-five percent due in two thousand thirty eight [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 102					102
Debt Instrument, Face Amount	$ 103
Debt Instrument, Interest Rate, Stated Percentage	6.45%	6.45%
Debt instrument, maturity year	2038
Debentures six point seventy-five percent due in two thousand twenty seven [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 103					103
Debt Instrument, Face Amount	$ 103
Debt Instrument, Interest Rate, Stated Percentage	6.75%	6.75%
Debt instrument, maturity year	2027
Notes Two Point Twenty-Five Percent Due in 2030
Debt Instruments [Line Items]
Long-term Debt	$ 991					989
Debt Instrument, Face Amount	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	3.25%	3.25%
Debt instrument, maturity year	2030
Bonds Zero Percent Due in 2023 [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 0					304
Debt Instrument, Face Amount							$ 300
Debt Instrument, Interest Rate, Stated Percentage			0%				0%
Debt instrument, maturity year	2023
Notes Two Point Seven Percent Due in Twenty Fifty-One
Debt Instruments [Line Items]
Long-term Debt	$ 732					731
Debt Instrument, Face Amount	$ 750
Debt Instrument, Interest Rate, Stated Percentage	2.70%	2.70%
Debt instrument, maturity year	2051
Other [Member]
Debt Instruments [Line Items]
Long-term Debt	$ 177					177
Notes Two Point Nine Percent due in 2032
Debt Instruments [Line Items]
Long-term Debt	744					744
Debt Instrument, Face Amount	$ 750
Debt Instrument, Interest Rate, Stated Percentage	2.90%	2.90%
Debt instrument, maturity year	2032
Notes Four Point Five Percent Due in 2033
Debt Instruments [Line Items]
Long-term Debt	$ 492					$ 0
Debt Instrument, Face Amount	$ 500				$ 500
Debt Instrument, Interest Rate, Stated Percentage	4.50%	4.50%			4.50%
Debt instrument, maturity year	2033

Stock Compensation (Narrative)

Stock Compensation (Narrative) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future grants (in shares)	13,500
Total compensation expense for option grants, Restricted Stock Awards and PSU's	$ 112	$ 147	$ 161
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
The weighted-average remaining contractual term of options outstanding	2 years
The weighted-average remaining contractual term of options exercisable	2 years
The aggregate intrinsic value of options outstanding (in dollars)	$ 59
The aggregate intrinsic value of options exercisable (in dollars)	59
The total intrinsic values of options exercised (in dollars)	20	117	37
Cash proceeds received from options exercised (in dollars)	$ 20	$ 90	$ 64
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Restricted Stock Awards And PSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common shares or units granted as Restricted Stock Awards and PSUs (in shares)	1,663	2,300	2,700
Total unrecognized compensation expense	$ 91
Period during which unrecognized compensation expense is expected to be recognized	3 years
Amount to be recognized as compensation expense year 1	$ 58
Amount to be recognized as compensation expense year 2	30
Amount to be recognized as compensation expense year 3	$ 3
Weighted average grant-date fair value of Restricted Stock Awards and PSU's, Granted (in dollars per share)	$ 78.90	$ 70.13	$ 53.28
Restricted Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Total fair value of Restricted Stock Awards vested during the period	$ 153
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage	33.33%
Performance Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Minimum [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
Maximum [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	5 years

Stock Compensation (Summary Of

Stock Compensation (Summary Of Option Activity During The Period) (Details) shares in Thousands	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Equity [Abstract]
Shares under option at beginning of period | shares	2,097
Shares under option, Exercised | shares	(483)
Shares under option, Forfeited or expired | shares	0
Shares under option at end of period | shares	1,614
Shares under option, Exercisable | shares	1,614
Weighted-average exercise price of Shares under option at beginning of period (in dollars per share) | $ / shares	$ 38.27
Weighted-average exercise price of Shares under option, Exercised (in dollars per share) | $ / shares	42.15
Weighted-average exercise price of Shares under option, Forfeited or expired (in dollars per share) | $ / shares	0
Weighted-average exercise price of Shares under option at end of period (in dollars per share) | $ / shares	37.11
Weighted-average exercise price of Shares under option, Exercisable (in dollars per share) | $ / shares	$ 37.11

Stock Compensation (Summary O_2

Stock Compensation (Summary Of Restricted Stock Awards And PSUs Activity During The Period) (Details) - Restricted Stock Awards And PSUs [Member] - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Restricted Stock Awards and PSU's, Non-vested at beginning of period	6,408
Restricted Stock Awards and PSU's, Granted	1,663	2,300	2,700
Restricted Stock Awards, Vested	(2,559)
Restricted Stock Awards and PSU's, Forfeited	(180)
Restricted Stock Awards and PSU's, Non-vested at end of period	5,332	6,408
Weighted average grant-date fair value of Restricted Stock Awards and PSU's, Non-vested at beginning of period (in dollars per share)	$ 57.22
Weighted average grant-date fair value of Restricted Stock Awards and PSU's, Granted (in dollars per share)	78.90	$ 70.13	$ 53.28
Weighted average grant-date fair value of Restricted Stock Awards and PSU's, Vested (in dollars per share)	45.66
Weighted average grant-date fair value of Restricted Stock Awards and PSU's, Forfeited (in dollars per share)	71.22
Weighted average grant-date fair value of Restricted Stock Awards and PSU's, Non-vested at end of period (in dollars per share)	$ 69.82	$ 57.22

Other (Income) Expense - Net (D

Other (Income) Expense - Net (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Income and Expenses [Abstract]
Gain (Loss) on Disposition of Assets	$ (38)	$ (78)	$ (100)
Pension settlement	0	0	83
Other (income) expense - net	(138)	(280)	(77)
Other Nonoperating Income (Expense)	$ (176)	$ (358)	$ (94)

Other (Income) Expense - Net (N

Other (Income) Expense - Net (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Nonoperating Income Expense [Line Items]
Gain (Loss) on Disposition of Assets	$ 38	$ 78	$ 100
Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component	18	$ 25	$ 16
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]		Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Other (income) expense - net	(138)	$ (280)	$ (77)
Foreign Currency Transaction Gain, before Tax	$ 85	105	24
Carbohydrate Solutions [Member]
Other Nonoperating Income Expense [Line Items]
Gain (Loss) on Disposition of Assets			$ 22
Vantage Corn Processors
Other Nonoperating Income Expense [Line Items]
Other (income) expense - net		(50)
Ag Services and Oilseeds [Member]
Other Nonoperating Income Expense [Line Items]
Other (income) expense - net		$ (110)

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Line Items]
Foreign earnings, as a percentage to total foreign earnings	57%	48%	35%
Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability	$ 85
Effective income tax rate reconciliation, GILTI, Amount	425	$ 684	$ 244
Effective income tax rate reconciliation, FDII, Amount	77	67	$ 87
Tax assets related to net operating loss carry-forwards related to certain international subsidiaries	494	496
Deferred Tax Assets, Valuation Allowance	216	209
Tax assets related to net operating loss carry-forwards related to capital losses	42	42
State tax attributes	25	21
Approximate undistributed earnings of foreign subsidiaries and affiliated corporate joint venture companies accounted for on the equity method	17,900
Accrued interest and penalties on unrecognized tax benefits	52	39
Positive impact on the tax expense if the total amount of unrecognized tax benefits were recognized by the Company at one time	$ 165
Minimum corporate income tax rate	15%
Valuation Allowance, Deferred Tax Asset, Explanation of Change	During 2023, the Company increased valuation allowances primarily related to net operating loss carryforwards.
Foreign [Member]
Income Taxes [Line Items]
Tax assets related to net operating loss carry-forwards related to certain international subsidiaries with no expiration date	$ 412
Tax assets related to net operating loss carry-forwards related to certain international subsidiaries with expiration date	82
Valuation allowance recorded against tax assets related to net operating loss carry-forwards related to certain international subsidiaries	160	142
Tax and Customs Administration, Netherlands [Member]
Income Taxes [Line Items]
Income tax assessment - Tax	90
Additional income tax assessment - Interest and Penalties	34
SEC Schedule, 12-09, Valuation Allowance, Other Tax Carryforward [Member]
Income Taxes [Line Items]
Deferred Tax Assets, Valuation Allowance	42	42
SEC Schedule, 12-09, Valuation Allowance, Operating Loss Carryforward [Member]
Income Taxes [Line Items]
Deferred Tax Assets, Valuation Allowance	$ 14	$ 15

Income Taxes (Earnings Before I

Income Taxes (Earnings Before Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
United States	$ 1,844	$ 2,725	$ 2,140
Foreign	2,450	2,508	1,173
Earnings Before Income Taxes	$ 4,294	$ 5,233	$ 3,313

Income Taxes (Significant Compo

Income Taxes (Significant Components Of Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current
Federal	$ 291	$ 379	$ 404
State	47	97	79
Foreign	513	481	224
Deferred
Federal	(52)	23	(59)
State	(10)	7	(12)
Foreign	39	(119)	(58)
Total Income Taxes	$ 828	$ 868	$ 578

Income Taxes (Significant Com_2

Income Taxes (Significant Components Of Deferred Tax Liabilities And Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Deferred tax liabilities
Property, plant, and equipment	$ 827	$ 811
Deferred Tax Liabilities, Intangible Assets	358	417
Deferred Tax Liabilities, Leasing Arrangements	263	237
Equity in earnings of affiliates	214	191
Deferred Tax Liabilities, Inventory	0	11
Debt exchange	50	52
Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals	49	86
Other	137	108
Deferred Tax Liabilities, Gross	1,898	1,913
Deferred tax assets
Pension and postretirement benefits	111	104
Deferred Tax Assets, Inventory	20	0
Deferred tax assets, leasing arrangements	268	244
Stock compensation	42	51
Foreign tax loss carryforwards	494	496
Capital loss carryforwards	42	42
State tax attributes	25	21
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves	5	22
Other	93	77
Gross deferred tax assets	1,100	1,057
Valuation allowances	(216)	(209)
Net deferred tax assets	884	848
Net deferred tax liabilities	(1,014)	(1,065)
Deferred Tax Liabilities, Net [Abstract]
Net deferred tax assets	884	848
Deferred Tax Liabilities, Gross	1,898	1,913
Deferred Tax Liabilities, Net	1,014	1,065
Domestic Tax Authority [Member]
Deferred tax liabilities
Deferred Tax Liabilities, Gross	1,106	1,183
Deferred Tax Liabilities, Net [Abstract]
Deferred Tax Liabilities, Gross	1,106	1,183
Foreign [Member]
Deferred tax liabilities
Deferred Tax Liabilities, Gross	203	219
Deferred tax assets
Net deferred tax assets	295	337
Deferred Tax Liabilities, Net [Abstract]
Net deferred tax assets	295	337
Deferred Tax Liabilities, Gross	$ 203	$ 219

Income Taxes (Reconciliation Of

Income Taxes (Reconciliation Of The Statutory Federal Income Tax Rate To The Company's Effective Tax Rate On Earnings) (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Statutory rate (as a percent)	21%	21%	21%
State income taxes, net of federal tax benefit (as a percent)	0.90%	1.40%	1.50%
Foreign earnings taxed at rates other than the U.S. statutory rate (as a percent)	(0.20%)	(3.80%)	(2.80%)
Foreign currency remeasurement (as a percent)	0.50%	0.60%	0%
Income tax adjustments to filed returns (as a percent)	(0.40%)	(0.10%)	0.70%
Biodiesel credit (as a percent)	(1.70%)	(1.20%)	(1.90%)
Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent	(1.50%)	(1.20%)	(2.00%)
Effective tax rate reconciliation, U.S. taxation of foreign income, percent	1.20%	0.20%	0%
Valuation allowance (as a percent)	(0.20%)	0%	0.70%
Other (as a percent)	(0.30%)	(0.30%)	0.20%
Effective income tax rate	19.30%	16.60%	17.40%

Income Taxes (Unrecognized Tax

Income Taxes (Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Beginning balance	$ 151	$ 157
Additions related to current years' tax positions	2	6
Additions related to prior years' tax positions	28	26
Unrecognized Tax Benefits, Increase Resulting from Acquisition	0	11
Reductions due to lapse of statue of limitations	(6)	(6)
Settlements with tax authorities	(7)	(43)
Ending balance	$ 168	$ 151

Leases (Narrative) (Details)

Leases (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Operating Leased Assets [Line Items]
Operating Lease, Right-of-Use Asset	$ 1,211	$ 1,088
Operating Lease, Liability, Current	300	292
Operating Lease, Liability, Noncurrent	$ 931	$ 816
Minimum [Member]
Operating Leased Assets [Line Items]
Lessee, Operating Lease, Renewal Term	6 months
Maximum [Member]
Operating Leased Assets [Line Items]
Lessee, Operating Lease, Renewal Term	49 years

Leases Lease Cost (Details)

Leases Lease Cost (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating Lease, Cost	$ 390	$ 356	$ 336
Short-term Lease, Cost	126	127	117
Lease, Cost	516	483	453
Operating Lease, Payments	374	339	325
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 327	$ 357	$ 197
Operating Lease, Weighted Average Remaining Lease Term	7 years	7 years
Operating Lease, Weighted Average Discount Rate, Percent	4.10%	3.70%

Liability Maturity (Details)

Liability Maturity (Details) $ in Millions	Dec. 31, 2023 USD ($)
Leases [Abstract]
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months	$ 334
Lessee, Operating Lease, Liability, Payments, Due Year Two	260
Lessee, Operating Lease, Liability, Payments, Due Year Three	186
Lessee, Operating Lease, Liability, Payments, Due Year Four	146
Lessee, Operating Lease, Liability, Payments, Due Year Five	101
Lessee, Operating Lease, Liability, Payments, Due after Year Five	339
Lessee, Operating Lease, Liability, Payments, Due	1,366
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(135)
Operating Lease, Liability	$ 1,231

Employee Benefit Plans (Narrati

Employee Benefit Plans (Narrative) (Details) shares in Millions, $ in Millions		12 Months Ended
	Apr. 01, 2021 USD ($) retirees	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of retirees | retirees	6,000
Pension settlement		$ 0	$ 0	$ (83)
Percentage of non-matching employer's contribution to eligible participants (as a percent)		1%
Employer's Common stock held under 401 (k) plan (in shares) | shares		5.7
Market value of employer's Common stock held under 401 (k) plan		$ 414
Cash dividend received on employer's Common stock held under 401 (k) plan		10
Increase (Decrease) in Obligation, Pension Benefits	$ 700
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Pension settlement		0	0	(83)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment		0	2	0
Accumulated other comprehensive income, unrecognized prior service cost (credit)		(56)
Accumulated other comprehensive income, unrecognized actuarial losses		272
Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets, Aggregate Projected Benefit obligation		1,500	1,300
Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation		1,500	1,200
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation		1,500	1,300
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets		1,000	900
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation		1,500	1,200
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets		1,000	800
Accumulated benefit obligation		1,800	1,600
Contributions and expected future benefit payments		$ 27
Pension Benefits [Member] | Minimum [Member]
Defined Benefit Plan Disclosure [Line Items]
Amortization period of actuarial gains and losses		4 years
Pension Benefits [Member] | Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Amortization period of actuarial gains and losses		27 years
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Pension settlement		$ 0	0	0
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment		0	$ 0	$ 0
Accumulated other comprehensive income, unrecognized prior service cost (credit)		1
Accumulated other comprehensive income, unrecognized actuarial losses		$ 20
Annual rate of increase in per capita cost of covered health care benefits assumed for transition period (as a percent)		6.90%
Annual rate for per capita cost of covered health care benefits assumed for 2025 and thereafter (as a percent)		4.50%
Year ultimate rate assumed for per capita cost of health care benefits is to be reached		2031
Contributions and expected future benefit payments		$ 14
Other Postretirement Benefits Plan [Member] | Minimum [Member]
Defined Benefit Plan Disclosure [Line Items]
Amortization period of actuarial gains and losses		5 years
Other Postretirement Benefits Plan [Member] | Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Amortization period of actuarial gains and losses		18 years

Employee Benefit Plans (Retirem

Employee Benefit Plans (Retirement Plan Expense) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Settlement charges	$ 0	$ 0	$ 83
Defined contribution plans	73	67	61
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost (benefits earned during the period)	$ 41	$ 48	$ 64
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Interest cost	$ 76	$ 48	$ 48
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Expected return on plan assets	$ (83)	$ (79)	$ (95)
Settlement charges	0	0	83
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment	$ 0	$ (2)	$ 0
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Amortization of actuarial loss	$ 3	$ 17	$ 33
Defined Benefit Plan, Amortization of Prior Service Cost (Credit)	(20)	(20)	(20)
Net periodic defined benefit plan expense	17	12	113
Pension Expense	90	79	174
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost (benefits earned during the period)	$ 0	$ 1	$ 1
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Interest cost	$ 6	$ 3	$ 2
Settlement charges	0	0	0
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment	$ 0	$ 0	$ 0
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Amortization of actuarial loss	$ 2	$ 5	$ 6
Defined Benefit Plan, Amortization of Prior Service Cost (Credit)	0	0	(2)
Net periodic defined benefit plan expense	8	9	7
Pension Expense	$ 8	$ 9	$ 7

Employee Benefit Plans (Changes

Employee Benefit Plans (Changes In Defined Benefit Obligation And Fair Value Of Defined Benefit Plan Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, beginning	$ 1,269
Fair value of plan assets, ending	1,415	$ 1,269
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Benefit obligation, beginning	1,587	2,178
Service cost	41	48	$ 64
Interest cost	76	48	48
Actuarial loss (gain)	83	(575)
Employee contributions	3	3
Curtailments	0	(2)
Settlements	(1)	(1)
Defined Benefit Plan, Benefit Obligation, Business Combination	(1)	0
Benefits paid	(53)	(47)
Foreign currency effects	30	(65)
Benefit obligation, ending	1,765	1,587	2,178
Fair value of plan assets, beginning	1,269	1,742
Actual return on plan assets	121	(438)
Employer contributions	54	60
Employee contributions	3	3
Settlements	(1)	(1)
Benefits Paid	(53)	(47)
Foreign currency effects	22	(50)
Fair value of plan assets, ending	1,415	1,269	1,742
Funded status	(350)	(318)
Prepaid benefit cost	63	60
Accrued benefit liability - current	(19)	(18)
Accrued benefit liability - long-term	(394)	(360)
Net amount recognized in the balance sheet	(350)	(318)
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Benefit obligation, beginning	118	154
Service cost	0	1	1
Interest cost	6	3	2
Actuarial loss (gain)	6	(24)
Curtailments	0	0
Settlements	0	0
Defined Benefit Plan, Benefit Obligation, Business Combination	0	0
Benefits paid	(17)	(16)
Foreign currency effects	0	0
Benefit obligation, ending	113	118	$ 154
Fair value of plan assets, beginning	0
Employer contributions	17	16
Benefits Paid	(17)	(16)
Fair value of plan assets, ending	0	0
Funded status	(113)	(118)
Accrued benefit liability - current	(14)	(14)
Accrued benefit liability - long-term	(99)	(104)
Net amount recognized in the balance sheet	$ (113)	$ (118)

Employee Benefit Plans (Princip

Employee Benefit Plans (Principal Assumptions In Developing Net Periodic Pension Cost) (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate	3.90%	1.90%
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate (as a percent)	4.80%	2.50%
Expected return on plan assets (as a percent)	6%	5%
Rate of compensation increase (as a percent)	4.30%	4.20%
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate (as a percent)	5.10%	2.70%

Employee Benefit Plans (Princ_2

Employee Benefit Plans (Principal Assumptions In Developing Year-End Actuarial Present Value Of The Projected Benefit Obligation) (Details)	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate	4%	3.90%
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate (as a percent)	4.50%	4.80%
Rate of compensation increase (as a percent)	4.80%	4.30%
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rate (as a percent)	4.90%	5.10%

Employee Benefit Plans (Schedul

Employee Benefit Plans (Schedule Of Fair Value Of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 1,415	$ 1,269
Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	37	68
Equity Securities [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	37	68
Mutual Fund [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	147	245
Mutual Fund [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	147	245
Common collective trust funds - International equity [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	60	76
Common collective trust funds - U.S. equity [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	15	23
Debt instruments - Corporate bonds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	473	318
Debt instruments - Corporate bonds [Member] | Significant Other Observable Inputs (Level 2) [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	473	318
Debt instruments - U.S. Treasury instruments [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	262	173
Debt instruments - U.S. Treasury instruments [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	262	173
Debt instruments - U.S. government agency, state and local government bonds [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8	5
Debt instruments - U.S. government agency, state and local government bonds [Member] | Significant Other Observable Inputs (Level 2) [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8	5
Other Debt Instruments [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7	9
Other Debt Instruments [Member] | Significant Other Observable Inputs (Level 2) [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7	9
Common Collective Trust - Fixed Income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	330	247
Common Collective Trust - Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	76	105
Fair Value, Recurring [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	934	818
Fair Value, Recurring [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	446	486
Fair Value, Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 488	$ 332

Employee Benefit Plans (Actual

Employee Benefit Plans (Actual Asset Allocation For Global Pension Plan Assets) (Details) - Pension Benefits [Member]	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	100%	100%
Percentage of U.S. pension plan to global pension plan assets (as a percent)	67%
Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	19%	33%
Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	77%	62%
Other Pension Plan Assets [Member]
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	4%	5%
UNITED STATES | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	20%
UNITED STATES | Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	80%
Foreign Plan [Member] | Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	17%
Foreign Plan [Member] | Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	71%
Foreign Plan [Member] | Other Pension Plan Assets [Member]
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	12%

Employee Benefit Plans (Expecte

Employee Benefit Plans (Expected Future Benefit Payments To Be Paid) (Details) $ in Millions	Dec. 31, 2023 USD ($)
Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months	$ 69
Defined Benefit Plan, Expected Future Benefit Payment, Year Two	75
Defined Benefit Plan, Expected Future Benefit Payment, Year Three	82
Defined Benefit Plan, Expected Future Benefit Payment, Year Four	88
Defined Benefit Plan, Expected Future Benefit Payment, Year Five	94
Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter	559
Other Postretirement Benefits Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months	14
Defined Benefit Plan, Expected Future Benefit Payment, Year Two	13
Defined Benefit Plan, Expected Future Benefit Payment, Year Three	11
Defined Benefit Plan, Expected Future Benefit Payment, Year Four	11
Defined Benefit Plan, Expected Future Benefit Payment, Year Five	10
Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter	$ 41

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Accumulated other comprehensive income (loss)
Balance of Accumulated Other Comprehensive Income (Loss) at beginning of period	$ (2,509)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	(2,487)	$ (2,509)
Treasury Stock, Value	2,700	1,700
Foreign Currency Translation Adjustment [Member]
Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Reclassifications, before Tax	204	(609)
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax	(153)	328
Accumulated other comprehensive income (loss)
Balance of Accumulated Other Comprehensive Income (Loss) at beginning of period	(2,622)	(2,248)
Net realized gains (losses)	0	0
Other Comprehensive Income (Loss), Tax	32	(93)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	83	(374)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	(2,539)	(2,622)
Deferred Gain (Loss) On Hedging Activities [Member]
Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Reclassifications, before Tax	337	268
Accumulated other comprehensive income (loss)
Balance of Accumulated Other Comprehensive Income (Loss) at beginning of period	148	225
Net realized gains (losses)	(322)	(352)
Other Comprehensive Income (Loss), Tax	(5)	7
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	10	(77)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	158	148
Pension Liability Adjustment [Member]
Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(46)	117
Accumulated other comprehensive income (loss)
Balance of Accumulated Other Comprehensive Income (Loss) at beginning of period	(22)	(147)
Net realized gains (losses)	(42)	23
Other Comprehensive Income (Loss), Tax	2	(15)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(86)	125
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	(108)	(22)
Unrealized Gain (Loss) On Investments [Member]
Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Reclassifications, before Tax	16	(12)
Accumulated other comprehensive income (loss)
Balance of Accumulated Other Comprehensive Income (Loss) at beginning of period	(13)	(2)
Net realized gains (losses)	0	0
Other Comprehensive Income (Loss), Tax	(1)	1
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	15	(11)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	2	(13)
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), before Reclassifications, before Tax	511	(236)
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax	(153)	328
Accumulated other comprehensive income (loss)
Balance of Accumulated Other Comprehensive Income (Loss) at beginning of period	(2,509)	(2,172)
Net realized gains (losses)	(364)	(329)
Other Comprehensive Income (Loss), Tax	28	(100)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	22	(337)
Balance of Accumulated Other Comprehensive Income (Loss) at End of period	$ (2,487)	$ (2,509)

Shareholders' Equity Narrative

Shareholders' Equity Narrative (Details) - USD ($) $ / shares in Units, $ in Billions	Dec. 31, 2023	Dec. 31, 2022
Preferred Stock, No Par Value	$ 0
Common Stock, Shares Authorized	1,000,000,000
Preferred Stock, Shares Authorized	500,000
Common Stock, No Par Value	$ 0
Preferred Stock, Shares Issued	0
Treasury Stock, Common, Shares	202,500,000	169,000,000
Treasury Stock, Value	$ 2.7	$ 1.7
Common Stock [Member]
Treasury Stock, Value	$ 4.9	$ 4.9

Shareholders' Equity Reclassifi

Shareholders' Equity Reclassification Components (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income [Line Items]
Revenues	$ (22,978)	$ (21,695)	$ (25,190)	$ (24,072)	$ (25,939)	$ (24,683)	$ (27,284)	$ (23,650)	$ (93,935)	$ (101,556)	$ (85,249)
Cost of products sold									86,422	93,986	79,262
Other Nonoperating Income (Expense)									176	358	94
Interest Expense									647	396	265
Restructuring, Settlement and Impairment Provisions									342	66	164
Loss (Earnings) before Income Taxes									(4,294)	(5,233)	(3,313)
Income Tax Expense (Benefit)									828	868	578
Net Loss (Earnings) Including Noncontrolling Interests									(3,466)	(4,365)	(2,735)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income [Line Items]
Loss (Earnings) before Income Taxes									(42)	23	99
Income Tax Expense (Benefit)									(10)	(4)	(26)
Net Loss (Earnings) Including Noncontrolling Interests									(52)	19	73
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income [Line Items]
Revenues									0	(1)	16
Cost of products sold									(322)	(351)	(490)
Loss (Earnings) before Income Taxes									(322)	(352)	(474)
Income Tax Expense (Benefit)									77	62	118
Net Loss (Earnings) Including Noncontrolling Interests									(245)	(290)	(356)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent
Accumulated Other Comprehensive Income [Line Items]
Other Nonoperating Income (Expense)									26	119	77
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent
Accumulated Other Comprehensive Income [Line Items]
Other Nonoperating Income (Expense)									$ 16	$ (142)	$ (176)

Segment Information (Narrative)

Segment Information (Narrative) (Details)	12 Months Ended
	Dec. 31, 2023 segment
Segment Reporting [Abstract]
Number of Reportable Segments	3

Segment and Geographic Inform_3

Segment and Geographic Information (Segment Information) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Information
Revenues	$ 22,978	$ 21,695	$ 25,190	$ 24,072	$ 25,939	$ 24,683	$ 27,284	$ 23,650	$ 93,935	$ 101,556	$ 85,249
Depreciation									825	794	807
Asset Abandonments and Impairments									108	35	73
Interest income									499	293	96
Equity in earnings of affiliates									551	832	595
Operating profit									4,294	5,233	3,313
Investments in and advances to affiliates	5,500				5,467				5,500	5,467
Assets	54,631				59,774				54,631	59,774
Segment, Expenditure, Addition to Long-Lived Assets									1,383	1,211
Restructuring, Settlement and Impairment Provisions									(342)	(66)	(164)
Operating Segments [Member]
Segment Information
Operating profit									5,900	6,549	4,638
Intersegment Eliminations [Member]
Segment Information
Revenues									(4,354)	(4,685)	(3,772)
Corporate, Non-Segment [Member]
Segment Information
Depreciation									29	24	27
Interest income									(36)	54	52
Equity in earnings of affiliates									(5)	1	1
Operating profit									(1,606)	(1,316)	(1,325)
Investments in and advances to affiliates	87				128				87	128
Assets	3,782				3,132				3,782	3,132
Segment, Expenditure, Addition to Long-Lived Assets									37	53
Segment Reconciling Items [Member]
Segment Information
Gain (Loss) on Disposition of Other Assets									17	47	77
Restructuring, Settlement and Impairment Provisions									(361)	(147)	(213)
Ag Services and Oilseeds [Member]
Segment Information
Revenues									73,426	79,563	67,047
Ag Services and Oilseeds [Member] | Ag Services [Member]
Segment Information
Revenues									47,420	53,181	45,017
Ag Services and Oilseeds [Member] | Crushing [Member]
Segment Information
Revenues									14,020	13,139	11,368
Ag Services and Oilseeds [Member] | Refined Products and Other [Member]
Segment Information
Revenues									11,986	13,243	10,662
Ag Services and Oilseeds [Member] | Operating Segments [Member]
Segment Information
Revenues									76,012	82,122	69,364
Depreciation									350	334	349
Asset Abandonments and Impairments									11	0	10
Interest income									54	52	27
Equity in earnings of affiliates									459	714	500
Operating profit									4,067	4,401	2,799
Investments in and advances to affiliates	4,888				4,863				4,888	4,863
Assets	25,473				28,657				25,473	28,657
Segment, Expenditure, Addition to Long-Lived Assets									732	568
Ag Services and Oilseeds [Member] | Operating Segments [Member] | Revised for Transfer Price Adjustment
Segment Information
Revenues									77,458	83,701	70,479
Operating profit										4,401	2,799
Ag Services and Oilseeds [Member] | Operating Segments [Member] | Previously Reported
Segment Information
Revenues									77,457	83,686	70,455
Operating profit									4,066	4,386	2,775
Ag Services and Oilseeds [Member] | Operating Segments [Member] | Revision of Prior Period, Error Correction, Adjustment
Segment Information
Revenues									1	15	24
Operating profit									1	15	24
Ag Services and Oilseeds [Member] | Operating Segments [Member] | Revision of Prior Period, Reclassification, Adjustment
Segment Information
Revenues									(1,446)	(1,579)	(1,115)
Ag Services and Oilseeds [Member] | Intersegment Eliminations [Member]
Segment Information
Revenues									(2,586)	(2,559)	(2,317)
Ag Services and Oilseeds [Member] | Intersegment Eliminations [Member] | Revised for Transfer Price Adjustment
Segment Information
Revenues									(4,032)	(4,138)	(3,432)
Ag Services and Oilseeds [Member] | Intersegment Eliminations [Member] | Previously Reported
Segment Information
Revenues									(4,031)	(4,123)	(3,408)
Ag Services and Oilseeds [Member] | Intersegment Eliminations [Member] | Revision of Prior Period, Error Correction, Adjustment
Segment Information
Revenues									(1)	(15)	(24)
Ag Services and Oilseeds [Member] | Intersegment Eliminations [Member] | Revision of Prior Period, Reclassification, Adjustment
Segment Information
Revenues									1,446	1,579	1,115
Carbohydrate Solutions [Member]
Segment Information
Revenues									12,874	13,961	11,110
Carbohydrate Solutions [Member] | Starches and sweeteners [Member]
Segment Information
Revenues									9,885	10,251	7,611
Carbohydrate Solutions [Member] | Vantage Corn Processors
Segment Information
Revenues									2,989	3,710	3,499
Carbohydrate Solutions [Member] | Operating Segments [Member]
Segment Information
Revenues									14,528	15,902	12,412
Depreciation									304	307	322
Asset Abandonments and Impairments									32	14	13
Equity in earnings of affiliates									76	94	70
Operating profit									1,375	1,413	1,318
Investments in and advances to affiliates	380				365				380	365
Assets	6,334				6,801				6,334	6,801
Segment, Expenditure, Addition to Long-Lived Assets									351	261
Carbohydrate Solutions [Member] | Operating Segments [Member] | Revised for Transfer Price Adjustment
Segment Information
Revenues									14,539	16,389	12,707
Operating profit										1,413	1,318
Carbohydrate Solutions [Member] | Operating Segments [Member] | Previously Reported
Segment Information
Revenues									14,509	16,336	12,672
Operating profit									1,345	1,360	1,283
Carbohydrate Solutions [Member] | Operating Segments [Member] | Revision of Prior Period, Error Correction, Adjustment
Segment Information
Revenues									30	53	35
Operating profit									30	53	35
Carbohydrate Solutions [Member] | Operating Segments [Member] | Revision of Prior Period, Reclassification, Adjustment
Segment Information
Revenues									(11)	(487)	(295)
Carbohydrate Solutions [Member] | Intersegment Eliminations [Member]
Segment Information
Revenues									(1,654)	(1,941)	(1,302)
Carbohydrate Solutions [Member] | Intersegment Eliminations [Member] | Revised for Transfer Price Adjustment
Segment Information
Revenues									(1,665)	2,428	1,597
Carbohydrate Solutions [Member] | Intersegment Eliminations [Member] | Previously Reported
Segment Information
Revenues									(1,635)	(2,375)	(1,562)
Carbohydrate Solutions [Member] | Intersegment Eliminations [Member] | Revision of Prior Period, Error Correction, Adjustment
Segment Information
Revenues									(30)	(53)	(35)
Carbohydrate Solutions [Member] | Intersegment Eliminations [Member] | Revision of Prior Period, Reclassification, Adjustment
Segment Information
Revenues									11	487	295
Nutrition [Member]
Segment Information
Revenues									7,211	7,636	6,712
Nutrition [Member] | Human Nutrition
Segment Information
Revenues									3,634	3,769	3,189
Nutrition [Member] | Animal Nutrition [Member]
Segment Information
Revenues									3,577	3,867	3,523
Nutrition [Member] | Operating Segments [Member]
Segment Information
Revenues									7,325	7,821	6,865
Depreciation									132	120	101
Asset Abandonments and Impairments									65	21	50
Interest income									(18)	2	1
Equity in earnings of affiliates									21	23	24
Operating profit									427	668	632
Investments in and advances to affiliates	145				111				145	111
Assets	10,341				10,615				10,341	10,615
Segment, Expenditure, Addition to Long-Lived Assets									262	314
Nutrition [Member] | Operating Segments [Member] | Revised for Transfer Price Adjustment
Segment Information
Operating profit										668	632
Nutrition [Member] | Operating Segments [Member] | Previously Reported
Segment Information
Revenues									7,466	7,836	6,933
Operating profit									458	736	691
Nutrition [Member] | Operating Segments [Member] | Revision of Prior Period, Error Correction, Adjustment
Segment Information
Operating profit									(31)	(68)	(59)
Nutrition [Member] | Operating Segments [Member] | Revision of Prior Period, Reclassification, Adjustment
Segment Information
Revenues									(141)	(15)	(68)
Nutrition [Member] | Intersegment Eliminations [Member]
Segment Information
Revenues									(114)	(185)	(153)
Nutrition [Member] | Intersegment Eliminations [Member] | Previously Reported
Segment Information
Revenues									(255)	(200)	(221)
Nutrition [Member] | Intersegment Eliminations [Member] | Revision of Prior Period, Reclassification, Adjustment
Segment Information
Revenues									141	15	68
Other Segments [Member]
Segment Information
Revenues									424	396	380
Other Segments [Member] | Operating Segments [Member]
Segment Information
Revenues									424	396	380
Depreciation									10	9	8
Interest income									499	185	16
Operating profit									375	167	$ 25
Assets	$ 8,701				$ 10,569				8,701	10,569
Segment, Expenditure, Addition to Long-Lived Assets									$ 1	$ 15

Segment And Geographic Inform_4

Segment And Geographic Information (Geographic Information) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Information
Revenues	$ 22,978	$ 21,695	$ 25,190	$ 24,072	$ 25,939	$ 24,683	$ 27,284	$ 23,650	$ 93,935	$ 101,556	$ 85,249
Long-Lived Assets	10,508				9,933				10,508	9,933
UNITED STATES
Segment Information
Revenues									38,783	43,272	35,396
Long-Lived Assets	6,660				6,322				6,660	6,322
Switzerland [Member]
Segment Information
Revenues									19,898	21,821	18,453
CAYMAN ISLANDS
Segment Information
Revenues									7,646	5,883	5,515
BRAZIL
Segment Information
Revenues									3,361	4,004	3,213
Long-Lived Assets	874				801				874	801
MEXICO
Segment Information
Revenues									3,185	3,709	2,934
CANADA
Segment Information
Revenues									2,400	2,272	1,818
UNITED KINGDOM
Segment Information
Revenues									2,219	2,231	1,848
Other Foreign [Member]
Segment Information
Revenues									16,443	18,364	$ 16,072
Long-Lived Assets	$ 2,974				$ 2,810				$ 2,974	$ 2,810

Asset Impairment, Exit, and R_3

Asset Impairment, Exit, and Restructuring Costs (Asset Impairment Charges And Exit Costs) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Restructuring, Settlement and Impairment Provisions [Abstract]
Restructuring Charges	$ 33	$ 29	$ 39
Goodwill and Intangible Asset Impairment	201	2	52
Other Asset Impairment Charges	108	35	73
Restructuring, Settlement and Impairment Provisions	$ 342	$ 66	$ 164

Asset Impairment, Exit, and R_4

Asset Impairment, Exit, and Restructuring Costs (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Asset Impairment Charges And Exit Costs [Line Items]
Restructuring Charges	$ 33	$ 29	$ 39
Other Asset Impairment Charges	108	35	73
Goodwill and Intangible Asset Impairment	201	2	52
Goodwill, Impairment Loss	137
Corporate [Member]
Asset Impairment Charges And Exit Costs [Line Items]
Restructuring Charges	6	1	4
Ag Services and Oilseeds [Member]
Asset Impairment Charges And Exit Costs [Line Items]
Other Asset Impairment Charges	10		10
Goodwill, Impairment Loss			5
Impairment of Intangible Assets, Finite-lived			$ 42
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]			Restructuring, Settlement and Impairment Provisions
Carbohydrate Solutions [Member]
Asset Impairment Charges And Exit Costs [Line Items]
Other Asset Impairment Charges	33	15	$ 13
Nutrition [Member]
Asset Impairment Charges And Exit Costs [Line Items]
Other Asset Impairment Charges	65	20	50
Goodwill, Impairment Loss			1
Impairment of Intangible Assets, Finite-lived	64	2	$ 4
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]			Restructuring, Settlement and Impairment Provisions
All Reportable Segments [Member]
Asset Impairment Charges And Exit Costs [Line Items]
Restructuring Charges	$ 27	$ 28	$ 35

Sale of Accounts Receivable (Na

Sale of Accounts Receivable (Narrative) (Details) $ in Millions, € in Billions	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2023 EUR (€)
Sale of Accounts Receivable [Line Items]
Proceeds from the collection of receivables sold	$ 53,600	$ 56,900	$ 47,300
Loss on transfer of accounts receivables to purchasers	56	21	11
Lines of credit	13,200
Transfer of Financial Assets Accounted for as Sales, Amount Derecognized	1,600	2,600
Amount of receivables sold	54,800	59,000	$ 50,300
Accounts Receivable, after Allowance for Credit Loss, Current	4,232	4,926
Asset Pledged as Collateral without Right
Sale of Accounts Receivable [Line Items]
Accounts Receivable, after Allowance for Credit Loss, Current	1,100	$ 600
Accounts Receivable Securitization Facility [Member]
Sale of Accounts Receivable [Line Items]
Lines of credit	3,000
Program [Member] | Accounts Receivable Securitization Facility [Member]
Sale of Accounts Receivable [Line Items]
Lines of credit	1,900
Second Program [Member] | Accounts Receivable Securitization Facility [Member]
Sale of Accounts Receivable [Line Items]
Lines of credit	$ 1,100			€ 1

Legal Proceedings, Guarantees_2

Legal Proceedings, Guarantees, and Commitments (Details) - AOT and Maize $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)
Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	$ 500
Maximum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	$ 2,000

Quarterly Financial Data (Detai

Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Quarterly Financial Information Disclosure [Abstract]
Revenues	$ 22,978	$ 21,695	$ 25,190	$ 24,072	$ 25,939	$ 24,683	$ 27,284	$ 23,650	$ 93,935	$ 101,556	$ 85,249
Gross Profit	1,740	1,810	1,883	2,080	1,762	1,811	2,100	1,897	7,513	7,570	5,987
Net Income (Loss) Attributable to Parent	$ 565	$ 821	$ 927	$ 1,170	$ 1,019	$ 1,031	$ 1,236	$ 1,054	$ 3,483	$ 4,340	$ 2,709
Basic earnings per common share (dollars per share)	$ 1.07	$ 1.52	$ 1.70	$ 2.13	$ 1.84	$ 1.84	$ 2.18	$ 1.86	$ 6.44	$ 7.72	$ 4.80
Diluted earnings per common share (dollars per share)	$ 1.06	$ 1.52	$ 1.70	$ 2.12	$ 1.84	$ 1.83	$ 2.18	$ 1.86	$ 6.43	$ 7.71	$ 4.79

Quarterly Financial Data (Narra

Quarterly Financial Data (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]
Impairment and restructuring, after tax	$ 158
Impairment and restructuring per share, after tax	$ 0.30
Gain (loss) on sale/revaluation of assets after tax	$ (5)	$ 2	$ (8)	$ (13)	$ (22)
Gain (loss) on sale of assets, after tax, per share	$ 0	$ 0	$ (0.02)	$ (0.02)	$ (0.04)
Gain (loss) on embedded derivative			$ (1)	$ 3	$ (8)
Gain (loss) on embedded derivative, per share			$ 0	$ 0	$ (0.01)
Tax expense (benefit) related to certain out of period discretes	$ 1		$ 21	$ 5	$ 7
Tax expense (benefit) related to certain out of period discretes per share	$ 0		$ 0.04	$ 0.01	$ 0.01
Impairment, settlement, and restructuring, after tax		$ 54	$ 93	$ 55	$ 40
Impairment, settlement, and restructuring per share, after tax		$ 0.10	$ 0.17	$ 0.10	$ 0.07
Acquisition-related expenses, after-tax	$ 1	$ 3	$ 2
Acquisition-related expenses, per share	$ 0	$ 0.01	$ 0

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Millions	1 Months Ended		12 Months Ended
	Feb. 29, 2024	Jan. 31, 2024	Dec. 31, 2021
Subsequent Event [Line Items]
Payments to Acquire Businesses, Gross			$ 1,600
Subsequent Event [Member] | Revela Foods
Subsequent Event [Line Items]
Payments to Acquire Businesses, Gross		$ 656
Subsequent Event [Member] | FDL
Subsequent Event [Line Items]
Payments to Acquire Businesses, Gross		$ 232
Subsequent Event [Member] | PT Trouw
Subsequent Event [Line Items]
Payments to Acquire Businesses, Gross	$ 18

Valuation And Qualifying Acco_2

Valuation And Qualifying Accounts And Reserves (Schedule Of Valuation And Qualifying Accounts) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-09, Allowance, Credit Loss
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Balance at Beginning of Year	$ 199	$ 122	$ 100
Additions	6	88	32
Deductions	(28)	(12)	(28)
Balance at End of Year	215	199	122
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount	215	199	122
Additions	6	88	32
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction	28	12	28
SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment	38	1	18
SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment	38	1	18
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Balance at Beginning of Year	209	281	339
Additions	58	18	7
Deductions	(51)	(90)	(65)
Balance at End of Year	216	209	281
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount	216	209	281
Additions	58	18	7
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction	51	90	65
SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment	0	0	0
SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment	$ 0	$ 0	$ 0